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i
The effect of DNA methylation on transcription from the SV40 early promoter 
was studied. The plasmid pVHCI containing the SV40 promoter in the early direction 
linked to the chloramphenicol acetyltransferase (CAT) gene was methylated in vitro with 
mouse Krebs II ascites cell DNA methylase. This resulted in methylation of 10-25% of 
CpG dinucleotides. Comparison of this DNA with unmethylated plasmid in a transient 
expression assay indicated a 30-40% inhibition of CAT expression by methylation. At this 
level of methylation an average of only 1 to 2 of the CpGs contained within the promoter 
region will be methylated and the enhancer sequence which does not contain any CpG 
dinucleotides will remain unmodified. Therefore it is unlikely that this effect is caused by 
the direct inhibition of transcription factor binding, it is most likely due to the formation 
of inactive chromatin structures induced by the presence of methyl groups throughout the 
plasmid. This theory is supported by the observation that binding of the transcription 
factor Sp1 to GC box motifs is unaffected by methylation. In experiments where mouse 
cells were cotransfected with pVHCI and oligonucleotides containing methylated or 
unmethylated GC boxes, the level of CAT expression was greatly reduced regardless of the 
methylation state of the GC box, indicating that methylation had no effect on Sp1 binding. 
Similarly in gel retardation assays, methylated and unmethylated GC box-containing 
oligonucleotides competed equally well with a labelled restriction fragment containing the 
SV40 promoter for Sp1 binding. These findings indicate that the SV40 promoter is 
methylation sensitive in a methylcytosine rich environment where these residues are most 
likely acting in an indirect manner, causing the formation of inactive chromatin and hence 
limiting transcription.
Chapter 1. Introduction
21.1. The Presence of 5-Methylcytosine in DNA
1.1.1 5-Methylcytosine Distribution
The presence of the modified bases 5-methylcytosine (m5C) and 
N6-methyladenine (m6A)(fig. 1.1) in DNA was first observed by Wyatt (1951).
Prokaryotes contain both modified bases and in some cases N4-methylcytosine (m4C), the 
product of the Ben I methylase reaction, also (Janulaitis et a!., 1984). Lower eukaryotes 
often contain both m5C and m6A, whereas higher eukaryotes contain only m5C. The content 
of this base in eukaryotic DNA varies greatly with species. Lower eukaryotes such as yeast 
and nematodes contain negligible levels. This is also true of insects, for example, less than 
0.02% of cytosines are methylated in Drosophila (Pollack etal., 1984). In higher 
eukaryotes, such as mammals, approximately 4-7% of cytosines are methylated | whereas I 
some plants contain up to 30% of methylated cytosines.
\  /
,CH
5-methylcytosine N6-methyladenine
Figure 1.1. 5-methylcytosine and N6-methyladenine
The m5C content of viral DNA is very variable. Despite their host cell 
genomes containing demonstrable levels of m5C, the DNAs of herpes saimiri virus 
(Desrosiers e t a l 1979), adenoviruses (Vardimon etal.,1980; Gunthert e ta l., 1976 ), 
polyoma virus (Kaye and Winocour,1967) and simian virus 40 (Ford eta l.,1980) have
3no detectable m5C. However, there are exceptions, Willis and Granoff (1980) observed 
that 20% of cytosine residues in frog virus 3 were methylated and Diala and Hoffman 
(1983) found that 14.5% were methylated in Epstein-Barr virus. In contrast to the 
majority of these animal viruses,|many,types of bacteriophage have m5C or m6A in their 
genomes at levels comparable to that of their bacterial host chromosomes. It has been 
shown (Desrosiers e ta l. ,1979, Vardimon etal., 1980) that the DNA of viruses infecting 
cells may be extensively methylated, for example when viral episomes are formed or when 
viral DNA is integrated into the host chromosome. This methylation is associated with 
relatively low levels of transcription from the viral genome or with the production of little 
or no virus.
Interest in the possible role of methylcytosine was initiated when Chargaff 
et al .,(1953,1955) observed that the distribution of m5C residues in calf 
thymus DNA was non random, implying some functional significance. In mammalian DNA 
m5C residues exist almost exclusively (>90%) in the dinucleotide CpG. Plants however 
also contain m5C in the sequence CpNpG, where N is any nucleotide. On the entire genome 
level, the extent of CpG methylation varies from tissue to tissue. Somatic tissues are 
relatively highly methylated, whereas extra embryonic tissues appear to be 
hypomethylated. For example, in mouse spleen cells 82% of CpGs are methylated 
compared with 49% in placental DNA. However, at the gene level, most tissue specific 
genes are highly methylated in embryonic tissue and unmethylated in somatic cells.
Satellite DNA is heavily methylated, the extent of methylation may be determined by the 
frequency of CpG sequences. Whereas in unique sequences the pattern of methylation 
varies from one tissue to another.
41.1.2 Detection of 5-Methylcytosine
There are several methods available for the identification and quantification 
of m5C in DNA including chromatographic methods (Adams and Burdon, 1983), high 
resolution mass spectrometry (Razin and Cedar, 1977) and high performance liquid 
chromatography (Ford et aI .,1980). In addition specific antibodies against m5C have been 
used to detect the presence of the base in intact chromosomes (Schreck eta l.,1977).
Much information regarding the methylation patterns of specific genes has been obtained by 
the use of bacterial restriction endonucleases. For example the isochizomers Hpa II and 
Msp I, both recognise the sequence CCGG, however the former will cleave the DNA only if 
the inner C residue is unmethylated. Waalwyk and Flavell (1978), developed an 
experiment whereby genomic DNA is cleaved by either of the enzymes, the DNA fragments 
are then separated according to size by agarose gel electrophoresis and transferred by 
blotting to nitrocellulose (Southern, 1975). The DNA fragments in or near the gene of 
interest are then visualised by hybridisation with a labelled probe. A comparison of the 
bands observed for the Hpa II digestion with those observed for the Msp I digested DNA 
shows the location of the methylated CCGG sites.
However detection of methylcytosines is limited to those contained within 
methylsensitive restriction enzyme sites. This limitation has been overcome by a method 
introduced by Church and Gilbert (1984) and recently updated by Saluz and Jost (1989), 
known as genomic sequencing. This technique is based on the observation that m5C 
residues could be detected in DNA by chemical sequencing (Maxam and Gilbert,1980).
The presence of a CH3 group in the pyrimidine ring of cytosine interferes with its reaction
with hydrazine and results in a gap in the sequencing ladder. Based on this principle,
5genomic sequencing enables the study of the methylation state of any gene in a strand and 
sequence -specific manner. This approach was used by Saluz et al .(1986) to study the in 
vitro methylation pattern of two CpG sites in the promoter region of the avian vitellogenin 
gene before and after hormone stimulus, in vivo protein-DNA interactions were also 
studied by combining this technique with the reaction in vitro of unprotected guanosine 
with dimethyl sulphate, known as genomic footprinting (Saluz et al.A 988). These 
methods will allow detailed investigation of the methylation patterns of inactive and 
activated genes and the relationship between methylation and protein DNA interactions in 
these genes.
1.1.3 Inheritance of Methylation Patterns.
The distribution of m5C residues in DNA i.e. the methylation pattern can be 
stably and accurately inherited from one generation to the next. This is achieved by a 
maintenance methylation mechanism. Following replication an unmethylated CpG in the 
daughter strand of DNA will be paired with the mCpG in the parental strand. This site will 
then be recognised by DNA methylase which will add a methyl group to the daughter strand 
resulting in a fully methylated site. Hemimethylated duplex DNA has been shown by 
several groups to be the preferred substrate for purified DNA methylase. Totally 
unmethylated duplex DNA is a poor substrate for the enzyme, this ensures that in vivo the 
existing methylation pattern is copied during DNA replication (figure 1.2).
This maintenance methylation was demonstrated in transfection experiments 
performed by Wigler et al .(1981), where a cloned chicken thymidine kinase gene was
6methylated at CCGG sequences using Hpa II methylase and introduced into TK" mouse cells. 
Twenty five generations later the methylation of the gene was shown to have been 
maintained with almost 100% fidelity.
De novo methylation i.e. methylation of totally unmethylated DNA, is thought 
only to occur during early development in non differentiated cells, where most genes 
require to be silenced.
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Figure 1.2. De Novo and Maintenance Methylation
71.1.4. DNA Methyltransferases
The addition of a methyl group to adenine and cytosine residues in DNA is a post 
replicative event which is catalysed by an enzyme known as DNA methyltransferase (DNA 
methylase, EC 2 .1.1.3.7). The methyl group donor in these reactions is S-adenosyl 
methionine. The methylation of cytosine residues is shown in fig 1.3 and probably 
proceeds via the formation of an enzyme-DNA covalent link (Santi ef a/.,1983,1984).
The products of the reaction are 5-methylcytosine and S adenosylhomocysteine, a potent 
inhibitor of the reaction.
H DNA
Methylase ^
Figure 1.3 Methylation of Cytosine: Proposed Mechanism of Action
In prokaryotes, DNA methylases (with the exception of the dam and dcm types) 
are associated with endonucleases as part of restriction modification systems. In contrast, 
eukaryote DNA methylases have no associated endonuclease and also unlike their prokaryote 
counterparts have no co-factor requirements and are not stimulated by ATP or Mg2+ . 
Mammalian DNA methylase has been isolated from a number of tissues including rat liver 
(Simon eta l.,1978), mouse ascites cells (Turnbull and Adams,1976), murine 
erythroleukemia cells (Bestor and Ingram, 1983) and Hela cells (Roy and
8Weissbach,1975). These enzymes have now also been purified from plants; Theiss et al. 
(1987) isolated DNA methylase from wheat embryo cells and Yesufu e ta l.{1989) from 
pea seedlings.
The molecular weight of these enzymes lie between 120,000 and 280,000 
and may differ between different vertebrate tissues. In vitro the enzyme 
aggregates in low salt but it is only under these conditions that it interacts with native DNA.
It is therefore not clear whether the active form of the enzyme in vivo is the monomer or 
some multimeric form.
The precise mechanism of action of DNA methylase is still unknown. In 
studies using the rat liver enzyme, Drahovsky and Morris (1971) proposed that the 
enzyme processed along the DNA in a "random walk" manner, adding methyl groups as it 
came to unmethylated DNA. This one dimensional diffusion or sliding would greatly 
increase the chances of the methylase finding its recognition sequence and hence would be 
more efficient than an association-dissociation mechanism. In support of this processive 
mechanism Taylor and Jones (1982) found that the mouse spleen enzyme bound to duplex 
DNA and remained associated after the addition of S-adenosylmethionine and 
hemi-methylated duplex DNA. No methylation of the hemi-methylated DNA was observed, 
indicating that once bound the enzyme remained associated with the DNA. Also, treatment 
of cells with low levels of 5-azacytidine resulted in an unexpectedly high inhibition of 
methylation. Substitution of 5% of cytosine residues with 5-azacytidine resulted in an 
80% drop in the level of methylation ( Jones and Taylor,1980). This can be explained if 
the occurrence of a 5-azacytidine residue at a methylation site impedes the progress of the 
enzyme as it travels down the newly synthesised DNA strand at DNA replication.
9All mammalian enzymes purified so far show a strong preference for 
hemimethylated DNA as a substrate. Since these enzymes are purified from fully 
differentiated cells their primary function in vivo would be the maintenance of established 
methylation patterns. There is no evidence for the presence of a separate enzyme in 
non-differentiated cells. Hence it is possible that an altered form of this enzyme performs 
the required de novo methylation during early development. Adams and Burdon (1985) 
proposed that DNA methylase may have a regulatory domain that recognises a methyl 
cytosine on one strand of the hemimethylated DNA and only then will the active site catalyse 
the transfer of a methyl group to the unmethylated strand. Such a mechanism could 
explain the increase in activity on unmethylated DNA following limited proteolysis of the 
enzyme (Adams et a l.,\983). Removal of the domain that recognises the hemimethylated 
site may relieve a constraint, thereby allowing the enzyme to work on totally unmethylated 
DNA.
Insight into the mechanism of action of DNA methylase may be gained from 
sequence analysis of the recently cloned mouse methyltransferase gene (Bestor et al.,
1988). The inferred protein sequence revealed a carboxy terminal region which showed 
homology with the bacterial type II cytosine methylase. Bestor postulated that the
/
amino-terminus portion of the molecule may be involved in regulating the activity of the 
enzyme.
10
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1.1.5 Possible Roles For DNA Methylation
The major part of the evidence arising from the studies on m5C in eukaryotic 
cells indicates that methylation is involved in the control of gene expression and this will 
be discussed in detail later. However, since m5C residues are present in sequences not 
associated with the control of transcription, other roles for cytosine methylation in 
eukaryotes have been postulated. These include;
(a) a restriction modification system similar to that present in prokaryotes.
However, sequence specific endonucleases in mammalian cells have not been detected. The 
only evidence in support of such a system comes from studies on the chloroplast 
inheritance in Chlamydomonas (Burton etal., 1979; Royer and Sager,1979). In 
gametogenesis methylation of the chloroplast DNA of the female gamete (mt+) protects it 
against degradation, whereas the unmethylated chloroplast DNA of the male gamete (m f)
is digested after fertilisation. A general role for DNA methylation in a possible eukaryotic 
restriction modification system is however unlikely, since eukaryotic genomes are only 
partially methylated and much of the DNA would therefore be unprotected.
(b) It has also been postulated that cytosine methylation plays a role in the 
mismatch repair mechanism in eukaryotes. It has been shown that m6A has a role in 
guiding strand selection in base mismatch repair in prokaryotes (Jones e ta l .,1987).
Cytosine methylation in post replicative hemimethylated DNA would enable discrimination 
between the methylated parental strand and the unmethylated daughter strand. Hare and 
Taylor (1985) found that mismatch repair occurred only on the unmethylated strand of 
hemimethylated SV40 DNA after transfection into host cells. Such a system would allow 
for the correction of mismatches overlooked by the proofreading enzymes present at
replication and the mCG/GT mismatch resulting from m5C deamination at CpG dinucleotides.
Brown and Jiricny, (1987) have reported that mammalian cells possess a specific repair 
pathway , which counteracts the mutagenic effects of this deamination by correcting GT 
mismatches almost exclusively to GC pairs. Wiebauer and Jiricny (1989) have recently 
shown that this repair action is present in Hela cell nuclear extracts and involves the 
excision of the aberrant thymidine monophosphate residue, followed by gap filling to 
generate a CG pair.
(c) DNA methylation has also been postulated to be involved in DNA 
replication, however, although evidence exists suggesting that methylation is involved in 
replication in prokaryotes (Razin, 1978; Billin, 1968), there is little evidence 
supporting the role of methylation in the control of replication in eukaryotes. Cooney et 
a i, (1988) studied the role of methylation in the control of replication in the rDNA of the 
slime mould Physarum polycephalum and found that of the four origins of replication 
present the single active origin was hypomethylated. They propose that hypomethylation 
has a role in selecting the active origin.
1.2. The Relationship Between DNA Methylation and 
Transcription
1.2.1 DNA Methylation and X Chromosome Inactivation
X
After fertilisation, female mammalian cells have two^chromosomes. In early 
embryogenesis, genetic inactivation of one of these chromosomes occurs to ensure that
these females are equivalent to XY males with respect to X chromosome dosage. This 
process of inactivation is thought to occur in at least three steps : the initial event in which 
one of the two active X chromosomes in each cell is chosen for inactivation, the spread of 
inactivation along the length of the chromosome and events that result in the heritable 
maintenance of repression of the genes on the inactivated X. This chromosome appears as 
heterochromatic and condensed, J t is late replicating and is known as a Barr body.
The role of methylation in the inactivation process was first proposed by Riggs 
(1975) and several lines of experimental evidence supporting this idea followed. For 
example, Liskay and Evans(1980) found that in transcription studies the hprt 
(hypoxanthine phosphoribosyl transferase) gene isolated from the inactive X chromosome 
could not transform HPRT" recipient cells to a positive phenotype; whereas the same gene 
from the active X could. This indicates that inactive and active X chromosome DNA 
fragments are differentially modified. Strong evidence for the involvement of methylation 
in this inactivation process comes from studies using 5 azacytidine. This compound is a 
strong inhibitor of DNA methylase when incorporated in DNA and results in the loss of 5mC 
and altered methylation patterns. Mohandas et a l ., (1981) exposed a mouse-human 
somatic cell hybrid, deficient in HPRT and containing a structurally normal inactive human 
X chromosome, to this drug , and tested for the reactivation of the human X linked hprt 
gene. They found that the frequency of HPRT positive clones after 5-azacytidine treatment 
was 1,000 times greater that obtained in untreated cells. Later Jones et al .,(1982) 
showed that this reactivation required that the hybrid cells be treated with the drug in the 
latter part of S phase of the cell cycle, when the inactive X chromosome is replicating, 
suggesting that it is involved in the alteration of methylation patterns.
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Reactivation is thought to be due to a demethylation of a CpG island upstream 
from these genes. Hansen et al .,(1988) observed that demethylation of specific sites 
within the CpG cluster of the X- linked phosphoglycerate kinase gene were important for 
DNAase I sensitivity and transcriptional activity of the gene.
From these experiments and others, it is generally accepted that DNA 
methylation is involved in the inactivation of the X chromosome. However, it is unknown 
at what stage in the inactivation process it is involved and how important a role it plays in 
relation to the other factors involved.
Monk (1986) proposed a model whereby after the initial event which . 
determines the inactive X chromosome, keysite sequences along the length of the 
chromosome are methylated resulting in inactivation of the entire chromosome. A 
conformational event demarcating the chromosome into segments of inactivity then occurs. 
Evidence for this step comes from studies indicating that X chromosome reactivation occurs 
in a segmented fashion. Finally a further methylation of the inactive genes on the inactive 
X chromosome in somatic tissue occurs. It would be this second methylation step that 
causes decreased transcription activity of the hprt gene since, if the same gene is isolated 
from the inactive X chromosome of extraembryonic tissue no decrease in activity is 
observed (Kratzer et al., 1982).
However, the initial role of methylation in inactivation presented in this 
model, is disputed by Lock etal., (1987). They studied the relationship between DNA 
methylation of the hprt gene and the inactivation of this gene on the X chromosome in 
teratocarcinoma cells and postimplantation mouse embryos. They found that the sequences 
studied are unmethylated prior to X inactivation and do not become methylated on the
inactive X chromosome until several days postinactivation. This suggests that methylation 
does not play any role in the primary events of X inactivation, but may function as a 
secondary mechanism for maintaining the inactive state.
This secondary or 'locking' mechanism, first introduced by Razin and Riggs
(1980), may function in a localised manner either in combination with or in some cases 
replacing the primary mechanism by which X linked genes are maintained in the repressed 
state.
1.2.2 DNA Methylation and Cellular Differentiation
The ordered expression of tissue specific genes during development is controlled 
by numerous cellular factors. The knowledge that DNA modification by methylation could 
be inherited from one generation to the next led Riggs (1975) to propose that DNA 
methylation was one of the factors involved in this complex process. Strong support for 
the involvement of DNA methylation in differentiation came from reports that agents that 
inhibit the methylation reaction, such as ethionine, butyrate, dimethylsulphoxide and 
5-azacytidine, induce differentiation in cultured cells. Christman et al .,(1977) 
observed that when Friend erythroleukaemia cells are grown in the presence of 
L-ethionine, globin mRNA accumulates and 25-30% of the cells produce haemoglobin 4-5 
days after initiation of treatment. The DNA isolated from these cells was significantly 
hypomethylated compared to that of uninduced cells. Also Jones and Taylor (1980) found 
that 5-azacytidine and other cytosine analogues could have profound effects upon the 
differentiation state of cultured mouse embryo cells. These cells developed into
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contractile muscle cells and biochemically differentiated adipocytes and chondrocytes 
several days or weeks after exposure to the analogue. These experiments suggest an 
important role for methylation in the maintenance and acquisition of differentiated 
phenotypes.
Further support for the role of methylation came from the observation 
that tissue specific genes are highly methylated in germline DNA and undermethylated in 
the tissue in which the gene is expressed. This led to the theory that de novo methylation 
occurs in the early embryo and tissue specific methylation patterns are produced by the 
loss or gain of critical methylated CpG dinucleotides during the process of differentiation. 
Cedar e ta l., (1983) found that teratocarcinoma cells derived from mouse embryos 
carried out de novo methylation of a transfected p-globin gene. The same DNA introduced 
into either L cells or Friend erythroleukaemia cells remained unmethylated.
Riggs and Jones (1983) proposed various mechanisms by which tissue 
specific methylation patterns might be set up during development. Specific demethylation 
at critical control sites during development could be directed by sequence specific proteins 
that sterically inhibit the relatively non-specific DNA methylase. Alternatively the 
pattern of methyl groups could be altered by the action of a demethylase that acts in a 
sequence and developmental specific manner. This event may occur before or after the 
activation of genes. Gjerset and Martin (1982), observed the presence of a m5C 
demethylase activity in murine erythroleukaemia cells, where this event was thought to 
occur via the removal of the methyl group from the DNA. Also Razin et al., (1986) 
observed a genome wide transient demethylation in differentiating erythroleukaemia cells. 
The kinetics of this event suggested that it did not depend on DNA synthesis indicating that 
demethylation was active rather than passive i.e not via DNA replication. This induced
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demethylation is thought to be due to the more feasible specific replacement of 
5-methylcytosines with cytosine residues. Studies on such enzyme activities are still in 
their infancy and have still to be confirmed by other groups. The third possibility for 
changing methylation patterns is to have some de novo methylation occurring at all 
developmental stages. Stewart et a / .,(1982) suggested that de novo methylation is most 
active in the pre-implantation embryo. However, gene transfer experiments performed 
by Doerfler, (1981), have shown that fully differentiated cells can perform de novo 
methylation.
In order to understand how methylation influences the tissue specific 
expression of genes during differentiation it is useful to consider the two classes of genes 
involved, that is, housekeeping genes and tissue specific genes. Housekeeping genes are 
constitutively expressed in all somatic tissues. Many of these genes contain CpG islands 
usually in their 5' flanking sequences. First identified by Bird et al .,(1985), these 
islands are regions of DNA, 500-2000bp long, which are C+G rich and contain a high 
proportion of unmethylated CpG dinucleotides. As cells move from germline to committed 
cells en route to differentiation these regions would remain free from the repressive 
effects of methylation, possibly by the aid of steric hindrance from permanently bound 
factors. CpG islands have also been found in the 3' or 5' flanking regions of some tissue 
specific genes and may in the distant past have been a characteristic of all genes. During 
early development these tissue specific genes would become methylated and in some cases 
the CpG rich character of 5'sequences would be lost due to high rates of mutation of mCpG. 
As differentiation proceeds tissue specific and stage specific factors may then alter the 
methylation patterns of these genes via one of the mechanisms outlined above.
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1.2.3 Evidence for an Inverse Relationship between Methylation and 
Transcription
The role of methylation in the regulation of transcription has been 
extensively studied. However the evidence accumulated so far does not provide a concrete 
theory for how or to what extent DNA methylation controls the expression of genes in 
eukaryotes. Evidence supporting the inverse relationship between methylation and 
transcription has come from studies on X-chromosome inactivation and cellular 
differentiation, discussed in sections11.2.1. and 1.2 .2j respectively. However, analysis of 
the relationship between extent of methylation and transcription of a number of genes 
provided more ambiguous conclusions. There are many known examples of genes in which 
methylation of specific sequences in the 5' regulatory region causes inactivation. Using 
the technique introduced by Waalwijk and Flavell (1978) involving the use of restriction 
enzyme isochizomers (outlined in section 1.1.2) the methylation patterns of several cloned 
genes have been studied. For example, studies on the methylation pattern of the active and 
inactive mouse metallothionein (MT-1) gene by Compere and Palmiter (1981) revealed 
that all Hpa II (CCGG) sites in the vicinity of the MT gene are methylated in cells in which 
the gene is never expressed but unmethylated in cells in which the gene can be induced by 
cadmium or glucocorticoids. In addition, pretreatment of non-expressing cells with 
5-azacytidine allowed the gene to be induced by these agents. Also, Weintraub et al.,
(1981) observed an undermethylation of Hpa II sites in the DNAase I sensitive domain 5' 
to the a-globin gene cluster in developing chicken embryos. A similar observation was 
made with the rabbit p-like globin genes (Shen and Maniatis, 1980) where analysis of 13 
sites flanking the gene cluster revealed that certain sites surrounding the embryonic and
adult genes are relatively undermethylated in DNA from embryonic and adult erythroid 
tissue respectively. Other examples include the chicken ovalbumin gene (Mandel and 
Chambon, 1979), where certain CpG's are unmethylated only in the oviduct of laying hens, 
the chicken p globin genes (McGhee and Ginder, 1979) and the mouse (Sellem e ta l.,
1985), and rat (Ott et al., 1982) albumin genes.
Further support for this inverse correlation between DNA methylation and 
gene expression came from DNA mediated gene transfer experiments, using both viral and 
cellular genes. For example, Stein et al .,(1982) methylated the cloned hamster adenine 
phosphoribosyl transferase (aprt) gene at all CCGG sequences using Hpa II methylase. 
The ability of this DNA to transform APRT- cells to a positive phenotype was compared to 
that of unmethylated DNA. Although both types of DNA became integrated into the host 
genome, only the unmethylated gene conferred an APRT+ phenotype, suggesting that 
expression is inhibited by methylation.
Christy and Scangos (1982) found that introducing a plasmid containing the 
herpes simplex virus thymidine kinase {tk ) gene into mouse TK" cells resulted in TK+ 
cell lines. A derivative of these cells lines that retained but no longer expressed the tk 
gene was found to be hypermethylated in the gene sequence compared to the expressing 
cells. Furthermore the inactive gene could be activated by exposing the cells to
5-azacytidine, suggesting a causative relationship between DNA methylation and 
transcription. Further experiments using this gene have confirmed its methylation 
sensitivity. Graessman and Graessman (1988) methylated this gene with Hpa II 
methylase and studied its expression on microinjection into the nuclei of TK" cells. They 
found that methylation could block transcription of this gene. The inhibitory effect was not 
immediate, suggesting that it is mediated via the formation of chromatin structures.
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DNA viruses have provided useful model systems for studying the effect of 
.methylation on transcription. Despite naturally possessing an unmethylated genome, in 
many cases viral gene expression can be inhibited by methylation of specific sites in 
promoter regions. These include the herpes saimiri virus (Desrosiers et al .,1979), 
hepatitis B virus (Miller and Robinson 1983) and Moloney leukemia virus (Stahlmann et 
al .,1981). Also, the methylation of the single Hpa II site in SV40 located near the late 
transcription start site inhibited transcription of late genes but had no effect on early 
transcription (Fradin et al., 1982). By far the most extensively studied virus, with 
respect to the effect of methylation on transcription, is the adenovirus system. Doerfler 
and co-workers (Sutter and Doerfler 1979 , Vardiman et a /.,1980 , )  have shown that 
although virion DNA and free viral DNA in infected cells is not detectably methylated, 
integrated viral DNA sequences are extensively methylated. Analysis of the methylation 
status of integrated adenovirus 12 (Ad 12) sequences in transformed cells revealed an 
inverse correlation between methylation of CCGG sites and transcription (Kruczek and 
Doerfler,1983).
Similar results were also obtained for the Ad 2 system, where early adenovirus 
genes were undermethylated in cell lines in which they were expressed; late viral genes not 
expressed in transformed cells were heavily methylated at CCGG sites. Also, they found 
that in vitro methylation of the Ad 12 E1 a promoter at Hpa II and Hpa I sites abolished the 
transcription of a linked chloramphenicol acetyl transferase gene. However, methylation 
of sites downstream of the promoter of the Ad 12 protein 1 x gene and greater than 300bp 
upstream of the TATA box had no effect on transcription. This experiment indicates that 
the effect of methylation is site specific and usually involves CpG's in or near promoter 
regions.
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In contrast to this, studies on the frog virus 3(RV3) which has a highly 
methylated genome (20% m5C , Willis and Granoff, 1980) revealed that methylation in 
the promoter region of an immediate early gene had no effect on transcription (Thompson et 
al.,1988). Also in vitro methylation of Hpa II sites on polyoma virus DNA had no effect 
on T antigen expression (Subramanian, 1982).
These contrasting results are typical of the data so far accumulated on the 
effect of methylation on transcription. The experiments discussed so far provide good 
evidence for an inverse relationship. However, a proportion of the studies carried out to 
date have revealed no obvious relationship between methylation and transcription in a 
number of genes suggesting that the control mechanisms are totally independent of 
methylation. These include the Xenopus vitellogenin genes A1 and A2 which are expressed 
in hepatocytes upon oestrogen treatment. Gerber-Huber et al .,(1983) found that these 
genes are heavily methylated in all adult tissues, irrespective of expression. In contrast 
the Xenopus p1 -globin gene and albumin gene are hypomethylated only in expressing cells, 
i.e. erythrocytes and hepatocytes. Also McKedn et al .,(1982) studied the methylation
pattern of the oc2 (type 1) collagen gene in DNA from different ceil types with varying 
rates of collagen synthesis. Using methylation sensitive restriction enzymes they found 
that DNA around the start site of transcription was unmethylated whereas the DNA from the 
central and 3' region of the gene is methylated. This methylation pattern was the same for 
collagen expressing and non expressing cells indicating that the level of expression of this 
gene is independent of methylation. Using the genomic sequencing technique Nick et a l .,
(1986) found that a 900bp fragment upstream of the non expressed maize alcohol 
dehydrogenase gene was unmethylated despite being rich in methylation sites indicating that
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methylation is not involved in repression. This group of apparently methylation ' 
insensitive genes also includes the rat (Cate et al .,1983) and human (Ullrich et a l .,
1982) insulin genes and the rat albumin and a fetoprotein genes (Kunnath and Locker, •
1983), where both genes are active in the liver of the 18 day old foetus despite being 
heavily methylated.
From these studies we can conclude that site specific methylation of CpG's in 
a large number of (but not all) viral, developmentally active and housekeeping genes has a 
direct effect on expression. It appears that methylation exerts its effect only at critical 
CpG's, the location of these sites differs for different genes. In some genes methylation in 
the body of the gene inhibits expression, whereas in the housekeeping aprt and dhfr genes 
the active gene is heavily methylated throughout except for the 5' regulatory region (Stein 
et al .,1983). It is possible that in these housekeeping genes regulation is not so rigorous 
and activity depends only on the upstream sequences, containing a CpG island, to be 
methylation free allowing the necessary ubiquitous transcription factors to bind. On the 
other hand , in tissue specific genes transcription control is more complex probably 
involving tissue specific factors as well as ubiquitous factors. Hence critical methylation 
sites within these genes would differ between genes depending on the control systems 
involved and where in the gene sequence the tissue specific factors bind.
Although these arguments indicate that methylation is involved in gene 
regulation, one cannot conclude whether this modification is a cause or an effect of 
transcriptional inactivation. It is possible that methylation or hypomethylation provides 
a means of stabilising the structure of a gene in an inactive or active state.
i
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1.3. Events Involved in the Transcription of Eukaryotic 
Genes
1.3.1. Transcriptional Activation in Cellular Genes
Transcription in eukaryotes is thought to be controlled by cis and trans acting 
mechanisms and by the accessibility of the template DNA to protein factors which initiate 
transcription. Transcriptionally active genes are known to be preferentially digested by 
pancreatic DNAase I. This sensitivity is not limited to the transcribed portion of a gene, 
but extends both 5' and 3' to define an active domain. For example, the ovalbumin domain 
in hen oviduct nuclei contains three genes and extends over a 100kbp of DNA, and the active 
p globin domain extends 6-7kbp 5’ and 8kbp 3' of the gene. These active or open 
chromatin domains often contain sites of nuclease hypersensitivity immediately preceding a 
transcribing gene. (Larson and Weintraub,1982). The dissociation of nucleosomes in 
these regions would greatly increase the accessibility of the DNA to RNA polymerase and 
transcription factors.
1.3.1.1 Common Control Elements in Eukaryotic Promoters
The upstream control region of many genes studied to date share several 
sequence elements. These include the TATA box, which has a consensus sequence TATAAA 
and is located 25-30bp upstream from the transcription start site. Mutation in this
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region results in 5’ heterogeneity in the transcripts produced, although the overall level of 
RNA synthesis remains similar. Further upstream is a region containing one or more 
sequence elements of 8-12 base pairs, known as upstream promoter elements (UPEs). A 
number of different UPEs have been identified and some of these, for example, the CCAAT 
box and GC box have been found in a large number of promoters. Others such as the 
metallothionein metal regulatory element (Karin et al., 1984) or the heat shock 
regulatory element (Pelham,1982), have a more specialised role. All of these sequence 
elements have been shown to bind specific cellular factors, indicating that cells contain 
both 'general' and cell type-specific transcription factors.
As well as the transcription factors that bind to the CCAAT and GC boxes, 
CTF and Sp1 respectively, a number of other ubiquitous transcription factors are also 
involved in transcription initiation. Roeder and co-workers found that purified RNA 
polymerase II lacks the ability to recognise promoters in an in vitro reaction. However, 
the addition of factors purified from crude cell extracts stimulated polymerase activity and 
allowed in vitro initiation of transcription. These factors have been identified as TFIIA, 
TFIID, TFIIE and TFIIB (Reinberg and Roeder,1987;Reinberg e ta i,1987). It is thought 
that TFIIA and TFIID act first to form a stable preinitiation complex on the -45 to +30 
region of the promoter, commiting the template to transcription. TFIIB interacts with 
RNA polymerase and TFIIE and this complex then interacts with the TFIID-TFIIA complex 
bound to the selector region and the gene is transcribed.
The activity of many promoters is modulated by an enhancer sequence. This 
is a separate cis-acting regulating element which can exert its effect at a distance of up to 
several Kbp from the promoter. These sequences are active in either orientation and may 
be located either upstream or downstream from the transcription start site. Enhancers
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usually bind one or more sequence specific factors. It is the interactions of these factors 
with those bound to the UPE's of the promoter that is thought to regulate transcription.
These factor-factor interactions and possible factor-polymerase interaction can be 
envisaged if the intervening DNA sequences 'loop-out' as the interaction occurs.
1.3.1.2 Tissue Specific Expression of Genes
In higher eukaryotes there are many examples of genes that are under tight 
developmental control and are transcribed only in specific differentiated cell types. The 
mechanisms by which the transcription of these genes is controlled are still largely 
unknown. Studies on two genes - the immunoglobulin gene and the albumin gene have 
provided some insight into how tissue specific expression is achieved. In transfection 
studies where the introduced DNA is believed to assume an accessible chromatin structure 
(Weintraub,1983), both these genes were shown to be active only in cell types that 
expressed the endogenous gene i.e. lymphocytes and hepatocytes respectively. This 
indicated that cell type specific transacting factors are required for their activity.
In the albumin gene transcriptional activity is dependent on sequences contained 
within the region of -32 to -164. Lichsteiner et a l ., (1987) tested the ability of 
nuclear extracts from several tissues to transcribe the albumin gene in an in vitro assay. 
They found that only the liver cell extract could direct efficient transcription and spleen 
and brain extracts were much less efficient. Footprinting analysis revealed at least six 
specific protein binding sites, four of which were occupied by nuclear proteins that are 
specifically more abundant in liver than in the other tissues tested.
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Similarly lymphocyte specific factors appear to be directly involved in 
mediating tissue-specific immunoglobulin transcription. Immunoglobulin heavy and light 
chain genes possess a conserved DNA sequence octomer (ATGCAAAT) shortly upstream from 
the transcription start site which is thought to be involved in tissue specific expression.
However there appear to be two species of factor that interact with this site. One factor is 
present in all cells and the other only in B and T lymphocytes (Landolfi eta ! .,1986 ,
Staudt et a ix 1986). It has been suggested that one factor may be a modified form of the 
other differing for example in phosphorylation state. However, there is evidence to 
suggest that two entirely different proteins may exist. Staudt et al .,(1986) found that the 
lymphocyte specific factor is inducible in a pre B cell line by lipopolysaccharides and that 
this induction could be blocked by the protein synthesis inhibitor cycloheximide. However 
it is unlikely that all inducible or tissue specific gene expression involves the synthesis of 
new proteins. Activation of pre existing transcription factors could be achieved by 
covalent modification of the protein or an allosteric change in its structure. It has been 
shown (Imbra and Karin,1987) that treatment of cells with phorbolesters can 
dramatically increase the activities of the SV40 and polyoma virus enhancers. These 
compounds stimulate protein kinase C activity, suggesting that enhancer binding factors
may be modified by phosphorylation. Phosphorylation has also been proposed as a 
regulatory mechanism for transacting factor E4F (Raychandhuri et a / .,1989 ) and for the 
heat shock transcription factor (HSTF)(Sorger et a!.,\987). Other regulatory 
mechanisms proposed are glycosylation (Jackson and Tjian,1988), induction by cAMP 
(Karin, 1989) and in the case of some Drosophila factors , self regulation 
(Serfling,1989).
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In many tissue specific and developmental^ regulated genes, control of 
transcription involves the action of steroid hormones. Hormone regulatory elements 
(HRE's) have been identified in a number of these genes including the chicken vitellogenin 
gene ( Klein-Hitpap et a/.,1986), the tyrosine aminotransferase gene ( Jantzen et 
al.,1987), and the mouse mammary tumour virus long terminal repeat (MMTV-LTR)
(Payvar et al., 1983; Scheidereit et al.A 983). These elements share many properties of 
the enhancer sequence; interactions with the hormone receptor molecule is followed by 
protein-protein interactions with transcription factors bound to promoter sequences and 
results in stimulation of transcription.
1.3.2. Transcriptional Activation in SV40
The SV40 DNA tumour virus is an ideal eukaryotic model system to study.
Its small ('v5.2Kbp) and well characterised genome has provided much information 
regarding the processes of DNA transcription and replication. The regulatory sequences 
for both these processes are contained within a region of the genome of approximately 
300bp. Detailed studies on this region revealed several interesting sequence motifs.
These include a 72bp repeat enhancer sequence, a bidirectional promoter sequence and the 
origin of replication including specific binding sites for T antigen.
The SV40 promoter region consists of two perfect 21 bp repeats and a 
degenerate 22bp repeat. Each of these repeats contain two hexanucleotide motifs known as 
GC boxes, which have been shown by several groups to be crucial for both early and late 
transcription (Brady et a/.,1984; Baty eta!., 1983; Benoist and Chambon,1981).
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Mutation studies on each motif from GC box I to VI lowered early transcription to 
4.8%,20%,15%>42%,33% and 56% of wild type respectively (Wildeman, 1985). This 
is in agreement with Gidoni et a /.,(1984) who observed that GC boxes), 11,and III are the 
most important for transcription in vitro in the early direction and boxes III,IV and VI are 
most important for transcription in the late direction.
Studies on these sequences revealed that they interact with a transcription 
factor known as Sp1. This protein has since been purified to 95% homogeneity and 
studied extensively by Tjian and co-workers (Kadonaga and Tjian,1986; Kadonaga et 
al.,1986) who observed that it has a molecular weight of 95-105K and is capable of 
enhancing transcription 10-50 fold from an apparently unrelated group of promoters.
Analysis of the conferred amino acid sequence from the cloned human Sp1 gene revealed that 
it interacts with its recognition sequence via three contiguous zinc finger motifs (Kadonaga 
et al .,1987). These metalloprotein structures were first identified by Miller et a l .,
(1985) in transcription factor IIIA and are now known to be common to many DNA binding 
proteins. In a complementation assay using Sp1 -deficient Drosophila tissue culture cells, 
Courey and Tjian (1988) were able to identify the protein domains that confer 
transcriptional activation. The two most active domains have a high glutamine content, a 
property shared by several Drosophila transcription factors and which is thought to 
represent a novel structure for transcriptional activation.
It appears that Sp1 does not bind to all GC boxes with equal affinity, and that the 
flanking nucleotides may play some part in binding. Analysis of Sp1 interaction with
several sites resulted in a decanucleotide consensus sequence (5’ g/j GGGCGG ggc /a at)»
(Kadonaga et a /.,1986). In SV40 boxes III and V are high affinity sequences whereas GC 
box I, shown by mutation studies to be most important for early transcription, is a low
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affinity Sp1 binding sequence. This surprising observation can be explained if one 
considers that in vivo there are other determinants of a site's activity such as, the position 
of the binding site relative to the RNA start site and to other factor binding sequences.
Sp1 is now regarded as an ubiquitous transcription factor since it appears 
to be involved in the regulation of a number of cellular and viral genes. These include the 
mouse dihydrofolate reductase (dhfi) gene (Dynan etal., 1986),the human 
metallothionein gene (Lee e ta l .,1987) and the HSV immediate early gene (Jones and 
Tjian,1985). Since this group of Sp1 responsive genes contains several housekeeping 
genes it has been suggested that Sp1 interacts with the methylation-free CpG islands which 
are often present upstream of these genes and allows constitutive expression in all cell 
types. However, Sp1 is also involved in tissue specific gene expression as indicated by an 
experiment performed by Hayashi et al .,(1986). Using the lens specific chicken
6-crystallin gene 1, they found that co-injection of this gene with GCbox-containing DNA 
fragments from 8-crystallin, SV40 early, or HSV tk promoters effectively suppressed 
expression in lens cells, whereas coinjection with DNA fragments not containing a GC box 
did not.
Sp1 sequences are often found near binding sites for other transcription 
factors, such as CTF (Jones etal.,1985) and AP-1. (Lee etal., 1987) which suggests that 
these may act in conjunction with each other to modulate transcription. In SV40 it is 
thought that Sp1 interacts with enhancer binding factors as well as other promoter binding 
factors to stimulate both early and late transcription. The SV40 enhancer sequence has 
been extensively studied and several transcription factor binding sites have been identified. 
The functional domains of this enhancer appear to have little stimulatory activity by 
themselves but act synergistically to give high levels of activity (Fromental,1988; Zenke
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et a l , \986). Individual domains are also found associated with other viral and cellular 
promoters such as the human metallothionein IIA gene and the human growth hormone gene 
(Imagawa et al., 1987).
Several proteins have been identified as binding to the SV40 enhancer 
motifs, the best characterised being the activator proteins (AP) 1,2,3 and 4. Mermod et 
al .,(1988) demonstrated that AP-1 and AP-4 act coordinately to activate late 
transcription in vitro. However,! with AP-2 and AP-3, although both factors activate | 
transcription , footprinting analysis revealed that their recognition sequences overlapped 
and it appears that these factors act in a mutually exclusive manner (Mercurio and 
Karin,1989). It has now become clear from several sources that multiple factors can 
recognise the same sequence of DNA (Schaffner,1989; Graves etal.,1986; Dorn e ta l.,
1987; Santoro etal., 1988; Clark and Hay,1989), indicating that the stimulatory or 
repressive nature of such a sequence may depend in the factors present in a given cell type.
Several other factors have been shown to interact with the SV40 
enhancer, these include c/EPB (Johnson etal., 1987) TEF-1 and TEF-2 (Davidson etal., 
1988), EBP1 (Clark et al., 1988) and NFkB (Kawakami,1988).
Tjian et al., (1987) proposed that it was the interplay between these 
factors with those that interact with the SV40 promoter region, such Sp1 and AP-2 
(Mitchell et a lx 1987) that results in the high levels of both early and late transcription 
in SV40.
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1.4 How Methylation Exerts its Effect on Transcription
1.4.1 The Effect of Methylation on DNA Structure and Stability
It appears that the presence of m5C in DNA molecules can induce changes in 
the conformation of the molecule. For example, methylation of DNA is known to enhance 
the formation of left - handed Z DNA from the traditional right handed anti-parallel form.
Behe and| Felsenfeld|(i 981) found that the transition of poly(dG - mdC) from B to Z forms 
occurs at close to physiological salt concentrations, whereas conversion of the 
unmethylated polymer requires very high salt concentrations. Fox (1986) studied 
changes in the precise local DNA structure of methylated DNA by examining its sensitivity 
to digestion by DNAase I. He found that the presence of a methyl group renders the bond on 
its 5' side more susceptible to cleavage, suggesting that it causes small changes in the local 
DNA phosphate orientation.
Cytosine methylation also decreases the buoyant density of DNA (Dawid etal., 
1970), probably due to an increase in volume due to the protrusion of the methyl group 
into the major groove, and increases the thermal stability. This increased helix stability 
is similar to that found in double stranded molecules containing thymine in place of uracil 
(Cassidy eta l.,1965). This property has been demonstrated using denaturing gradient 
gel electrophoresis of methylated and unmethylated linear DNA fragments ( Collins and 
Myers,1987). Murchie and Lilley (1989) examined the effect of base methylation of 
inverted repeats on the rate of cruciform extrusion; the results obtained are consistent
31
with the above, in that increased stability caused by cytosine methylation inhibited the 
initial opening of the DNA.
Although it appears that some properties of DNA are influenced by 
methylation, the change in the overall structure of the molecule would be less than that 
induced by a point mutation.
1.4.2 The Effect of Methylation on Chromatin Structure
DNA methylation probably inhibits gene expression by affecting the 
protein DNA interactions required for transcription. This theory was first proposed by 
Riggs (1975 and Razin and Riggs,1980) in light of evidence indicating that the binding to 
DNA of proteins such as the lac repressor, histones and hormone receptors were affected 
by changes in the major groove (Lin and Riggs,1972; Lin et al .,1976). For example, 
changing a thymine residue to a uracil or cytosine in the major groove of the lac repressor 
recognition sequence resulted in a decrease in affinity of the protein for the DNA.
Inserting iYi5C at this site restores affinity, indicating that the repressor only senses the 
presence or absence of a methyl group at this position (Fisher and Caruthers,1979).
A clear example of methylation affecting the binding of proteins comes from 
the bacterial restriction modification system (Yuan and Meselson,1970). | Some restriction \ 
endonucleases will not bind or cleave their recognition sequence on DNA in the presence of 
methylated adenine or cytosine.
What is not clear about this theory is whether methylation directly inhibits 
the transcriptional machinery, Le. transcription factors and RNA polymerase, or whether
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it creates altered chromatin states rendering the DNA inaccessible to these factors and 
hence.indirectly inhibiting their interaction with DNA. Over the past few years much 
study has been directed to answering this question. Results to date indicate that there is 
evidence for both mechanisms and that it appears that the mechanism involved depends on 
the gene and possibly the tissue in question.
Insight into the altered chromatin mode of action can be gained by 
examining the chromatin structure of genes introduced into cells by DNA mediated gene 
transfer. Keshet etal., (1986) found that unmethylated DNA adopts a DNAase I sensitive 
structure characteristic of active genes, whereas fully methylated sequences are resistant 
to DNAase I and are structurally similar to the inactive genes of the cell. Further support 
for this theory came from studies on the Herpes virus tk gene where experiments show 
that the inhibitory effect of methylation is most likely due to an altered chromatin state. 
Keshet et al., (1986) showed that methylation in the body of this gene, thought to be 
devoid of sequence specific protein binding, can inhibit expression even when the clearly 
defined promoter region is unmethylated. This suggests that methylation is altering the 
level of expression by mechanisms that do not involve the direct alteration of recognition 
sequences for RNA polymerase. Further studies on this gene by Buschhausen et a l .,
(1987) showed that inhibition of this gene by methylation occurred with a latency period 
of 8 hours after microinjection into mouse LTK- cells, indicating that chromatin 
formation is necessary for inactivation. Ben-Hatter and Jiricny (1988) looked at the 
effect of promoter methylation on the expression of this gene. They observed that 
methylation (on both strands) of any of the four CpGs present resulted in a 20 fold 
reduction in the expression of the tk gene in Xenopus oocytes. This dramatic effect is 
unlikely to be due to the inhibition of transcription factor binding since in the same study
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it was shown that the binding of both Sp1 and CTF is unaffected by methylation. Hence it 
is more likely that the presence of these methyl groups is resulting in the formation of 
altered chromatin structures which are not conducive to active transcription. This also 
appears to be the case for the y-globin genes, where a minimum length of methylation 
-free DNA ( 100bp) in the 5' region is required for expression of these genes (Murray 
and Grosveld,1987).
The precise structure of this altered chromatin or how it is brought about is 
still unknown. However, it is thought that methylation prevents the formation of 
"activated" chromatin in the regulatory regions of genes. Activated chromatin containing 
DNAase I hypersensitive sites allows access of transcription factors and RNA polymerase 
to the DNA. This has been demonstrated in vitro, where the ability of the transacting 
factor TFIIIA to generate a transcriptionally active 5S gene template depends on the 
addition of the factor prior to or during nucleosome formation, but not after (Kmiec and 
Worcel,1985). However there appears to be no direct evidence to indicate how 
methylation might interfere with this process. It is possible that DNA methylation 
increases the local stability of the DNA, preventing cis acting DNA sequences from forming 
DNAase I hypersensitive sites. Alternatively a GC-rich region containing several 
methylated sequences could form an altered DNA structure, similar to Z DNA which may be 
resistant to packaging into nucleosomes and hence the activation process may not occur. 
Binding of a methyl cytosine specific factor such as the MDBP (methylated DNA binding 
protein), identified by Huang e ta l.,(1984) may amplify these effects of methylation. In 
the presence of such a factor the DNA would not be free to form single stranded regions of 
DNA in preparation for transcription.
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1.4.3 The Effect of Methylation on Specific Protein-DNA Interactions
There are several known examples where methylation at sequence specific 
sites in promoter regions cause gene inactivation. Examples include the adenovirus E1 a 
and E2a genes (Kruczek and Doerfler,1983;Langer etal., 1984;1986), and the hamster 
adenine phosphoribosyl transferase (aprt) gene (Keshet et a l.,\985). Hence it has been 
suggested that methylation may not only alter the overall structure of a gene but may also 
interfere with the binding of protein factors at discrete cis acting loci. Studies on the 
effect of methylation on the binding of several transacting factors (these are discussed in 
detail in section 5.10.), revealed the presence of both methylation sensitive and 
insensitive factors.
However it can be argued that the effect of methylation on binding in vitro is 
irrelevant to the situation in vivo. Methylation sensitivity in vitro may solely be 
determined by the stereochemistry of a given factor's interaction with its recognition 
sequence or the choice of key interactive bases within the sequence. Whereas in vivo, the 
methylation sensitivity of a gene may be determined by the DNA sequence, if the gene is 
methylation sensitive it will assume an inactive conformation inhibiting the access of 
transcription factors. The methylation sensitivity or insensitivity of these factors would 
hence be irrelevant.
However, Yisreali e ta l .,(1986) demonstrated that tissue specific factors can 
overcome the repressive effects of methylation. The methylated a- actin gene was 
inactive when introduced into fibroblasts but active when introduced into myoblasts. This 
can be explained if one considers the presence of a tissue specific transcription factor. 
Binding of this factor to sequences upstream of the gene may result in the formation of a
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transcriptionally active form of chromatin. In the absence of this factor the presence of 
methyl groups throughout the gene may be sufficient to maintain an inactive form of 
chromatin. Such a situation may exist in vivo during differentiation, where the binding 
of such factors may be determined by the methylation state of their recognition sequences. 
This would be important in switching genes to tissue specific expression . After DNA 
replication, the binding of a transcription factor would, via the formation of active 
chromatin, render a gene active . However, in genes to be silenced in that cell type , the 
binding of such a factor could be inhibited by methylation, hence preventing the formation 
of active chromatin and transcription of the gene.
1.4.4 Reversing the Inhibitory Effect of Methylation
Several lines of evidence now suggest that promoter inhibition by 
methylation in certain genes is a reversible process. In addition to the active 
demethylation of certain sequences by proposed demethylase enzymes (Razin e ta l .,1986; 
Hughes e taU  1989), more subtle mechanisms such as the partial release of the 
inhibitory action of methylation by a transactivating protein or by the juxtaposition of a 
strong enhancer have been proposed by Doerfler et al., (1988). In the first instance it 
was observed that the methylation sensitive adenovirus 2 E2a gene could be partially 
reactivated in the presence of the adenovirus 5 E1 a gene product (Langer et al.,1986; 
Weisshaar et al.,1988). In a similar set of experiments the activity of transfected 
methylated Ad 12 E1a and E2a promoters was restored by subsequently infecting the cells 
with frog virus 3 (FV3)(Thomson et al., 1986). Also, insertion of the strong enhancer of
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the human cytomegalovirus. (HCMV) into a construct containing the E2a gene resulted in 
high levels of expression in transfection studies irrespective of methylation state of the 
gene (Knebel-Mordorf, et a/.,1988).
The alleviation of the repressive effects of methylation was also 
observed in a mammalian gene. As described in the previous section, Yisreali et al.,
(1986) observed that the methylated a-actin gene is activated in myoblasts but not 
fibroblasts. Only the former expresses the endogenous gene. In myoblasts demethylation 
of specific sites occurred in the exogenous gene resulting in an identical pattern of 
methylation to the endogenous gene. This is consistent with the observation that tissue 
specific genes are highly methylated in germline DNA and during very early development, 
then undergo demethylation in a tissue specific manner, probably involving tissue specific 
determinator proteins (Yisreali and Szyf, 1984).
1.5. Aims of Project
It is generally accepted that there exists an inverse relationship between DNA 
methylation and transcription. However, it is still unclear how methylation interferes 
with transcription or how important a role methylation plays in the complex control 
processes of eukaryotic gene expression.
Recent advances in the identification and purification of cellular factors that 
stimulate gene expression have provided some insight into answering these questions. 
Two mechanisms of transcriptional inactivation by methylation have been proposed: (a) an
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indirect effect whereby the presence of methyl groups in and around a gene results in the 
formation of an inactive form of chromatin, rendering the gene inaccessible to the 
transcriptional machinery, (b) A direct effect whereby methyl groups in the promoter 
regions of genes inhibit the binding of sequence specific transcription factors, hence 
limiting transcription.
The aim of the present study was to look at the effect of DNA methylation on 
eukaryotic transcription using the well characterised SV40 promoter as a model system.
In previous studies using this promoter, all but one of the experiments involved the use of 
bacterial DNA methylases (Fradin et al., 1982; Waechter et a!., 1982). No effect on 
early transcription was observed. The disadvantage of using these enzymes is that they 
only allow modification of cytosines in the enzyme recognition sequences, such sites do not 
always lie in the regions of genes that control transcription. In the SV40 promoter, 
despite having a high CG content, containing a cluster of six GC boxes, there are no 
bacterial methylase recognition sites. Since this region is known to be extremely 
important for transcription in SV40, use of these enzymes to study the effect of 
methylation on transcription would not be conclusive.
A more relevant experiment was performed by Graessman et a/.,(1983 ), who 
methylated the CpGs in the SV40 promoter using mammalian DNA methylase purified from 
rat liver. No effect in the level of early or late gene expression was observed upon 
microinjection of this DNA into CV1 cells. However, the SV40 genome is CpG deficient, 
containing only 54 dinucleotides in 5243bp, hence in this experiment the SV40 promoter 
is contained in methylation deficient surroundings. It was the objective of the present 
study to examine the effect of methylation on transcription from the SV40 promoter in a 
CpG rich environment. This can be achieved by linking the promoter to a reporter gene,
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the chloramphenicol acetyltransferase (CAT) gene contained within a bacterial plasmid. 
Unlike eukaryote DNA prokaryote DNA is not CpG deficient. This plasmid DNA can then be 
methylated in vitro using DNA methylase isolated from mouse Krebs II ascites tumour 
cells and used in transient expression assays. Such an experiment would provide 
information on the effect of regional methylation on transcription.
In addition, studying the effect of methylation on the binding of the 
transcription factor Sp1 to DNA would provide a possible mechanism for transcriptional 
inactivation by DNA methylation. This can be achieved by the use of synthetic 
oligonucleotides containing m5C. The use of these DNA molecules in gel retardation assays 
allows the effect of methylation on transcription factor-promoter interactions to be 
analysed in vitro. Since Sp1 is also known to bind to several cellular promoters such an 
experiment would provide information on the possible role of DNA methylation in v ivo .
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Chapter 2. Material and Methods
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2.1. Materials
2.1.1. List of Suppliers 
Cell Growth Medium
Eagle's Minimal Essential Medium (EMEM) and the Glasgow modification of Eagle's medium 
(GMEM) were supplied as 10x concentrates by Gibco, Paisley, U.K. Newborn calf serum, 
sodium bicarbonate (7.5%), L-glutamine (200mM), penicillin (10,000U/ml) / 
streptomycin (10,000pg/ml) and non-essential amino acids (100x) were also obtained 
from Gibco.
Bacterial Growth Media
Bactotryptone, yeast extract and Bactoagar were obtained from Difco, Detroit, U.S.A.
Fine Chemicals
Amberlite MB3, acrylamide, ammonium persulphate, ammonium sulphate (enzyme 
grade),| bromophenol blue, caesium chloride, EDTA, 99% formic acid (Analar), 
8-hydroxyquinoline, NN' methylene bis/acrylamide, perchloric acid (PCA), 
polyethyleneglycol 6000, NNN'.N'-tetramethylene diamine (TEMED), trichloroacetic acid
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(TCA), SDS and xylene cyanol, were obtained from BDH Chemicals, Poole, Dorset, U.K. 
Acetyl- CoA, agarose, ampicillin, 5-bromo-4-chloro-3-indolyl-B-galactosidase 
(X-gal), butyryl-CoA, chloramphenicol, deoxynucleotide triphosphates (dNTPs) ethidium 
bromide, isopropyl-B-D-thiogalactoside (IPTG), Low Melting Point (LMP) agarose, M. 
luteus DNA, nucleotide triphosphates (NTPs), phenol (Ultrapure),' 
phenylmethylsulphonylfluoride (PMSF), salmon testis DNA and urea (Ultrapure) were 
obtained from Sigma Chemical Co., Poole, Dorset,U.K.
Chloroform, ethylacetate, glycerol and xylenes were obtained from May & Baker, 
Manchester, U.K.
Deoxynucleotide triphosphates (dNTPs) and dithiothreitol (DTT) were supplied by 
Boehringer Mannheim, East Sussex, U.K.
Salicylic acid and tetramethylpentadecane (TMPD) were supplied by Aldrich Chemical Co., 
Gillingham, Dorset, U.K.
All other reagents were of the highest grade available. All solutions were prepared, where 
appropriate with de-ionised, distilled water (dH20).
Chromatographic Media
DEAE-Sepharose, CNBr activated Sepharose and Heparin Sepharose were obtained from 
Pharmacia (GB) Ltd., London, U.K.
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Enzymes
Proteinase K and T4 polynucleotide kinase were supplied by Boehringer Mannheim 
Bacterial restriction endonucleases, T4 DNA ligase, Klenow fragment of E.coli DNA 
polymerase I were supplied by Gibco BRL Ltd., Paisley, Scotland, ILK.
Lysozyme and trypsin were supplied by Sigma.
Restriction Enzyme Digestion Buffers
Restriction enzyme digests were performed in the appropriate "REact" buffer. These 
buffers were supplied with the restriction enzymes from Gibco BRL Ltd.
Radiochemicals
[^32p].adenosine triphosphate (6000Ci/mmol)
[a-32P]-deoxyadenosine triphosphate (3000Ci/mmol)
[a-32P]-uridine triphosphate (400Ci/mmol)
[a-35S]- deoxyadenosine triphosphate (600Ci/mmol)
Chloramphenicol D- threo-[dichloroacetyl-1,2-14C] (54Ci/mmol)
S-adenosyl-[3H-CH0]-methionine (0.5Ci/mmol, 15Ci/mmol)
were obtained from Amersham International, pic, Amersham U.K.
f
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Bacterial Strains
E. coli HB101 (Boyer and Roulland, 1977) was the host used for the growth of all plasmid 
DNA. It has the following genotype:F_,pro, leu, thi, lac Y, hsd R, endA,rec A, rsp L20, ara 
14, gal K2, xyl 5, mt 11, sup E44-
E.coli TGI cells ( T. Gibson, unpublished) were the host used for propagation of M13 DNA. 
It has the following genotype: A( lac, pro), thi, sup E, Ftra A36, pro AB, lac 19, lac Z 
AM15, hsdA5 (Eco Kr-m-).
Both these strains are used routinely in the Department of Biochemistry.
Continuous Cell Lines
Hela S3 cells ( Gey et a l, 1952) which are human, cervical carcinoma cells were used in 
the preparation of whole cell and nuclear extracts for in vitro transcription and gel 
retardation assays respectively.
L929 cells (Sanford etal.,1948) which are mouse fibroblast cells were used in transient 
expression assays.
CVI cells ( Sweet and Hilleman, 1960), a monkey kidney cell line was used for the 
preparation of SV40 DNA.
Plasmids j
pVHCI and pSVCI were constructed as described in text ( figures 3.3. and 4.2.) pTK3CAT, p200, 
pLW4 and pLW2 were a gift from Dr. J. Lang.
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2.1.2. Media 
Cell Culture Media
Glasgow modified Eagle's minimal essential medium (GMEM) was stored as a 10X 
concentrated solution. For use, the concentrate was diluted with sterile distilled water to 
500ml and supplemented with 50ml newborn calf serum, 20ml of 7.5% sodium 
bicarbonate, 5ml of (200mM) L-glutamine and 5ml of penicillin/strepomycin 
(10,000U/ml / 10,000pg/ml).
Eagles minimal essential medium (EMEM) was made up in a similar manner but 
supplemented with 50ml newborn calf serum, 5ml (200mM) L-glutamine, 5ml (100x) 
non. essential amino acids and 5ml of penicillin - streptomycin (10,000U/ml /
10,000|ig/ml). The pH was adjusted to 7.1 by the addition of approximatetly 250p.l of 5M 
NaOH.
All freshly made media were checked for contamination by a 2-3 day incubation at 37°C 
before storage at 4°C.
The complete composition of EMEM and GMEM is presented in table 2.1 
Versene
A stock solution of versene (diaminoethanetetraacetic acid) 0 .2g/l was made up in PBS A 
containing 1% phenyl red and autoclaved before use.
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Non Essential Amino Acids
Eagle's non essential amino acids were supplied as a 100x concentrate which contained:
Oil
L-Alanine 0.98
L-Asparginine-H20  1.50
L-Aspartic acid 1.33
L-Glutamic acid 1.47
Glycine . 0.75
L-Proline 1.15
L-Serine 1.05
Table 2.1 Eagle's media formulations (amino acid and vitamin components)
EMEM GMEM
Amino acids
(mg/l)
L-arginine-HCI 126.0 42.0
L-cysteine 24.0 24.0
L-glutamine 292.0 292.0
L-histidine HCI. H20  42.0 21.0
L-isoleucine 52.0 52.4
L-leucine 52.0 52.4
L-lysine-HCI 72.5 73.1
L-methionine 15.0 15.0
L-phenylalanine 32.0 33.0
L-threonine 48.0 47.6
L-tryptophan 10.0 8.0
L-tyrosine 36.0 36.2
L-valine 46.0 46.8
Vitamins
(mg/l)
D-Ca pantothenate 1.0 1.0
choline chloride 1.0 1.0
folic acid 1.0 1.0
a| Inositol 2.0 2.0
nicotinamide 1.0 1.0
pyridoxal-HCI 1.0 1.0
riboflavin 0.1 0.1
thiamin-HCI 1.0 1.0
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Bacterial Growth Medium
Media (liquid) Constituents per litre 
L- Broth (LB) 10g bactotryptone
10g NaCI 
5g yeast extract 
( adjusted to pH 7.2 with NaOH)
2 X TY 16g bactotryptone
5g NaCI
10g yeast extract 
made up to 1 litre with dH20.
Media ( solid) Constituents per litre 
L - Agar as LB + 15g agar
H - Agar 10g bactotryptone
8g NaCI 
12g agar
H - top agar 10g bactotryptone
8g NaCI 
8g agar
made up to 1 litre with dH20 .
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2.1.3. Solutions
Table 2.2 Commonly used solutions
During the course of this work a number of solutions were used repeatedly the composition
of these solutions are presented here.
Buffer M 50mM Tris-HCI,pH7.8,1 mM EDTA, 1mM DTT,
0.02%NaN3, 10% glycerol
M+ indicates that PMSF(60jig/ml) has been added just before use
0.172mMNaCI, 3.35mM KCI, pH7.2 
B- 5mM CaCI2.6H20
C- 4.6mM MgCI2.6H20
A,B and C were autoclaved separately, when appropriate, and mixed 
in ratio of 8 :1:1 before use.
PBS A- 10mM Na2HP04,1.84mM KH2HP04,
T.E. 10mM Tris-HCI, pH 8.0,1 mM EDTA
TBE 89mM Tris, 89mM boric acid, 25mM EDTA, pH8.3
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Sterilising solutions
All solutions used in the preparation or manipulation of DNA or involvimg the use of tissue 
cultured cells were sterilised either by autoclaving, 15psi for 20 minutes, or by passing 
through a Millipore sterilising filter unit (0 .22jim).
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2.2 Methods
2.2.1 General Procedures
During the course of this work a number of procedures were frequently used. 
The following section describes these general procedures.
2.2.1.1 Culture of Continuous Cell Lines
Continuous cell lines such as mouse L929 cells and CV1 cells were grown in the 
Glasgow modification of Eagle's minimal essential medium (GMEM) as monolayers in 
80cm2 tissue culture flasks. At confluency the cells were subcultured as follows: the 
medium was removed and the cells washed with 5ml of prewarmed trypsin-versene 
(0.25% trypsin : versene, 1:4 ) solution at 37°C. This was immediately removed and 
replaced with 5ml of fresh trypsin -versene. This was then incubated at 37°C for 3-5 
minutes while the cells became released into suspension. To prevent excess trypsin action 
20ml of GMEM containing serum was added and the appropriate volume of cell suspension 
transferred to new flasks and fresh medium added to 25ml. The cells were gassed with 5%
CO2 in air ( to create a pH of 7.3-7.5) and incubated at 37°C. Generally the cells were
split 1:3 every 6-7 days.
Hela cells were grown in suspension with constant stirring in Eagle's minimal 
essential medium (EMEM) at 37°C. Cells were fed by adding an equal volume of medium 
every second day.
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2.2.1.2. Infection of CV1 cells with SV40
CV1 cells were grown to approximately 80% confluency in six 175cm2 tissue 
culture flasks in GMEM. The medium was removed and the cells washed with 10ml of 
serum free medium. SV40 infected cell sonicate was diluted 1:100 in serum free medium 
and 10ml of this was added to each flask creating a viral concentration of approximately 1 
p.f.u. per 10 cells. The flasks were incubated at 37°C for one hour. Fresh GMEM 
containing 10% newborn calf serum was added and the cells incubated at 37°C for one 
week.
2.2.1.3 Isolation of SV40 DNA
SV40 DNA was isolated from infected CV1 cells according to the method of Hirt 
(1967). Six 175cm2 tissue culture flasks of infected CV1 cells were harvested and SV40 
DNA prepared as follows. The cells were washed in PBS A then lysed by adding 5ml of 
0.6% SDS, 20mM EDTA, pH 8 , to each flask and incubating at room temperature for 20 
minutes. 1 ml of 5M NaCI was added and the viscous lysate scraped into Corex tubes. After 
incubation at 4°C overnight the lysate was centrifuged at 8000g for 30 minutes at 4°C.
The supernatant containing the viral DNA was carefully removed and extracted with an 
equal volume of phenol, then chloroform. The DNA was precipitated with two volumes of 
cold ethanol at -20°C overnight. The precipitate was collected by centrifugation and 
washed with 70% ethanol at -20°C, dried by lyophilization, and resuspended in T.E. buffer
(300jxl). The DNA was then subjected to CsCIi/EtBr centrifugation, to remove
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contaminating cellular DNA, as follows. The DNA was transferred to two 5ml VH65 heat 
sealable centrifuge tubes and made up to 5ml with a solution containing CsCI (0.96g/ml) 
and EtBr (0.6mg/ml) in T.E. buffer. The density of the solution was checked using a 
refractometer and adjusted to a density of 1.59g/ml by the addition of solid CsCI when 
necessary. The tubes were sealed and centrifuged at 350000g for 16 hours in a Beckman 
Uitracentrifuge. Two bands were visible under normal light, the upper band represents 
cellular DNA and nicked circular SV40 DNA. The lower band represents supercoiled SV40
DNA. The latter was removed from the CsCI- /EtBr gradient and the EtBr removed by
extracting at least four times with two volumes of isopropanol. The DNA was then dialysed 
against several changes of 100 volumes of T.E. buffer at 4°C. The concentration and purity 
of the DNA was checked both spectrophotometrically and by agarose gel electrophoresis.
2.2.1.4. Storage of Bacterial Stocks
Long term storage was as a 50% (v/v) glycerol/LB solution at -20°C. Short 
term storage was on a suitable sealed agar plate at 4°C.
2.2.1.5. Transformation of Bacterial cells with DNA
Competent E.coli cells were prepared by a modified version of the method of 
Dagert and Erlich (1979). 0.5ml of an overnight 10ml LB culture of HB101 was used to 
inoculate 50ml of LB medium. The cells were grown at 37°C, with shaking for 4-5 hours
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(to an optical density of 0.4 at 650nm). The ceils were cooled on ice for 10 minutes then 
harvested by centrifugation at 2500 rpm ,4°C, for 10 minutes in a Beckman Benchtop
centrifuge. The cells were gently resuspended in 20ml of ice cold sterile 2M CaCl2 and left
on ice for 20 minutes. The cells were pelleted as before and resuspended in 1 ml sterile
50mM CaC^. Transformations were carried out in plastic, 5ml, sterile bijoux tubes.
DNA (10 -20ng) was added to 10Ojil of competent cells and the mixture incubated on ice 
for 10 minutes, then heat shocked at!42i°C for 5 minutes. 2ml of prewarmed (37 °C) LB 
medium was added and the cells incubated at 37°C for 1.5 hours before plating on a 
suitable, antibiotic-containing plate. Plates were incubated at 37°C overnight allowing 
colony formation.
2.2.1.6. Small Scale Isolation of Plasmid DNA
A modification of the method of Holmes and Quigley (1981) was used for small 
scale plasmid preparations.
A 5ml culture of plasmid transformed cells in L. Broth was grown up overnight. The cells 
were pelleted by centrifugation at 3000 rpm, 4°C, for 10 minutes in a Beckman Benchtop 
centrifuge. The supernatant was carefully removed and the cells resuspended in 1 ml of
dH20 and transferred to a microfuge tube. The cells were pelleted by centrifugation for 2
minutes in a microfuge. The supernatant was removed and the cells resuspended in a 
buffer containing 50mM Tris-HCI, pH8.0, 8% Sucrose, 5% Triton X-100,50mM EDTA.
A fresh solution of lysozyme was prepared (5mg/ml) and 30jllI of this added to the
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resuspended cells and the solutions mixed by a brief vortex. Denaturation was achieved by a 
90 second incubation in a boiling water bath. After centrifugation in a microfuge the 
supernatant was removed to a fresh tube and the plasmid DNA precipitated by addition of
200jil 5M NH4 acetate and 1ml of isopropanol followed by a 10 minute incubation at
-20°C. Plasmid DNA was recovered by centrifugation at 4°C for 10 minutes. The DNA 
pellet was washed with 1ml of cold ethanol at 4°C and resuspended in 25^il of T.E. buffer.
2.2.1.7. Large Scale Isolation of Plasmid DNA
The alkaline lysis method of Birmboin and Daly (1979) was used to prepare 
milligram amounts of pure plasmid DNA.
10ml of L-Broth containing ampicillin (100u.g/ml) was inoculated with a single colony of 
bacteria (usually HB101) transformed with the appropriate plasmid and incubated 
overnight at 37°C. This culture was used to inoculate one litre of L-Broth. The bacteria 
were grown at 37°C with vigorous shaking to an optical density of 0.8 at 630nm. 
Chloramphenicol was added to a final concentration of 170pg/ml. This increases plasmid 
copy number per cell by preventing the bacteria multiplying while still allowing plasmid 
DNA replication. The culture was incubated for a further 16 hours at 37°C with vigorous 
shaking.
The bacteria were pelleted by centrifugation at 4000g for 10 minutes at 4°C. 
The supernatant was removed and the cells resuspended in 6ml of cold alkaline lysis 1 
buffer( 50mM glucose,10mM EDTA, 25mM Tris-HCI, pH 8.0). The bacterial 
suspension was then distributed between two 30ml Ti60 centrifuge tubes on ice. To each
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was added 150^1 of lysozyme (40mg/ml in the above buffer). After mixing the tubes were 
incubated on ice for 30 minutes before adding 6ml of alkaline lysis 2 buffer (0.2M NaOH,
1% SD S) and a further 5 minute incubation on ice. 3M Na acetate, pH 4.8 (7.5ml per 
litre culture) was added and incubation on ice continued for a further 60 minutes. 
Centrifugation was then performed at 65,000g t20°C, for 30 minutes in a Beckman 
ultracentrifuge. The supernatant containing the plasmid DNA was retained, the volume 
measured and isopropanol, 0.6x the total volume added. The DNA was precipitated by 
incubation at room temperature for 10 minutes and pelleted by centrifugation 7,000g,
20°C, for 15 minutes in a Sorval SS-34 rotor. The DNA precipitate was resuspended in
T.E. buffer (30ml) and subjected to CsCI / EtBr centrifugation as follows. CsCI (28.6g)
and EtBr (1.8ml of a 10mg/ml stock) were added and the density of the solution checked
using a refractometer and adjusted to a density of 1.59 g/ml by the addition of solid CsCI if
necessary. The solution was transferred to VTi50 heat -sealable tubes and centrifuged at 
200000g ,20°C, for 16 hours in a Beckman LH-8 ultracentrifuge. Long wave U.V. light 
was used to visualise the plasmid DNA band which migrates ahead of the host chromosomal 
DNA in the caesium gradient. Plasmid DNA was removed by side puncture of the tube using 
a 21 gauge needle and a 5ml syringe to withdraw the band. Further purification was 
achieved by a second centrifugation in a VTi65 rotor, in heat sealable centrifuge tubes at 
350,000g, 20°C, for 16 hours. The lower band was collected as before and the EtBr was
removed by four extractions with two volumes of isoamylalcohol. The lower aqueous phase 
was collected and made up to a final volume of 1 ml with T.E. buffer and dialysed against 
several changes of 100 volumes of T.E. buffer at 4°C. The DNA concentration was 
determined spectrophotometrically and the purity examined by agarose gel electrophoresis.
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2.2.1.8. Quantitation of Nucleic Acids by Optical Density (O.D.)
Measurement
The absorption at 260nm of various dilutions of DNA samples was measured using quartz 
1 ml cuvettes in a Cecil linear readout U.V. spectrophotometer. The concentration was 
estimated assuming that O.D.=1.0 is equivalent to 50jig/ml of double stranded DNA.
2.2.1.9. Extraction of DNA with Phenol/Chloroform and Precipitation with 
Ethanol
DNA was routinely purified free of protein by extraction with 
phenol/chloroform and precipitated with ethanol. Solid phenol was melted and saturated 
with T.E. buffer. It was then mixed with an equal volume of chloroform:isoamylalcohol 
(24:1) and stored at 4°C.
The volume of the sample to be extracted was adjusted to 100pl with T.E., when 
necessary. 10Opil of the phenol mixture was added and the solution was vortexed for 1 -2 
minutes, then centrifuged for 4 minutes in a microfuge. The upper aqueous layer was 
removed to a fresh microfuge tube and the extraction procedure repeated. The sample was 
then twice extracted with ether saturated with water to remove the residual phenol.
The DNA was precipitated by adding one tenth volume of 3M sodium acetate pH 6.0 and 2.5 
volumes of cold ethanol. This was vortexed and placed at -20°C overnight or at -70°C for 
1 hour.
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2.2.1.10. Restriction Enzyme Digests of DNA
DNA was incubated at 37°C for at least 3 hours with the appropriate 
restriction enzyme (10U of enzyme per jig of DNA) in the presence of the appropriate 
"REact" (BRL) buffer in a total volume such that the DNA is at a final concentration of 
0.1pg/jil. For digestion with two enzymes the reactions were carried out simultaneously 
if the enzymes operated under the same salt conditions. If not the two digestions were 
carried out separately. After the first digestion the DNA was phenol/chloroform extracted 
and ethanol precipitated. The DNA was pelleted by centrifugation and resuspended in a 
small volume of| buffer jand the second digestion performed.
2.2.1.11. Agarose Gel Electrophoresis
Electrophoresis on 1%(w/v) agarose gels was used routinely to visualise and 
quantitate plasmid and SV40 DNA and to check the result of restriction enzyme digestions. 
The agarose was dissolved in TBE buffer containing 0.5pg/ml EtBr by boiling for 5 
minutes. It was then cooled to approximately 50°C before pouring. One tenth volume of 
BPB-containing sample buffer (15% Ficoll, 100mM EDTA, 0.1% BPB) was added to the 
DNA samples before being applied to the gel. Electrophoresis was carried out at ambient 
temperature at 70 volts, 30mA for 2-3 hours in TBE buffer containing 0.5 pg/ml EtBr.
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2.2.1.12. Purification of DNA from Low Melting Point Agarose
Restriction fragment DNA from pVHC1 and pSVC1 to be used for cloning into 
M13 vectors or for gel retardation assays was isolated from 1-1.5% low-melting point 
agarose gels. The gels were prepared and run as described in section 2 .2 .1 .11. The 
separated bands were visualised under longwave U.V. light and the appropriate band excised 
using a sterile scalpel. The gel slice was transferred to a sterile 1.5ml microfuge tube 
and an equal volume of T.E. buffer added . The agarose was melted at 65°C for 5 minutes. 
The DNA was extracted first with phenol/T.E. then phenol,as described in section 2.2.1.9. 
The aqueous phase, containing the DNA was then subjected to three extractions with 1 ml of 
ether to ensure all phenol was removed. The DNA was precipitated at -20°C with 2.5 
volumes of cold ethanol in the presence of 0.3M Na [acetate! for 16-20 hours.
’’ O
2.2.1.13. Non-denaturing Polyacrylamide Gel Electrophoresis
A stock solution of 30%(w/v) acrylamide:1%(w/v) NN'-methylene
bisacrylamide was prepared in dH20 . The solution was deionised using "Amberlite" mono
bed resin MB-1 and filtered through Whatman No.1 filter paper, then stored at 4°C.
50ml of the appropriate % gel mix was prepared using the following components: 
5m lTB E x10
400pl 10% ammonium persulphate 
appropriate volume of stock acrylamide
dH20 to 50ml
16|il TEMED
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TEMED was added last and the mixture poured immediately. Electrophoresis was carried 
out in TBE buffer at 30mA for 2 hours. Gels were dried under vacuum at 80°C for 2 hours 
using a Bio-rad model 1125 gel drier.
2.2.1.14. Denaturing Polyacrylamide Gel Electrophoresis
This method was used to analyse synthetic oligonucleotides and to purify single 
stranded restriction fragments for use in gel retardation assays. The polyacrylamide stock 
solution was prepared as above. The components of the gel were in the same concentration 
as for non-denaturing gels with the addition of urea to a final concentration of 7M.
Samples were heated to 95-100°C for 5-10 minutes before loading.
2.2.1.15. Photography of Gels
DNA was visualised by ethidium bromide (EtBr) fluorescence on a trans - 
illuminator (U.V Products Inc.). Gels were photographed with a Polaroid CU-5 camera and 
type 665 positive/negative film. -
2.2.1.16 Autoradiography
Dried polyacrylamide or agarose gels were exposed to a sheet of Kodak-X-Omat 
H-film with or without an intensifying screen at -70°C. The exposure times varied 
between 1 and 10 days depending on the type and amount of radioactivity involved.
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2.2.1.17. Fluorography
Agarose gels containing Hpa II digests of methylated pVHC1 were subjected to 
fluorography allowing the detection of tritium incorporation into the restriction 
fragments. This was performed according to the method of Chamberlain (1979). The gel
l 1 M l
was soaked for two hours in a solution of^sodium salicylate made from equimolar amounts of 
salicylic acid and NaOH adjusted to pH 5-7. The gel was then dried as described previously 
and autoradiographed.
2.2.1.18. Estimation of Protein Concentration
Protein concentration was estimated by the method of Bradford (1976)
2.2.2. In  Vitro Methylation of DNA with Mouse Ascites DNA 
Methylase
2.2.2.1. Preparation of DNA Methylase
Mouse Krebs II ascites tumour cells were obtained from mice 7 days after 
inoculation. Nuclei were prepared as described in Turnbull and Adams (1976). Cells 
were washed twice with PBS, each time the cells were pelleted by centrifugation at
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2000rpm for 10 minutes in a Beckman Benchtop centrifuge. The cells were then swollen
in dH2 0  containing PMSF (60jig/ml), pelleted (3000 rpm, 5 minutes), then resuspended
in 1% Tween 80 containing PMSF (60ng/ml). The cells were lysed by two passages 
through a Yamato LSC LH-21 homogenizer and checked microscopically for cell lysis. The 
nuclei were pelleted by centrifugation at 2000 rpm, 4°C, for 10 minutes, as before. The 
supernatant was carefully decanted and the nuclei stored at -70°C until required.
DNA methylase activity was extracted from ascites nuclei by stirring them 
with an equal volume of buffer M+ containing 0.4M NaCI for 20 minutes. The nuclei were 
pelleted by centrifugation at 3000 rpm, 4°C, for 15 minutes in a Beckman Benchtop 
centrifuge and the supernatant labelled A and retained. The extraction process was 
repeated by adding an equal volume of buffer M+ containing 0.2M NaCI, the nuclei were 
pelleted as before and the supernatant labelled B and retained. Supernatants A and B were 
combined to give a nuclear extract which was then absorbed onto phosphocellulose and 
eluted batchwise with buffer M+containing 0.5M NaCI. This material was made 50%
saturated with respect to ammonium sulphate j and the precipitated material
collected by centrifugation (8000g, 20 minutes,4°C). The pellet was redissolved in a 
minimum volume of buffer M+ and desalted on a small column of Sephadex G-50. The 
non-retarded fraction from this column was bound directly to an 8ml column of tRNA 
Sephadex (made from E.coli tRNA and CNBr-Sephadex according to the method of Arnt- 
Jovin et a/.,1975). The tRNA column was washed with at least a column volume of buffer 
M+ and the enzyme eluted with buffer M+ containing 0.18M NaCI. The 1 ml fractions 
collected were assayed for protein by measuring absorbance at 280nm and the protein peak 
dialysed overnight against buffer M+ containing 50% v/v glycerol at -20°C. Each 
fraction was then assayed for enzyme activity.
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2.2.2.2. DNA Methylase Assay
The enzyme was assayed in a reaction mixture containing: 5pg heat denatured 
M.luteus DNA, S-Adenosyi [Me-3H] methionine (3.3jlxM;1 .08|_LCi), BSA (1.4mg/ml) and 
5p.l of enzyme, made up to 70}il with buffer M+ containing 0.1 M NaCI. After incubation at 
37°C for one hour the reaction was stopped by adding 500pl of stopper solution ( 1% SDS, 
2mM EDTA, 3% aminosalicylic acid (PAS), 5% n-butanol, 0.5M NaCI andj salmon] testis 
DNA (0.5mg/ml) to act as a carrier). Protein was removed by adding an equal volume of 
phenol mix (88% phenol/12% m-cresol/0.1 % 8 hydroxyquinoline). After 
centrifugation (microfuge, 20°C, 4minutes), the upper aqueous layer was removed to a 
fresh tube and the DNA precipitated by the addition of two volumes of ethanol. The DNA was 
pelleted by centrifugation and redissolved in 0.3M NaOH and incubated at 37°C for one hour 
to remove RNA. The DNA was precipitated onto filter paper (Whatman 3MM, 2.5cm) by 
washing 5 times at 4°C with 5% TCA. The DNA was washed with ethanol and ether and 
dried under a stream of air then transferred to scintillation vials prior to solubilisation in 
0.5M perchloric acid at 60°C for 20 minutes. "Ecoscint" scintillator (5ml) was added and 
the radioactivity counted on a liquid scintillation counter.
2.2.2.3. Methylation of Plasmid DNA
S-Adenosyl-(Me-3H)-methionine (0.5Ci/mmol)*, 0.1 mg/ml BSA, DNA methylase at a 
concentration of 1 U/pmol CpG present in buffer M+. The final reaction volume varied
1-10|xg | of plasmid DNA was methylated in a reaction containing 10pM
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such that the plasmid concentration was at a concentration o ff 0.1|iig/jil|. The reaction was 
performed at 37°C for 4 hours.
'except when the methylated DNA was to be subjected to fluorography when 
S-adenosyl-(Me-3H)-methionine with a specific activity of 4.6Ci/mmol was used.
2.2.3. Chloramphenicol Acetyl Transferase Transient 
Expression Assay
2.2.3.1. Transfection of Cells with Plasmid DNA
All solutions used in these transfection experiments were sterilised either 
by autoclaving at 15psi for 20 minutes or by passage through a 0.22pM Millipore filter 
before use. All manipulations were performed in a flow hood to prevent microbial 
contamination. The reactions were carried out in sterile 5ml plastic bijoux bottles. The 
quantities specified are for transfection of approximately 106 cells grown in 25cm2 tissue 
culture flasks. Each reaction was carried out in duplicate.
10ng of plasmid DNA, 125jnl 2M CaCl2 and 30jig of salmon testis DNA (used as carrier 
DNA) was made up to 1ml with sterile dH20  and mixed thoroughly by inversion or 
pipetting. The mixture was then added dropwise, with mixing, to a tube containing 1 ml 2 x
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HBS buffer (50mM Hepes, 280mM NaCI, 1.5mM Na2HP04,1.5mM NaH2P04, pH7.12), to 
ensure the formation of a fine precipitate. It was then incubated at room temperature for 
30 minutes, without agitation, to allow the formation of the Ca3(P04)2-DNA precipitate.
1 ml of this precipitate was added dropwise into the medium of duplicate flasks 
containing mouse L929 cells. It is important that these cells are in log phase when 
fransfected. For |this reason they were set up the previous day at the appropriate density 
(106/flask) from a stock flask. The cells were incubated with the precipitate at 37°C for 
12 to 16 hours . The medium was then removed and the cells washed twice with 
prewarmed PBS before fresh prewarmed growth medium was added. Incubation was 
continued for a further 24 hours (unless otherwise specified). The cells were then 
harvested as follows. The medium was removed and the cell monolayer washed twice with 
PBS. 1 ml of TEN buffer (0.04M Tris-HCI, pH7.8, 0.01 M EDTA, 0.12M NaCI) was then 
added and the cells incubated for 5 minutes at room temperature before being scraped off 
the dish using a rubber policeman. The cells were pelleted by centrifugation at 1,000 
rpm in a microfuge for 5 minutes at 4°C and resuspended, by pipetting, in 90|xl of 0.25M 
Tris-HCI, pH7.8 on ice. The cells were lysed by three cycles of freeze / thawing 
consisting of 5 minutes incubation on dry ice (-70°C) followed by a 5 minute incubation at 
37°C. The cell debris was pelleted by centrifugation at 5,000 rpm for 5 minutes in a 
microfuge. The supernatant was removed to a fresh tube. Aliquots of the supernatant 
were used for protein estimation and for assaying CAT activity and the remainder stored at 
-20°C.
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2.2.3.2. Chloramphenicol Acyl Transferase Assay
(a) According to the method of Cohen et al. (1980)
A fresh solution of 4mM acetyl CoA was used for each set of assays. 10p.l of 
this was added to an microfuge tube containing 100jj.M 14C chloramphenicol (54Ci/mmol), 
30-60jj.I cell extract, in 0.1 M Tris-HCI, pH 7.8, in a final volume of 90jjJ. The reaction 
was performed at 37°C for 1 hour, then stopped by the addition of 400jil of ethyl acetate.
The tubes were then shaken for 15 seconds. The organic and aqueous layers were separated 
by centrifugation at high speed in a microfuge for 30 seconds. The top, organic layer was 
removed to a fresh tube and lyophilised. The chloramphenicol products were resuspended 
in 30pJ of ethyl acetate and spotted onto silica thin-layer chromatography (TLC) plates. 
Ascending chromatography was in 95% chloroform and 5% methanol. The TLC plates 
were' allowed to dry and then subjected to autoradiography with an exposure time of 1-2 
days. The radioactive spots were marked, cut out and removed to scintillation vials. 5ml 
of "Ecoscint" was added and the radioactivity counted on a liquid scintillation counter.
(b) According to the method of Seed and Sheen (1988)
30-60 \i\ of cell extract was added to a microfuge tube containing a buffered 
solution of substrates constituted to give a final volume of 100p.l, and final concentrations 
of 100mM Tris-HCI, pH 8 .0 ,100^iM [14C] chloramphenicol (54Ci/mmol) and 250pM 
butyryl CoA (fresh). After ihcubation at 37°C for 1 hour, the reaction was terminated by
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addition of two volumes of a 2:1 mixture of TMPD(tetramethylpentadecane): xylenes, and 
mixed vigorously by vortexing. After centrifugation for 1 minute in a microfuge,90% of 
the upper, organic phase was removed to a fresh tube and extracted with an 100pJ of 
10OmM Tris-HCI, pH8.0. The solutions were mixed as before and the organic layer 
removed to a scintillation vial and counted.
2.2.4. Gel Retardation Assays
2.2.4.1. Preparation of Hela Cell Nuclear Extract
Hela cell nuclear extracts were prepared according to the method of Dignam
efa/., (1983).
Hela cells were grown in stirring flasks at 37°C in EMEM containing 10% calf serum.
They were grown to a density of 3 to 5 x 105 cells per ml prior to harvesting, 4 to 7 x10^ 
cells were used for a typical extract preparation.
Hela cells were harvested from cell culture media by centrifugation (at room temperature) 
for 10 minutes at 2000g . Pelleted cells were then suspended in five volumes of PBS 
(4°C) and collected by centrifugation as above; all subsequent steps were performed at 
4°C. The cells were resuspended in five packed cell volumes of buffer A (10mM Hepes (pH 
7.9), 1.5mM MgC^, 10mM KCI, 0.5mM DTT, 0.5mM PMSF) and incubated on ice for 10
minutes. The cells were collected by centrifugation as before and resuspended in two 
packed cell volumes of buffer A and lysed by homogenisation (10 strokes). The homogenate
was checked microscopically for cell lysis and centrifuged at 2000g, 4°C, for 10 minutes 
to pellet nuclei. The supernatant was removed and the nuclei subjected to a second 
centrifugation for 20 minutes at 25000g, to remove residual cytoplasmic material. The 
nuclei were resuspended in 3ml of buffer C (20mM Hepes, pH 7.9,25% (v/v) glycerol, 
0.42M NaCI, 1.5mM MgCI2, 0.2mM EDTA, 0.5mM PMSF and 0.5mM DTT) per 109 cells, 
using ten strokes of homogenisation. The resulting suspension was stirred gently with a 
magnetic stirring bar for 30 minutes at 4°C, then centrifuged for 30 minutes at 25000g. 
Theresulting clear supernatant was dialysed against 50 volumes of buffer D (20mM 
Hepes,pH7.9,20% (v/v) glycerol, 0.1MKCI,0.2mM EDTA, 0.5mM PMSF and 0.5mM DTT) 
at 4°C. The dialysate was centrifuged at 25000g for 20 minutes as before, the 
supernatant, designated the nuclear extract, carefully removed and stored at -70°C in 
aliquots.
2.2.4.2. Fractionation of Hela Cell Nuclear Extract
(a) Using Heparin Sepharose Affinity Chromatography
Nuclear extracts were prepared as in section 2.2.4.1. After dialysis a final 
volume of 1.4ml (2.5-3mg/ml) of nuclear extract was obtained. A 200jnl aliquot was 
saved as nuclear extract, the remainder was applied to a 2ml heparin agarose column
equilibrated in TM buffer (50mM Tris-HCI, pH 7.9, 20% glycerol, 12.5mM MgCl2,1mM
EDTA, 1 mM DTT) containing 0.1 M KCI. The column was then washed with 1.5 column 
volumes of the same buffer and the "run through" collected. The bound protein was then 
eluted stepwise as follows; the column was washed with 1.5 column volumes of TM 
containing 0.2M KCI, then 2 column volumes of TM containing 0.4M KCI. Finally the
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column wasj regenerated by washing with h  i  TM plus 0.1 M KCI. 0.2ml fractions were 
collected throughout, the protein content was estimated as described in section 2.2.1.18. 
Approximately 5|ig of protein from each fraction was used in a gel retardation assay.
(b) Using DEAE Sepharose Ion -Exchange Chromatography
Nuclear extract was prepared as described in section 2.2.4.1. 1.6ml(4mg) 
was loaded onto a 1.5ml DEAE Sepharose column pre-equilibrated in buffer D ( 20mM 
Hepes, pH7.9, 20% (v/v) glycerol, 0.1 M KCI, 0.2mM EDTA, 0.5mM PMSF and 0.5mM 
DTT). The column was washed with 1.5ml of buffer D and 10Op.1 fractions were collected 
at 4°C. Approximately 5^g of protein from each fraction was used in a gel retardation 
assay.
2.2.4.3. End Labelling of Restriction Fragments
Restriction fragments of DNA were purified from low-melting point agarose 
(section 2.2.1.12.) and end labelled using the Klenow fragment of DNA polymerase and 
[a - 32P]-dATP, and used in gel retardation assays.
After ethanol precipitation the DNA was dried by lyophilisation.The following reaction 
components were added to the dried DNA:-
3.75pl 10X medium salt buffer (10mM Tris-HCI, pH7.5, 50mM NaCI,10mM M gC y 
3(il (30jn.Ci) [a-32pj-dATP (3,000 Ci/mmol)
1 \i\ 1 OOjiM dTTP.dCTP, dGTP 
1U Klenow fragment of DNA Polymerase I
dH20 was added to give a final reaction volume of 25pil
t
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The reaction was performed at 25°C for 30 minutes. To remove unincorporated
deoxyribonucleotide the DNA was extracted twice with ethanol, as follows. 90pJ 2.5M NH4
Acetate and 360^1 of cold ethanol were added and the DNA precipitated by incubation on dry 
ice (-70°C) for 10 minutes. The labelled DNA was pelleted by centrifugation in a 
microfuge for 10 minutes at 4°C, then resuspended in 1 OOjllI 0.3M Na acetate, pH6.0, and 
SOOjxl of cold ethanol added. The DNA was precipitated for 15 minutes on dry ice, pelleted 
as before and lyophilised until dry. It was then resuspended in the appropriate volume of
dH2 0  and used in gel retardation assays.
2.2.4.4. Synthesis of Oligonucleotides
Oligonucleotides were synthesised by the phosphoamidite method on an 
Applied Biosystems model 381A DNA Synthesizer by Dr. V. Math, Department of 
Biochemistry. This involved successive diester bond formation between the 5'-OH group 
of one nucleotide derivative and the 3'-OP of another (the nucleotide derivative in this case 
being dialkyl phosphoamidite) resulting in a phosphite triester which must be oxidised 
(e.g. with aqueous iodine) to a stable phosphotriester before the next step. The potentially 
reactive groups elsewhere in the molecules are "protected" by reversible chemical 
modification. The oligonucleotide chain is chemically synthesised in a 3' to5’ direction.
The first nucleotide is directly linked to a solid support (e.g. silica gel) packed in a column, 
allowing the excess reagents to be washed off the column after each step. At the end of the 
synthesis the oligonucleotide must be chemically released from the column and deprotected. 
The DNA was then purified by ethanol precipitation.
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2.2.4.5. Annealing and Ligation of Oligonucleotides
Synthetic oligonucleotides were annealed as described in Kadonaga and Tjian 
(1986). 10jig of each of the two complementary oligonucleotides were annealed in a
reaction containing 67mM Tris-HCI,pH7.6f13mM MgCl2, 6.7mM DTT, 1.3mM spermidine
andl .3mM EDTA in a final volume of 20jjJ. The annealing was performed in at 88°C  for 2 
minutes, 65°C for 10 minutes, 37°C for10 minutes, followed by 5 minutes at room 
temperature. An aliquot was analysed by electrophoresis on a 2% agarose gel and the 
remainder stored at -20°C, for later use, or ligated as follows. The DNA was precipitated 
by ethanol, dried and resuspended in a total volume of 40jjI containing 66mM Tris-HCI,
pH7.6,6.6mM MgC^, 0.5mM ATP,1 OmM DTT and 10U of T4 DNA ligase. The mixture was
incubated at 16°C fori 6-24 hours. The DNA was phenol extracted and ethanol precipitated 
and an aliquot analysed on a 2% agarose gel.
2.2.4.6. End Labelling of Oligonucleotides
Both single and double standed oligonucleotides were end labelled using 
polynucleotide kinase and [y-32P]- ATP and used in gel retardation assays. 10Ongof 
synthetic oligonucleotide in a total volume of 11 pi containing 0.05M Tris-HCI, pH8.0,
0.01 M MgCl2, 5mM DTT, 12pmoles (60p.Ci) [y-32P] ATP and 10 units T4 polynucleotide
kinase was incubated at 37°C for 1 hour. The labelled oligonucleotide DNA was recovered 
and separated from unincorporated radioactivity by two ethanol jprecipitations, as follows.
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40jil 2.5M NH4acetate and 160jil of cold ethanol were added to the incubation mix and the
DNA was precipitated at -70°C for 15minutes. The DNA was pelleted by centrifugation at 
4°C for 10minutes in a microfuge. The pellet was resuspended in 100pJ 0.3M Na acetate, 
300|xl of cold ethanol was added and the DNA precipitated and collected as before. The 
labelled oligonucleotides were dried by lyophilisation for 2-3 minutes.
2.2.4.T. Base Composition Analysis of Oligonucleotides
5pg of oligonucleotide DNA was hydrolysed using 8% formic acid at 180°C for 
90 minutes. The formic acid was evaporated and the bases dissolved in ammonium 
carbonate buffer (20mM, pH 10.0, at room temperature) and applied to a column of 
Aminex A6 (BioRad; 27cm x 12cm). The column was then eluted with the same buffer at 
50°C with a flow rate of approximately 1 ml/minute. Bases were quantified by measuring 
absorbance at 260nm. This analysis was performed by Dr. R. Adams.
2.2.4.8. Gel Retardation Assay
A 91 bp Sph VNco I restriction fragment of pSVC1 was 32P end labelled as 
described in section|2!z^4J3-5ng of this was incubated in the presence of 2-10jig of Hela 
cell nuclear extract in a total volume of 10pJ containing 20mM Hepes (pH7.9), 20%v/v 
glycerol, 0.1MKCI, 0.2mM EDTA, 5mM DTT and 5fig of poly(dl-dC) DNA. The assay 
mixture was incubated at 25°C for 30 minutes. 1 OjliI of sample buffer (15%  Ficoll,
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100mM EDTA, 0.1%|bromophenol|blue) was then added and the samples loaded onto a 4% 
polyacrylamide gel. The gel was prerun for 30minutes at 20Vcnr1, then run at 
10Vcnrr^ for 2.5-3 hours after the samples were applied. Gels were dried as described 
and autoradiographed without an intensifying screen.
2.2.5. In Vitro Transcription Assays
2.2.5.1. Preparation of Hela Cell Extract
Soluble whole cell extracts were prepared from Hela cells by the method of 
Manley et a / .,(1980) for use in in vitro transcription assays.
Hela cells were grown in suspension culture in Eagle’s minimal essential medium 
supplemented with 10% newborn calf serum to a density of approximately 8x105 
cells/ml. Generally 1-1.5 I of cells were used for each preparation. All steps were 
performed between 0 and 4°C. Cells were pelleted by centrifugation at 3000 rpm,4°C, 
for 10 minutes in a Beckman Benchtop centrifuge. The pelleted cells were washed in PBS 
by resuspending them in 3-5 ml of cold PBS followed by centrifugation as before. The cell 
pellet was resuspended in 4 packed cell volumes of buffer I (0.01 M Tris-HCI, pH9.0,
0.001 M EDTA, 0.005M DTT). After a 20 minute incubation on ice, the cells were lysed by 
8 strokes of homogenisation. Four packed cell volumes of buffer II (0.05M Tris-HCI,pH
7.9, 0.01 M MgCl2,0.002M DTT,25% sucrose,50% (v/v) glycerol) were then added and
the mixture stirred gently on ice. To this suspension one packed cell volume of saturated
(NH4)2S04 was added dropwise, the lysate was gently stirred for an additional 20minutes.
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The extract was then centrifuged at 180000g for three hours in a Beckman Ti60 rotor.
The supernatant was carefully decanted to a fresh tube and precipitated by the addition of
solid (NH4)2S04  (0.33g/ml of suspension), slowly with stirring. After the (NH4)2S04
had completely dissolved, 0.01ml of 1M NaOH per 10g (NH4)2S0 4 was added and the 
suspension stirred on ice for 20 minutes. The precipitate was collected by centrifugation 
at 15000g, 4°C, for 20 minutes and resuspended in 1/10th the volume of high speed 
[supernatant j of buffer III (50mM Tris-HCI,pH7.9,6mM MgC^, 40mM (NH4)2SO4,0 .2mM 
EDTA, 1 mM DTT, 15% glycerol). This suspension was then dialysed for 4-8 hours 
against two changes of 100 volumes of the same buffer. The diasylate was centrifuged at 
10000g, 4°C, for 10 minutes and the supernatant aliquotted into small samples and stored 
at -70°C.
2.2.5.2. In Vitro Transcription Assays
In vitro transcription assays were performed in a final volume of 20^il 
containing 10fil(20-25jig) of Hela cell extract, 250jiM CTPjGT^ATP, 25pM (10pCi) 
[<x-32P]-UTP (400Ci/mmol) and 100-200ng of DNA template. The reaction was 
performed at 30°C for 1 hour. The reaction was terminated by the addition of 50pl of 
proteinase K mix ( proteinase K, 1 mg/ml, 0.05% SDS, 0.5mg/ml E.coli tRNA ) and a
further 20 minute incubation at 37°C. 90jil of 1M NH4 acetate was added and the protein
removed by the addition of 200jil of phenol/j chloroform^ followed by a 1 minute vortex and 
centrifugation for 4 minutes in a microfuge. The upper aqueous layer was removed to a
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fresh tube and the phenol back-extracted by addition of 200pl of 1M NH4 acetate, mixed
and centrifugated as before, the upper aqueous layer was then removed and mixed with the 
previous one. The nucleic acids were then precipitated by the addition of 2.5 volumes of 
cold ethanol, followed by incubation on dry ice (-70°C) for 15 minutes. The RNA was
dried by lyophilisation and redissolved in 12pl of dH20 . 8|il of formamide dye mix 
(deionised formamide containing 0.3% BPB, 20mM EDTA) was added and the samples loaded 
onto a 5% denaturing polyacrylamide gel or a 1.4% agarose gel and electrophoresed for 
3hours at 250V.
2.2.6. Cloning Into M13 Vectors
The protocols used to generate recombinant M13 molecules were as described in 
t h e " M13 Cloning and Sequencing Handbook” (Amersham International Pic).
2.2.6.1. Large Scale Preparation of M13 RF DNA
5ml of a 1:100 diluted overnight culture of TG1 cells was inoculated with a 
single plaque of virus-containing cells. Cells were grown with vigorous shaking for 4 
hours. The cells were then pelleted by centrifugation at 3000 rpm, 4°C, for 10 minutes 
in a Beckman Benchtop centrifuge and the virus-containing supernatent used to inoculate a 
500ml culture of exponentially growing (with an jopticalj density of 0.2-0.3 at 600nm)
TG1 cells. Cells were grown for a further 4-5 hours at 37°C with shaking, then harvested
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by centrifugation at 4000g, 4°C,for 10 minutes . Viral RF DNA was then isolated by the • 
alkaline lysis method described in section 2.2.1.7.
2.2.6.3. Preparation of M13mp19 RF DNA for Cloning
1pg of RF DNA was digested with the restriction enzymes Eco Rl and Kpn I as 
described in section 2.2.1.10. The extent of digestion was checked by agarose gel 
electrophoresis. The DNA was phenol/chloroform purified free of enzyme and ethanol 
precipitated, as described in section 2.2.1.9.
202.6.3. Preparation of Insert DNA
5jag of pVHC1 plasmid DNA was digested with 50U of Kpn I in low salt buffer
(10mM Tris-HCI, pH 7 .5 ,10mm MgC^, 1mM DTT) in conditions described in section
2.2.1.10 JNaCljconditions were adjusted to final concentration of 100mM and the DNA 
subjected to partial digestion with Eco Rl as follows. 25U of Eco Rl was added to the 
incubation mix at 37°C and aliquots were removed aftei2,5,10,20,30and 60 minutes. The 
DNA fragments were separated by electrophoresis on a 1 % low-melting point agarose gel 
alongside DNA size markers (as in figure 2 .1.). The 601 bp fragment containing the SV40 
promoter-enhancer sequence and the 2107bp fragment containing the 
promoter-enhancer-CAT gene and terminater sequence were excised from the gel and 
purified.
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Figure 2.1. Kpn I / Eco Rl Digestion of pVHCl
(a) Kpn I / Eco Rl Restriction Map of pVHCl (see figure 3.3.)
(b) Kpn I / Eco Rl digestion of pVHCl
Kpn I digested DNA was treated with 25U of Eco Rl for 2,5,10,20,30, or 60 minutes 
(lanes 1-6), as described in section 2.2.6.3., and subjected to electrophoresis on a 1% 
agarose gel. Lane M contains X DNA digested with Hind III and Eco Rl, as marker DNA.
Kbp 2 5 10 204060 M
4 .736
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2.2.6.4. Ligations
Ligations were performed using bacteriophage T4 DNA ligase, in a final volume of
20pl containing 66mM Tris-HCI, pH7.6, 6 .6mM MgC^, 0.5mM ATP, 10mM DTT, 100ng
vector DNA and 20ng of insert DNA. 1U of DNA ligase was added and the reaction carried 
out at 15°C for 16hours.
2.2.6.5. Transformation of E. coli (TG1) cells with M13 DNA
TG1 cells were made competent for DNA uptake as described in section 2 .2 .1.5. 
The entire ligation mix was added to 300pl of competent cells and the mixture incubated on 
ice for at least 1 hour. The cells were then heat shocked at 42°C for 3 minutes and 
returned to ice. The transformation mix was then added to 3ml of molten top agar 
containing 40jliI of 100mM IPTG, 40pl of 2% (w/v) X-gal (in dimethyl formamide) and 
200|il of fresh (exponentially growing) TG1 cells 10OmM IPTG, at 45°C. The contents 
were mixed and plated out on a prewarmed (37°C) H plate. Plates were incubated at 37°C 
overnight.
2.2.6.6. Preparation of Single Stranded Template DNA
The M13 cloning system allows the easy identification of recombinant phage by 
the inactivation of the p-galactosidase gene. A simple plaque assay can be used to
t
differentiate recombinants (colourless plaques) from non-recombinants (blue plaques).
A 10ml 2TY overnight culture of E. coli was used to inoculate fresh 2TY medium at a ratio 
of 1 ml:100ml. A single plaque was lifted using a sterile Eppendorf pipette tip and used to 
inoculate 1.5 ml of the low density E. coli TG1 culture. The culture was shaken at 37°C 
for 5 hours then centrifuged for 5 minutes in a microfuge. The supernatant was carefully 
removed to a fresh tube and recentrifuged to remove any residual cells. The supernatant 
was added to 200jil PEG/NaCI (20%w/v polyethylene glycol 6000 / 2.5M NaCI), mixed 
thoroughly and left for 15 minutes at room temperature. Precipitated phage were 
harvested by centrifugation in a microfuge for 5 minutes and residual PEG/NaCI removed 
by a second centrifugation and capillary action of a drawn out Pasteur pipette. The viral 
pellet was resuspended in 100pl T.E. buffer, 50|il of phenol/T.E. was added , the mixture 
vortexed for 20 seconds and left at room temperature for 15 minutes. The upper aqueous 
layer was transferred to a fresh microfuge tube and extracted with 500pl of chloroform.
Na acetate (pH6.0) was added to a final concentration of 0.3M, 250pl of ice cold ethanol 
was added and the DNA precipitated at -20°C overnight. The DNA was recovered by 
centrifugation at 4°C (10 minutes, microfuge) and the template DNA resuspended in 20pl 
of T.E. buffer and stored at -20°C. The purity of the DNA template was examined by 
electrophoresis on a 1 % agarose gel.
2.2.6.7. T-Track Analysis
Potential recombinant clones were screened for insert by T-tracking and comparison with 
vector DNA.
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For each ten recombinants to be analysed the following priming mix was prepared : 4jil 
M13 primer(25pg/ml), 6jil 10x Klenow buffer(100mM Tris-HCI, pH7.8,100mM
M g C y  and 12pl dH2 0 . 2|il of this priming mix was annealed to 2)nl of each template at
60°C, for 1.5-2 hours.
The M13 sequencing primer is a 17mer with the sequence 5' - GTA AAA CGA CGG CCA GT 
-3'.
3fil (30|iCi) of [a-35S] dATP (600 Ci/mmol) and. 16pl 0.5mM dTTP/0.5mM ddTTP mix® 
and 2U of Klenow fragment of E  coli DNA polymerase I were mixed and 2jil of mix added to 
each annealed primer/template. After a 20 minute incubation at room temperature, 1pl of 
a 0.5mM uniform chase solution of all four dNTPs was added and the reaction continued at 
room temperature for a further 15 minutes. Reactions were stopped by the addition of 1 pi 
of formamide dye mix (96% w/v deionised formamide, 0.03% w/v xylene cyanol FF,
10mM EDTA). The samples were incubated at 95-100°C for 3 minutes and the primer 
extended DNA fragments resolved by denaturing polyacrylamide gel electrophoresis 
(20x40x0.4cm). The gels were then fixed in 10% v/v acetic acid, 10% v/v methanol for 
20 minutes. Gels were dried onto a sheet of Whatman 3MM paper using a Bio-rad model 
1125 gel drier. Autoradiography was carried out as described in section 2.2.1.16 with 
exposure times of 24-48 hours. Figure 2.2. shows identification of recombinant M13 
molecules by comparison with M13mp18 and mp19 in a T-Tracking experiment.
* The dTTP/ ddTTP mix used also contains dCTP and dGTP at a concentration of 0.08mM. |
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Figure 2.2. T-Track Analysis of M13 Recombinants
T-Tracking was performed as described in section 2.2.6.7. Lanes 3,4,5,10,11 and 12
correspond to the sequence 5' GAATTCgg2 CTTAAg0o of pVHCl indicating the presence
of the Kpn I (392)/ Eco Rl (992) insert. Lanes 1,2,8 and 9 are probably artefactual.
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2.2.6.8. Synthesis of second strand
M13 single stranded recombinants were used as templates for preparation of double 
stranded molecules containing methyl dCTP in one strand.
The universal primer was annealed as for T-Tracking (section 2.7.7.), using 15pl (1jig) 
of single stranded recombinant DNA and 4jil of primer DNA (25pg/ml) and 2 jil of Klenow
buffer (100mM Tris-HCI ,pH 7 .8 ,100mM MgCl2 ).
Primer extension was carried out as follows. To the 11 pi of the above annealing mixture 
the following was added: 3pl dNTP cocktail containing 2.5mM dCTP, dTTP, dGTP, 3pl of 
15pM dATP, 30pCi [a-32P]-dATP (3000Ci/mmol) and 10U of Klenow fragment of DNA 
polymerase in a final volume of 25pl. The contents were mixed and incubated at room 
temperature for 10 minutes before the addition of 3pl of 2.5mM dATP and the incubation 
continued for a further 20 minutes. The reaction was stopped by incubating at 68°C for 
10 minutes. The reaction mix was cooled and restriction enzyme digested by adding 2pl of 
the appropriate "REact" buffer x10 and 10U of restriction enzyme. The DNA was digested 
at 37°C for three hours. Protein was removed by phenol/chloroform extraction and the 
DNA precipitated with ethanol. The second digest was then performed. The reaction was 
stopped by incubation at 68°C for 10 minutes. The restriction fragment (usually Sph 
UNco I) was separated from the remainder of the DNA by electrophoresis on a 7% 
non-denaturing polyacrylamide gel. After autoradiography of the gel the desired 
restriction fragment was identified and cut out of the gel using a sterile scalpel blade.
500pl of sterile dH20  was added and the acrylamide broken up by several passings through
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a 1 ml syringe. The DNA was extracted by incubating this at 65°C for 1 -2 hours. The 
mixture was centrifuged for 10 minutes in a microfuge to pellet the acrylamide. The 
supernatent was removed and the radioactivity estimated by Cherenkov counting in a liquid 
scintillation counter. This provided an estimation of percentage recovery of the DNA. The 
labelled restriction fragment DNA was then precipitated with ethanol at -70°C and pelleted 
by centrifugation at 4°C for 10 minutes in a microfuge. It was then resuspended in the
appropriate volume of dH20 and used in a gel retardation assay.
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Chapter 3. In Vitro Methylation of DNA
with Mouse Krebs II Ascites Tumour 
Cell DNA Methylase
t
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Introduction
In the following experiments DNA methylase purified from mouse Krebs II 
ascites tumour cells was used to methylate SV40 and plasmid DNA in vitro. 
Unmethylated, double stranded DNA is a poor substrate for the enzyme, requiring it to 
perform de novo methylation. Hence, conditions were optimised to obtain maximum
incorporation of CH3 groups into the DNA.
|3.L, Purification of DNA Methyltransferase from Mouse 
Krebs I I  Ascites Tumour Cells.
Since tumour cells are rapidly dividing and therefore have a high level of 
DNA synthesis, they provide a good starting material for the purification of enzymes such 
as DNA methylase. Purification of DNA methylase from mouse Krebs II ascites tumour 
cells was first performed by Turnbull and Adams (1976). Improvements to the 
original method have also been published (Adams et al.A 1979). DNA methylase was 
prepared as described in section 2 .2 .2 .1.
A typical purification table is as follows:
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FRACTION TOTAL
PROTEIN
(mg)
Nuclear Extract 1352
Phosphocellulose 84
tRNA-Sepharose 5.1
(1 unit = 1 pmol CH3 /h)
TOTAL
ACTIVITY
(units)
SPECIFIC
ACTIVITY
(units/mg)
36600 27
16100 192
10100 1980
Table 3.1. Purification of DNA Methylase from Mouse Krebs II Ascites Tumour Cells
Preparation of the low salt nuclear extract from the original cell suspension 
generally gives a 30 fold purification. Hence the overall purification is approximately 
2000 fold and the enzyme is around 10% pure at this stage.
Preparation of DNA methylase for use in some of the later experiments was 
performed by M. McGarvey and in these purifications the tRNA Sepharose step was 
replaced by DNA Sepharose. However, the level of purity remained similar.
DNA methylase has been purified to homogeneity in our laboratory (Adams et 
a!., 1986) by adding further affinity chromatography and gel filtration steps to the 
procedure. However, these preparations were unstable as DNA methylase loses activity at 
low protein concentrations, and produced low yields of enzyme. For these reasons, 
partially purified enzyme was used in these in vitro methylation experiments.
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|3.2.L Stimulation of DNA Methylase Activity by Partial 
Proteolysis.
Adams et al .,(1983) reported that de novo methylase activity could be 
stimulated 3-30 fold by limited proteolysis of the enzyme. The native molecular weight 
of mouse DNA methylase is 185 KDa (Adams et al., 1979J). On treatment with trypsin, 
at an enzyme to protease ratio of 200, several.peptides are generated. The Mr of the
major species being 170,100 and 50KDa. The stimulation is restricted largely to 
activity on native, unmethylated DNA substrates, such as plasmid DNA, and is much less 
obvious with a denatured or hemi-methylated substrate. Most mammalian DNA 
methylases exhibit a preference for denatured DNA over native DNA. For the mouse 
enzyme the ratio is approximately 5:2, this is reduced to 5:4 or 1:1 on partial proteolysis 
with trypsin. Hence to increase methyl group incorporation most plasmid methylation 
experiments were performed using pre-trypsinised methylase.
In general, the enzyme was treated with trypsin at a ratio of methylase to 
protease of 200 for 1 -5 minutes at 37°C. The reaction was then stopped by adding a five 
fold excess of trypsin inhibitor.
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3.3.. Methylation of SV40 DNA
Duplex SV40 DNA contains 54 potential methylation sites (i.e. CpG 
dinucleotides), 70% of these exist in a 400 bp region containing the overlapping early and 
late promoters and the origin of replication (see figure 3.1).
SV40 DNA was methylated in vitro by incubating 8jig of DNA with 20U of DNA
methylase and S-adenosyl (Me-3H) methionine (3.3jiM , 1.08fiCi) in buffer M+ in a total
volume of 70|xl. The reaction was performed at 37°C and1 2j i l (0.23|ug) Jwere removed at
0,1,2,4 and 6 and 24 hours. An additional 10U of methylase was added at 6 hours.
Aliquots were assayed for tritium incorporation as described in section 2 .2 .2 .2 i, except 
|that toluene/PPO scintillant (efficiency 40%) was used.
Figure 3.2 shows that the reaction proceeds in a linear manner over this 
period of time with a maximum of 51% incorporation achieved at 24 hours.
Due to the lack of sufficient DNA methylase some of the methylation 
experiments presented in this chapter were not performed in duplicate. However, these 
experiments were always repeated more than once and the results of each experiment 
followed the same trend.
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Figure 3.1. Map of the SV40 genome showing the distribution of CpG 
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Figure 3.2. Methylation of SV40 DNA
SV40 DNA was methylated for 0-24 h as described in section 3.3. The level of 
methylation is expressed as cpm(3H) incorporated and percentage of total CpG 
dinucleotides methylated.
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3.4. In  Vitro Methylation of Plasmid DNA
3.4.1. pVHCI
pVHCI is a pl)C8 derivative containing the SV40 promoter region in the early 
direction linked to the bacterial chloramphenicol acetyl transferase (CAT) gene. Hence, 
the effect of modifications in the promoter will be reflected in the level of CAT expression 
when the plasmid is introduced into mouse cells. The plasmid is 4736bp in size, it 
retains the ampicillin resistance gene present in pUC8 and also contains a 950 bp SV40 
fragment, containing a termination sequence, linked to the CAT gene.
pVHCI was constructed by inserting a 342bp Pvu II / Hind III fragment, 
containing the SV40 promoter region isolated from pSV2CAT (Gorman et al.,1982a) into a 
plasmid known as p200. p200 is a derivative ofjpTK3CATjminus the tk (Thymidine 
Kinase) promoter but containing a multiple cloning sequence isolated from a plasmid 
known as plC20H (Marsh et al., 1984) linked to the CAT gene and SV40 terminator (see 
figure 3.3). pTKCAT3 and p200 were a gift from Dr. J. Lang.
This plasmid was constructed by Sandra Hislop previously of our laboratory.
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Figure 3.3. Construction of pVHCI
Details are described in the text in section 3.4.1.
t
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3.4.2 In vitro methylation of pVHCI
The following experiments were performed to achieve optimum conditions 
for maximum incorporation of CH3 groups at CpG dinucleotides.
3.4.2.1 DNA Methylase concentration curve
|pVHC1 (0.2|igj[was incubated in a total volume of 10Ojxl containing S-adenosyl
(Me-3H) methionine(3.3|iM,ll .08p.Ci)md the specified concentration of enzyme in buffer 
M+ at 37°C for 4 hours. The reaction was stopped, the DNA recovered and the 
incorporated tritium estimated as described in section 2 .2 .2 .2 .
Figure 3.4 shows that incorporation of methyl groups increases with increasing enzyme 
concentration and plateaus at 1U of enzyme per pmol CpG.
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Figure 3.4. Methylation of pVHCI: Enzyme Concentration Curve
pVHCI was methylated using 0.5-1.5 U enzyme / pmol CpG as described In section 3.4.2.1. 
The extent of methyl group incorporation is expressed as cpm of 3H incorporated and 
percentage of total CpG dinucleotides methylated.
94
3.4.2.2 Time Course Methylation pVHCI
1 jig of pVHCI was incubated at 37°C for 0,2,4 or 6 hours in a total volume of 
1 OOj-lI containing S-adenosyl (Me-3H) methionine (20 pM ,2jj.Ci), 140U of DNA 
methylase and bovine serum albumin (1 mg/ml) in buffer M+.
After the specified incubation time, a 0.1 pg DNA aliquot was removed and assayed for 3H 
incorporation as described in section 2.2.2.2. The remainder of the DNA was isolated by 
stopping the reaction at 68°C for 10 minutes followed by phenol/chloroform extraction 
and ethanol precipitation of the DNA. The level of methylation in this DNA can be analysed 
by its resistance to cleavage by restriction enzyme Hpa II (Section 3.4.2.5).
Figure 3.5 shows that the reaction proceeds linearly over this time span, with a maximum 
of 61% incorporation at six hours.
However, it was found that increasing the incubation time beyond six hours led
to a decrease in CH3 group incorporation (this was also occasionally observed at 6 hours),
which meant that saturation was never achieved. This phenomenon was also observed by 
Simon et a l . (personal communication) with the rat liver enzyme and in both cases it was 
due to a reduction in the level of recovery of the DNA. This was most likely due to the 
formation of tight protein-DNA complexes which fail to dissociate at 68°C. This leads to a 
loss of DNA in the subsequent phenol extraction - the tightly bound DNA remaining 
associated with the protein at the interphase.
In more recent experiments the problem has been overcome by the inclusion of a 
post-methylation trypsinisation step, causing complete proteolysis of the enzyme and 
release of the DNA.
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Figure 3.5. Time Course Methylation'of pVHCI
1jig of pVHCI DNA was methylated for 0,2,4, or 6h. The level of methylation is expressed 
as cpm of (3H) incorporated [per 0.5jig of DNA and percentage total CpGs methylated. |
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3.4.2.3. Effect of Temperature on DNA Methylase Activity
Duplex native DNA i.e. plasmid DNA, is not an ideal substrate for DNA 
methylase. The enzyme will only interact under conditions favourable for "DNA 
breathing" i.e. low salt and high temperatures. Drahovsky et al .,(1971) in studies using 
rat liver DNA methylase found that the enzyme may interact with DNA in a different 
manner depending on the temperature of the reaction. Interaction at 0°C led to the 
formation of a loosely bound enzyme - DNA complex, dissociable by 0.2M salt. However, 
interaction at 37°C resulted in a tightly bound salt resistant complex. In the latter case 
methylation proceeded in a linear fashion in the presence of salt, suggesting that this tight 
complex has formed and remains attached to the DNA between successive methyl transfers. 
Also, at higher temperatures DNA 'breathing' is encouraged which may allow a greater 
number of stable enzyme - DNA interactions to occur and hence increase the the number of
CH3 groups incorporated.
In an attempt to improve thejefficiency |of pVHCI methylation the effect of 
temperature on enzyme binding was examined.
0.5pg of pVHCI was incubated with S-Adenosyl (Me-3H) methionine (20^M ,1jiCi) in a 
total volume of 40pl in buffer M* at 0, 20,37,40 or 45°C for five minutes. 80U of 
DNA methylase was added to each tube and the incubation continued for a further five 
minutes before all samples were transferred to 37°C for 4 hours.
Figure 3.6 shows that the optimum temperature for enzyme DNA interaction is 20°C, and 
preincubation at higher temperatures decreased CH3 group incorporation.
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Figure 3.6. The Effect of Temperature on DNA Methylase Activity
0.5jig of pVHCI was preincubated with 80U of DNA methylase at 0,20,37,40 or 45°C for 5 
minutes.. 3H -SAM was added to each tube and the incubation continued at 37°C for 4 hours. The 
resulting levels of methylation are expressed as cpm of 3H incorporated.
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3.4.2.4. Estimation of Level of Tritium Incorporation
Since the sequence of the plasmid pVHCI is known the percentage of methylated 
CpG dinucleotides can be estimated as follows :
Specific Activity of S-Adenosyl (Me -3H) Methionine isj5mCi j/(imol i.e. 1pmol/10,000 
dpm.
The efficiency of counting using liquid scintillant is 20%* and the estimated recovery is 
50%.*
(*-see over)
Therefore 1 pmol CH3 = 1000cpm
The number of pmols of CpG present in any reaction is as follows : 
amount DNA (jig) X No. of CpG dinucleotides/plasmid
___________________________________   X 106 = pmols CpG present
Mr nucleotide (pair) X No. bp/plasmid
Therefore, percentage incorporation can be calculated
cpm/assay
__________________  X100
No. pmols CpG x 1000
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* The efficiency of counting for tritium was estimated from the H number obtained.
The H number is the method used in L-8000 series liquid scintillation systems to 
determine the amount of quench in each sample and provides a means for correcting all the 
data to some common point of reference.
From the published calibration curves (The H number concept, D.L. Hurrocks,Beckman 
Ltd) the typical H number obtained (100-120) was consistent with an efficiency of 
counting for tritium of 20-25%.
(The H number measures the response produced in any liquid scintillation sample by the 
same electron energy and hence is a measure of the decrease in the light produced by that 
amount of energy due to the quenching that is present in the sample.)
The estimation of % recovery was calculated from data obtained from experiments where 
labelled 14C DNA was included in the methylase assay. ■
i.e. 20ng of 14C labelled DNA (41 pCi/mg) was included in a methylase assay containing 
5jig of M. luteus DNA.
Assuming an efficiency of counting for 14C in channel 2 of 65% (from the H number 
obtained), the expected cpm was 1172. 595 and 611cpm were obtained for duplicate 
assays indicating 53% recovery of the DNA.
100
S.4.2.5. Resistance of Methylated pVHCI to Cleavage by Hpa II
Methylation sensitive restriction enzymes have proved to be a very useful tool 
in studies on DNA methylation. The methylation status of a CpG dinucleotide, in an enzyme 
recognition sequence can be assessed from its resistance or susceptibility to cleavage by 
that enzyme. The restriction enzyme Hpa II recognises and cleaves DNA at the sequence 
CCGG only if the inner cytosine is unmethylated.
Computer analysis of pVHCI revealed 14 Hpa II sites, and this was confirmed 
by a restriction digest of the DNA (see fig. 3.7). Treatment of methylated pVHCI with the 
enzyme allows the analysis of the extent of methylation of the DNA and some insight of how 
the methyl groups are distributed.
Fig. 3.7(a) shows that pVHCI DNA methylated for 0, 2, 4, or 6 hours becomes 
increasingly resistant to Hpali although even after 6 hours there are some molecules still 
completely susceptible to Hpa II cleavage and none completely resistant. The 
corresponding fluorograph of the gel is represented by lanes [7-1 oj Figure 3.7(b) shows 
an Hpa II digest of pVHCI DNA methylated to approximately 75% saturation, and the 
corresponding fluorograph of the gel. This pattern of Hpa II inhibition indicates that not 
all molecules are methylated to the same degree and the estimated level of incorporation is 
a mean value. From the fluorograph it is evident that those molecules most resistant to 
cleavage contain the highest level of tritium incorporation.
Msp I digestion of methylated DNA resulted in a few DNA molecules being 
resistant to cleavage at a small number of sites. This suggests that at these sites cytosine 
in the dinucleotide CpC has been methylated. It has been reported by Graessman etal., 
(1983) that the rat liver methylase will methylate cytosines in the sequences CpA, CpT as
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well as CpG. When DNA methylated by the ascites enzyme was subjected to the nearest 
neighbour analysis technique (Urieli-Shovel etal.,1982), Adams et a / .,(1988) found 
that untrypsinized DNA methylase methylated only cytosines in CpG dinucleotides. 
However, a small proportion of methylcytosines in CpC and CpT dinucleotides were found 
in DNA methylated by pre-trypsinized enzyme, indicating that some trypsinized enzyme 
molecules have reduced specificity.
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Figure 3.7. Resistance of Methylated pVHCI to Cleavage by Hpa II
(a) Hpa II Digestion of a Time Course Methylation of pVHCI
1(ig of pVHCI was methylated for 0,2,4,or 6h (in conditions described in section
2.2.2.S.) then digested with Hpa II (section 2.2.1.10.), shown in lanes 3-6. The 
corresponding fluorograph is shown in lanes 7-10. Lane 1 contains Hind\\\ and Eco Rl 
digested X DNA as markers. Lane 2 contains untreated pVHCI.
Figure 3.7. Resistance of Methylated pVHCI to Cleavage by Hpa II
(b) Hpa II Digestion of Methylated pVHCI
1 jug of pVHCI was methylated to approximately 75% saturation. 0.5p.g of this was 
digested with Hpa II and the fragments visualised on a 1% agarose gel (lane 3). The 
corresponding fluorograph is represented by lane 4. Lane 1 contains Hind III and Eco Rl 
digested X DNA as markers. Lane 2 contains Hpa II digested mock methylated pVHCI 
<ipg)-
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3.4.2.6. CpG Distribution in pVHCI
Computer analysis of the pVHCI sequence provided a CpG distribution map. 
From figure 3.8 it is evident that pVHCI unlike SV40 DNA, has an even distribution o f 
CpG's apart from the CpG deficient SV40 terminator fragment. Also, unlike SV40, pVHCI 
is not CpG deficient, being largely made up of prokaryotic DNA. It contains 430 CpG 
dinucleotides in its 4736bpj, i.e. 215 CpG per strand, j
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Figure 3.8. CpG Distribution in pVHCI
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3.5. Discussion
The aim of the experiments presented in this chapter was to optimise conditions 
for maximum methylation of native DNA in vitro, Double stranded, unmethylated DNA is a 
poor substrate for mammalian DNA methylase. DNA methylase isolated from fully 
differentiated cells has a primary in vivo function of maintaining established methylation 
patterns. Although the enzyme is capable of both maintenance and de novo methylation in 
vitro, it exhibits a strong preference for hemimethylated DNA. Also, most mammalian
enzymes prefer denatured DNA to native, indicating that the enzyme requires single
\
stranded regions of DNA with which to interact. Such sites also become available when 
duplex DNA "breathes"- a situation that is encouraged at low salt and high temperatures. 
Adams et al .,(1979) reported that the ascites methylase was strongly inhibited by salt, 
retaining only 50% activity in 50mM NaCI. This was also observed when methylating 
SV40 DNA. In addition, the enzyme preferred to methylate supercoiled SV40 DNA, a 
conformation conducive to the formation of single stranded protrusions. There was a ten 
fold drop in incorporation if the DNA was linearised or nicked with N. crassa nuclease 
before methylation (results not shown).
Several groups have reported difficulty or failure in methylating SV40 DNA 
in vitro. Simon et al., (1978) and Roy and Weissbach (1975) have reported resistance 
of SV40 DNA to methylation by the rat liver and Hela cell methylases respectively. It is 
also a relatively poor substrate for the mouse ascites enzyme as shown in section 3.3.
Even in conditions of zero salt and long incubation periods, saturation is never achieved. 
This resistance to methylation is probably due to the uneven distribution of CpG 
dinucleotides in the molecule. SV40 DNA is CpG deficient and 70% of the 54 dinucleotides
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present are clustered in a region of 400bp. Using synthetic oligonucleotides, Bolden et al 
.,(1986) found that DNA substrates containing more than one CpG in close proximity were 
better substrates for the enzyme than those containing only a single site. This would 
suggest that the enzyme once bound can methylate more than one CpG before dissociating. 
The idea of a "walking" mechanism was first introduced by Drahovsky and Morris (1971) 
who found that the enzyme and DNA formed a tightly bound complex which was resistant to 
salt and where the addition of methyl groups was linear for 30 minutes. This "walking" 
theory may predict that SV40 DNA would be a good substrate for the enzyme, since if the 
enzyme bound near the CpG cluster it could methylate a large proportion of the sites before 
dissociating. However, DNA methylase binds to DNA in a fairly non-specific manner and 
the point of attachment may depend on the ability of a particular sequence to "melt" or it 
could simply be which part of the DNA molecule collides with the enzyme. Hence, the 
point of attachment in most SV40 DNA-enzyme interactions will not be adjacent to the CpG
cluster and so most enzyme molecules will bind, scan and dissociate without adding a CH3
group. This is reflected in the results shown in section 3.4.'were the presence of pneunit - 
’ [six!
of enzyme for ever^pmol of CpG results in only 2% incorporation in the initial hour of
the reaction. Indeed, the addition of a further 10units of enzyme and a longer incubation 
time (24h) resulted in a maximum of only 50% incorporation. We can compare this to 
the methylation of pVHCI, section 3.4. Being largely composed of prokaryotic DNA, 
pVHCI is not CpG deficient, having 460 CpGs in 4736bp and these CpGs are evenly 
distributed, with the exception of the 950bp CpG deficient SV40 terminator fragment.
This makes it a better substrate for DNA methylase than SV40 DNA. 1U of enzyme per 
pmol of CpG in pVHCI resulted in 60% methylation after 4 hours (figure 3.5) compared 
to 10% for SV40 DNA . This difference is most likely due to the even distribution of CpGs
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in pVHCI (figure 3.9). Once bound the enzyme in most cases does not have to migrate far 
to reach a CpG. So with pVHCI most enzyme-DNA interactions will be "successful" with
the enzyme adding a CH3 group at one or more sites before dissociating. However, figure
3.4 shows that optimum methylase concentration is 1U per CpG present. This is 
consistent with the enzyme having a turnover of one and the addition of methyl groups 
being distributive rather than processive. Simon et al .,(1978) found that the rat liver 
DNA methylase has a turnover of 7, this is consistent with the estimated turnover of the 
ascites enzyme. The requirement of a high enzyme-DNA ratio can be explained if one 
considers the possibility that in zero salt conditions the enzyme is not operating in a 
monomeric form. The DNA maybe interacting with a high molecular weight enzyme
aggregate, with only the enzyme molecule directly in contact with DNA transferring a CH3
group. It would appear that once bound these aggregates do not readily dissociate from the 
DNA (see section 3.4.2.2.). This would limit the access of "new" enzyme molecules from 
binding to the DNA. Also, since the enzyme preparations used were generally only 
10-20% pure it is likely that other DNA binding proteins such as transcription factors 
and histones are also present. In the methylation reaction these proteins would bind to the 
DNA preventing the binding of DNA methylase and hence limiting the efficiency of the 
reaction. This phenomenon was also observed by Kautiainen and Jones (1985).
The precise mechanism of action of DNA methylase is still unknown and needs 
to be studied in greater detail to understand fully both the de novo and maintenance 
reactions. However in vitro methylation studies are currently hindered by the lack of 
procedures for obtaining sufficient amounts of pure and stable preparations of mammalian 
DNA methyltransferases.
When methylating any type of DNA it is important to keep the S-adenosyl
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methionine concentration at or above the Km, which is around 2^M. This is due to the fact 
that the by-product of the reaction S-adenosylhomocysteine is a potent inhibitor of the 
reaction. It has been shown (Adams and Burdon,1985) that when present in equimolar 
concentration with Ado Met this inhibitor reduces methyl transfer by 84% and even a 
ratio of Ado Met: S adenosylhomocysteine of 10:1 will reduce methylation by one third.
In summary, the optimised conditions for plasmid methylation are as follows: 
DNA concentration of 1|ig per 10Ojil total volume, DNA methylase concentration of 1 unit 
per pmol of CpG present, S-adenosylmethionine at 20|iM in buffer M+ with a 4 hour 
incubation period at 37°C. With active and stable preparations of DNA methylase this led 
to a 50-70% saturation of the plasmid DNA. However, the efficiency of methylation was 
somewhat reduced when the reaction was scaled up. Methylation of 5-1 Ojig of pVHCI led 
to only 20-30% saturation. This problem could not be overcome even when the enzyme 
was stabilised by the addition of 1 mg/ml BSA or when the final reaction volume was 
increased or decreased.
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Chapter 4. Effect of Methylation on Transcription 
from the SV40 Early Promoter
4.1. Introduction
In the following experiments the effect of DNA methylation on transcription 
from the SV40 early promoter was studied using a transient expression assay. The plasmid 
pVHCI (described in section 3.4.1) containing the SV40 promoter in the early direction 
linked to the bacterial chloramphenicol acetyl transferase gene, was methylated using 
mouse ascites DNA methylase in conditions described in section] 3.5. j. This methylated DNA 
was then introduced into mouse L929 cells by the calcium phosphate - DNA 
co-precipitation method (sectionj 2.2.3.1. !). The effect of methylation could then be 
analysed by measuring the cellular levels of chloramphenicol acetyl transferase and 
comparing them to levels obtained with methylated DNA.
The Chloramphenicol acetyl transferase assay
The chloramphenicol acetyl transferase expression assay was first introduced 
by Gorman etal., (1982a) and has been used to study a number of viral and cellular 
promoters (Gorman et al., 1982(a), Gorman et a/.A 1982b , Levison et al.x 1982). This 
assay exploits the fact that mammalian cells do not possess the gene for chloramphenicol 
acetyl transferase, hence any activity found in transfected cells is derived from the 
exogenous DNA.
There are several ways of introducing foreign DNA into tissue cultured cells, 
the method used here was the calcium phosphate - DNA co-precipitation method (see 
section 2.2.3.1 for details). Once the DNA has entered the nucleus of the cells it associates
11 2
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with histones to form chromatin (Gilmour et al .,(1982) and CAT activity has been 
detected twelve hours after transfection. In the experiments described here CAT activity 
was normally measured 48 hours after transfection, a time shown by Gorman e ta i,
1982(a) to be optimum for transient expression assays. ;
Chloramphenicol acetyl transferase interacts with chloramphenicol by adding 
acetyl groups to the hydroxyl groups on C1 and C3 of the molecule (see figure 4.1). CAT 
activity can be measured by quantifying the level o f14C labelled chloramphenicol 
acetylated in a given time.
Initially the method designed by Cohen etal.x (1980) was adopted in which the 
acetylation of chloramphenicol is measured by silica gel thin layer chromatography. 
However, a new method introduced by Seed and Sheen.A (1988) provided a simpler and 
more sensitive assay for CAT activity. This increased sensitivity is advantageous when 
studying changes in activity induced by DNA methylation. This assay exploits the 
relatively low specificity of CAT for the acyl donor, allowing butyryl CoA to be substituted 
for acetyl CoA. The greater hydrophobicity of butyrylated chloramphenicol allows an 
effective discrimination between free and acylated chloramphenicol by a simple phase 
extraction assay. Details of both assays are presented in section 2.2.3.2(a) and (b).
1 1 3
C i
^  C H 0OH
Figure 4.1. Structure of [14C] chloramphenicol and positions of acyl 
group additions.
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4.2. Comparison of Different Promoter Activities in 
Expressing the CAT Gene
The ability of the SV40 early promoter in pVHCI to initiate expression of the 
CAT gene was compared to that of the HSV2 immediate early (IE) promoter. Two 
plasmidsj pLW2 and|pLW4 [ containing the IE promoter linked to the CAT gene were used in 
this experiment (Fig 4.2(a)). These plasmids were constructed by Lindsay Whitton 
(Gaffney etal.,1985) at the Institute of-Virology , Glasgow . In addition to the immediate 
early promoter, PLW4 contains an activator sequence which has been shown to increase 
transcriptions 2-3 fold in transfection assays. Figure 4.2(b) shows that both these 
plasmids are more active thanpVHCI |in initiating CAT activity. These plasmids were used 
as positive controls in the following transfection experiments. The plasmid p200 (see 
section 3.4.1) which is identical to pVHCI minus the SV40 promoter shows negligible 
levels of activity and was used as a negative control. The stimulatory effect of the SV40 
enhancer is evident from reduced activity obtained on transfection with the plasmid pSVCI. 
This plasmid was constructed by inserting the Sph \-Xho I fragment of pVHCI into p200 
(see figure 3.3) immediately preceding the CAT gene. Hence in this construct the 
promoter consisted of the 21 bp repeat region and only 22bp of the first 72bp repeat of the 
enhancer (Fig 4.2(a)). Fig 4.2(b) shows that deletion of the enhancer sequence 
significantly reduces CAT expression. This observation is in agreement with Gorman et 
al. (1984), although the effect is not as pronounced as the 10 fold inhibition they 
observed using a pSV2CAT deletion.
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Figure 4.2. Comparison of Different Promoter Activities in Expressing 
the CAT Gene
(a) structures of plasmids used
(b) Mouse L929 cells were transfected with 5jng of plasmid DNA and the resulting CAT
activity quantified by the method of Cohen et al., (1980)and expressed as cpm of 
acetylated 14C -chloramphenicol.
4.3. DNA Concentration Curve
Tissue cultured mouse L929 cells (approximately 106 per 25cm2 flask) 
were transfected with 0-5^g of pVHCI in the presence of carrier DNA (total DNA 20pg). 
Figure 4.3 shows that CAT production increases with increasing DNA over this range of 
concentrations. Transfecting with higher concentrations of DNA did not lead to a 
reproducible increase in CAT production using this number of cells (results not shown). 
Since purified DNA methylase was not available in large quantities it was necessary to 
limit the amount of DNA used in these transfection experiments. For these reasons, in the 
transfection experiments that follow 3-5pg of pVHCI was used per 106 cells.
Kruczek et a l ., (1983) showed that the amount of CAT expressing plasmid 
could be reduced to 0 .1-1jig by cotransfecting with a promoterless construct (in this case 
pSVOCAT). This reduced amount still yielded efficient expression of the CAT gene. 
Transfecting with smaller amounts of DNA would overcome the restrictions of the 
methylation step. However significant levels of CAT activity were not obtained when 
0.5-2^g of pVHCI were cotransfected with 5pg p200. Hence this approach was 
discontinued.
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Figure 4.3. Chloramphenicol Acetyitransferase Assay: DNA Concentration 
Curve / Effect of Methylation
(a) Mouse L929 cells were transfected with 0,3 or 5pg of pVHCI in conditions described 
in section 2.2.3.1. CAT activity was measured 48 hours after transfection by the 
method of Cohen etal., (1980) and expressed as cpm 14C labelled acetyl 
chloramphenicol.
The open circle shows the activity obtained on transfecting 3|ig pVHCI methylated to 
8-10% saturation (see section 4.4).
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4.4. The Effect of DNA Methylation on CAT Activity
pVHCI DNA was methylated in vitro using mouse ascites DNA methylase as 
described in section] 3.5 ]^ This resulted in 8-25% of CpG dinucleotides being methylated. 
The following results show that even these low levels of methylation cause a significant 
inhibition of CAT expression. In initial experiments CAT expression was almost totally 
abolished by 8-10% methylation of the DNA. Figures 4.3(a) and (b) show that 
transfecting with 3jig of methylated pVHCI results in only 10% of the activity obtained 
with unmethylated DNA. CAT activity was measured by quantifying the level of acetylated 
chloramphenicol by silica gel thin layer chromatography. However, in these experiments 
the control unmethylated DNA was not 'mock' methylated before transfection. This 
involves incubating the control DNA with DNA methylase, in the absence of S-adenosyl 
methionine, in conditions identical to the methylation experiment. This eliminates the 
possibility of reduced CAT activity caused by loss of DNA , possibly due to poor recovery or 
nuclease digestion. Hence, in these experiments it is possible that the effect of 
methylation may have been exaggerated by one of the above. However, the methylated 
pVHC1(1jig) was analysed by agarose gel electrophoresis before transfection (results not 
shown) indicating that DNA was present at the stated concentration. Also, pVHCI activity 
was always compared to that of PLW4. The ratio of pLW4 to pVHCI activity was 
comparable whether pVHCI was mock methylated or not.
This almost complete inhibitory effect of DNA methylation was not observed 
when these experiments were later repeated. 4^g of pVHCI was methylated or 'mock' 
methylated as described above and introduced into mouse L929 cells. Figure' 4 .4 |shows
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the effect of 15-20% methylation of pVHCI on CAT activity. In these experiments only a 
30-40% drop in activity was observed.
It is evident from the Hpa II digestion of methylated DNA (Figure 3.7) that 
not all DNA molecules are methylated to the same extent. There are some molecules that 
remain completely susceptible to Hpa II. Hence one would always expect to see CAT 
activity from these DNA molecules and from those in which the transcriptionally 
important CpG dinucleotides have not been methylated.
When using DNA mediated gene transfer experiments to study the effects of 
methylation one must consider the possibility that methylated DNA behaves differently 
from unmethylated DNA when used to transfect cultured cells. Although there is evidence 
that methylated DNA is less efficient at transforming cells compared to unmethylated DNA 
(Wigler e t a l (1981), Stein e ta /.,(1982)) [,"there is no evidence tolndlcatelhat| ] 
methylated DNA is less efficiently taken up by the cell, or slowly packaged and poorly 
integrated into the host chromosome. In order to try to allow for some inconsistency in 
transfection, some experiments were performed involving cotransfection with a marker 
plasmid that encodes a separate enzyme activity. For this a plasmid containing the 
p-galactosidase gene linked to the HSV-2 IE4 promoter, pHSVpgal was used. However, 
although CAT activity was regularly present in the extracts little p-galactosidase activity 
was found and any comparisons attempted were worthless.
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Figure 4.4 | Effect of DNA methylation on CAT expression
CAT activity was assayed by the method of Seed and Sheen.* (1988)(section2.2.3.2(b)) 
and calculated as pmoi acylated chloramphenicol / pg/hour, presented here as a percentage 
of 'mock' methylated DNA activity. Methylated pVHCI activity is presented as a mean value 
for two separate experiments +/- standard deviation.
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4.5. The Effect of Methylation at Various Times After 
Transfection
From these transfection experiments it is clear that DNA methylation has an 
inhibitory effect on transcription from the SV40 early promoter. This effect is most
likely due to the presence of CH3 groups interfering with protein DNA interactions, and it
is possible that this is mediated via the formation of altered chromatin structures when 
the DNA is introduced into host cells. This was observed in microinjection studies using 
the cloned HSV thymidine kinase gene (Buschhausen et al. ,1987) where the inhibitory 
effect of methylation was only evident after the formation of chromatin in the recipient 
cell i.e. 8 hours after injection.
In an attempt to determine whether chromatin formation is involved in SV40 
promoter inhibition , mouse L cells were transfected with methylated (10-20% 
saturation) or unmethylated pVHCI and CAT activity measured 12-48 hours after 
transfection. Figure 4.5 shows the results obtained. Since the level of CAT activity is 
initially very low it is difficult to compare activities for the early time points. However 
is appears that the inhibitory effect of methylation is at its strongest (approximately 
50%) 48 hours after transfection suggesting that chromatin formation may be involved in 
inhibition. This experiment would have provided more information if longer time points 
had been included , increased inhibition at say 72 hours would have strengthened the 
argument.
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Figure 4.5. Analysis of CAT Activity 0-48 Hours After Transfection
Mouse L929 cells were transfected with methylated or 'mock'methylated pVHCI (5jig). 
CAT activity was measured 12,24,36 and 48 hours after transfection and expressed as a 
percentage of control CAT activity after 48 hours, +/- standard deviation.
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4.6. Co-transfection of pVHCI With Methylated and 
Unmethylated Oligonucleotides
The experiments presented in sections 4.4 and 4.5 indicate that methylation 
has an inhibitory effect on CAT expression in this system. However it remains to be 
established how this effect is mediated. The SV40 early promoter contains several 
functional motifs essential for transcription, (see section 1.3.2).
The 21 bp repeat region has been shown by several groups to be crucial for efficient 
transcription (Brady etal., 1984; Benoist and Chambon,1985). To establish the 
importance of Sp1 binding and the effect DNA methylation may have on it mouse L929 cells 
were co-transfected with pVHCI and oligonucleotides containing Sp1 binding sequences in 
the methylated or unmethylated state. The oligonucleotides used are shown in figure 
4.7(a) and are described in detail in section 5.5. All three oligonucleotides bind Sp1 in 
vitro (section 5.5). Figure 4.7(b) shows that cotransfection with either methylated or 
unmethylated oligonucleotides reduces CAT expression to approximately 20% of that 
obtained for pVHCI alone. This suggests that the presence of these oligonucleotides is 
eliminating the stimulatory effect of the 21 bp repeat region and/or the binding of Sp1. It 
is possible that the pool of Sp1 and other protein factors that bind to this region is being 
depleted by these oligonucleotides which are in a 30-40 fold molar excess compared with 
the SV40 promoter sequence. This depleted pool of transacting factors would be less 
efficient at initiating transcription from the SV40 promoter. This effect occurs 
irrespective of the methylation state of the binding site, indicating that methylation has. no 
effect on Sp1- DNA interactions.
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Figure 4.6. Cotransfection o f pVHCI w ith Methylated and Unmethylated 
O ligonucleotides
(b) Mouse L929 cells were transfected with 5jig of pVHCI either alone or with 5pg each 
of the oligonucleotides. The results show the effect of the oligonucleotides expressed as 
a percentage of control +/- standard deviation for 7 separate estimations.
Activity was assayed 48h after transfection, j
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To rule out the possibility that these small double stranded DNA molecules are
in some way inhibiting DNA uptake by the cells or are limiting expression in a 
non-specific manner, L929 cells were co-transfected with small DNA fragments obtained 
from a Hae III restriction digest of the plasmid pAT153. (This produces fragment sizes of 
approximately 500-50bp).
Table 4.1 shows that co-transfection with this DNA had no effect on CAT expression. The 
possibility that the inhibiting effect was due to inhibition by a chemical contaminant, 
remaining from oligonucleotide synthesis, was eliminated by co-transfecting cells with an 
unrelated oligonucleotide which had been prepared in the same manner. Again no 
inhibitory effect was observed .
Table 4.1
DNA CAT
TRANSFECTED ACTIVITY 
(% control)
pVHCI 100
pVHCI +oligo 22 19 (+/-13.7)
pVHCI +oligo m22 18.25 (+/-10.8)
pVHCI +oligo m40 9 (+/- 4.7)
pVHCI +pAT153/Hae III 108 (+/-3.5)
pVHCI +oligo 62 116 (+/-15.5)
| Oligo 62 was prepared as described in section 2.2.4.4. and has the sequence:- j
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4.7. Discussion
The experiments presented in this chapter indicate that transcription from 
the SV40 early promoter is methylation sensitive. This conclusion contradicts previous 
studies involving the methylation of this promoter. However, since pure mammalian 
methylases are difficult to obtain, all but one of these experiments have involved the use of 
bacterial methyltransferases. These enzymes are not ideal since they only methylate a 
small proportion of CpG dinucleotides which may not always occur in important control 
regions. The SV40 promoter region , although GC-rich is completely deficient in methyl 
sensitive restriction enzyme sites.
Fradin et al.x (1982) found that complete methylation at the single Hpa II 
site, located near the 5'end of the late coding region in SV40, caused a marked reduction in 
the synthesis of the viral capsid protein VP-1, but had no effect on the production of early 
proteins (the large and small tumour antigens). Weachter et al.x (1982) used Eco R1 
methylase to methylate the SV40 large T antigen gene at adenine residues in 24 sites and 
found that the expression of this gene remained unchanged. A more relevant experiment 
was performed by Graessman et a lx (1983), who used rat liver DNA methylase to 
methylate the cytosines of all CpG dinulcleotides in SV40 before microinjection into CV1 
cells. They found no change in either early or late expression caused by methylation.
In contrast, the experiments reported here have shown that relatively low 
levels of methylation caused inhibition of transcription from the SV40 early promoter.
These observations can be explained if one considers the mechanism by which methylation 
is thought to inhibit gene expression. There are two favoured theories of how methylation
interferes with gene expression : (a) a direct effect, whereby the presence of a CH3 group
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inhibits the binding of sequence specific DNA binding proteins, such as transcription 
factors , hence reducing the level of transcription, (b) An indirect effect, where DNA 
methylation by altering the binding of chromatin forming proteins, such as histones or 
HMG proteins, causing the formation of an inactive, DNase I insensitive form of chromatin. 
Evidence suggests that both (a) and (b) exist and the mechanism of inactivation of gene 
expression by methylation is dependent on the gene involved.
An example of the former was provided by Doerfler and co workers. 
Kruczek and Deorfler,(1983) showed that methylation of certain CpG dinucleotides in the 
promoter of the adenovirus type 12 E1 a gene causes transcriptional inactivation, whereas 
methylation of the coding region has no effect. This is also true for the Ad2 E2a gene 
promoter (Langer et a/.,1984). This suggests that inhibition is due to 
methylation interfering with sequence specific protein DNA interactions in the promoter 
region. This also appears to be the case for the rat grow(h hormone gene promoter. A 
recent study demonstrated that methylation of two Bsu E (CGCG) sites in this promoter 
inhibited expression of a linked CAT gene by 60% in a transient expression assay. 
Methylation of plasmid sequences outside the promoter and CAT gene had no effect on 
expression (Gaido and Strobl,1989). Further support for the direct method of inhibition 
comes from the recent identification of methylation sensitive transcription factors , for 
example the adenovirus major late transcription factor (Watt & Molloy, 1988), see 
section 5.7.
In support of the indirect method of inhibition, direct evidence for chromatin 
disruption by DNA methylation comes from DNA mediated gene transfer experiments 
performed by Keshet et al.x (1986). They found that although both fully methylated and 
unmethylated M13 constructs could integrate into the host genome only the latter formed
130
potentially active DNasel sensitive , chromatin structures. This indicates that DNA 
methylation directs DNA into an inactive type of structure. Buschhausen et a l, (1987) 
in microinjection experiments found that transcriptional inactivation of the HSV 
thymidine kinase gene requires chromatin formation in the recipient cells. Also 
reconstitution of minichromosomes in vitro showed that methylated chromatin was always 
inactive after microinjection whereas 'mock' methylated chromatin was fully active.
The effect of methylation observed in the present experiments involving the 
SV40 promoter is most likely due to an indirect inhibition of transcription. The DNA used 
in these experiments was methylated using mouse ascites DNA methylase, resulting in 
methylation of 10-25% of CpG dinucleotides. From the Hpa II restriction digest of this 
DNA it appears that methyl group incorporation at CpGs is random with some molecules 
more resistant to Hpa II than others and some remaining totally susceptible to Hpall 
cleavage, although these fragments are methylated at other sites (see figure 3.8(a)). At 
this level of methylation , on average only 1-2 CpGs of the 10 present in and around the 
promoter will be methylated. Hence it is unlikely that inhibition is due to interference 
with sequence specific protein-DNA interactions in the promoter. There are no CpG 
dinucleotides in the enhancer and 6 clustered in the 21 bp repeat region. Fig. 4.6 shows 
that oligonucleotide competition is unaffected by methylation suggesting that Sp1 -DNA 
interactions are not directly affected. It is more likely that the presence of methyl groups 
throughout the entire molecule causes a disruption of chromatin structure when 
introduced into cells, hence reducing the transcriptional efficiency of the promoter. This 
is particularly relevant as pVHCI is rich in CpG's, containing' 215 CpG dinucleotide pairs 
in 4736b.
A similar situation exists in the herpes simplex thymidine kinase gene, where
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the presence of a single methylated CpG dinucleotide in the promoter region was sufficient 
for transcriptional inactivation of the gene (Ben Hatter and Jiricny ,• 1988). This 
methylation could be at any one of the four CpG's within a region containing the Sp1 and 
CTF (CAAT-binding transcription factor) binding sites. Since it has been shown that Sp1 
binding is not affected by methylation (see chapter 5) it is likely that this effect is due to 
the alteration of chromatin structures. This is supported by the fact that methylation of 
the coding sequences of the tk gene inhibits expression even when the promoter is 
unmethylated (Keshet et a l ., 1985). This region specific effect of methylation was also 
observed by Murray and Grosveld (1987) in studies involving the p-globin gene , where 
although methylation in the body of the gene did not affect transcription , a minimum 
length of methylation free DNA in the promoter was required for expression. Also, there 
appeared to be a correlation between the level of expression and the extent of the 
methylation free area around the promoter. An area of 1500bp upstream of the gene was 
required to be unmethylated to achieve a level of expression similar to totally 
unmethylated DNA.
Hence it is likely that the inhibitory effect of methylation observed in the 
present transfection studies is due to the presence of methyl groups in the CAT gene and 
pUC8 sequences as well as the promoter region. It is possible that there is a threshold 
level of methyl group content above which the rate of transcription is severely reduced. 
This region-specific inhibitory effect of methylation is presently being investigated in 
our laboratory using "gap-duplex" molecules (see section 6.3).
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Chapter 5. The Effect of Methylation on the Binding 
of Sp1 to DNA
133
5.1. Introduction
In chapter 4 the effect of DNA methylation from the SV40 early promoter 
was studied using a transient expression assay. The results suggested that transcription 
from this promoter is methylation sensitive. It is possible that this effect is mediated by 
the direct inhibition of transcription factors binding to the promoter region. Since the
CH3 group of 5-methyl cytosine protrudes into the major groove of the DNA helix, the site
of protein - DNA interaction, it is possible that the presence of a methyl group could 
stereochemically inhibit protein binding.
To study this hypothesis the effect of cytosine methylation on the binding of the 
transacting factor Sp1 to its recognition sites in the 21 bp repeat region of the SV40 
promoter was investigated. Although Sp1 was first identified as binding to this region of 
SV40 and stimulating early and late transcription, Sp1 recognition sequences, GC boxes, 
have also been located upstream of several other viral genes and many cellular genes 
(Dynan and Tjian, 1983; Dynan e ta i,  1985; 1986, see section 1.3.2 for details).
Although no shared regulatory feature is evident among the diverse promoters in which Sp1 
binding sites have been found, the occurrence of these sites in such a wide range of 
eukaryotic genes makes Sp1 binding a good model system to study.
The 21 bp repeat region of SV40 has been shown in deletion experiments 
(Wildeman et al ,1984) to be crucial for SV40 transcription in vitro. It contains 6 GC 
box motifs (figure 5.1) which are known to bind Sp1 with varying affinity (Gidoni et al 
,1984). These are interesting from a DNA methylation viewpoint since each GC box 
contains a CpG dinucleotide, i.e. a potential in vivo methylation site and a substrate for 
purified DNA methylase in vitro.
The effect of methylation on Sp1 binding was studied using a gel retardation assay
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(Fried and Crothers, 1981). In this assay an end labelled DNA fragment is incubated with 
an Sp1-containing Hela cell extract. Free DNA is separated from protein-DNA complexes 
by differences in their electrophoretic mobility in polyacrylamide gels. Assay conditions 
are described in section! 2.2.4.8.!
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5.2. Preparation of Hela Cell Nuclear Extract
Nuclear extract was prepared from Hela S3 cells according to the method of 
Dignam etal., 1983, as described in section 2.2.4.1. A typical protein concentration for 
the extract was 2.5-4mg/ml. It has been shown that these extracts can be fractionated by 
DEAE ion-exchange chromatography (Dynan and Tjian,1983) or heparin Sepharose 
affinity chromatography (Harrington etal.,1988), to give a partially purified Sp1 
fraction. However in this study, gel retardation assays using nuclear extract fractionated 
by either method (see section 2.2.4.2.(a) and (b)) showed patterns of retardation 
identical to those obtained using unfractionated extract (results not shown).
Sp1 has been purified to homogeneity and studied extensively by Tjian and 
co-workers (Kadonaga et al.,1986; Kadonaga and Tjian, 1986). Since transcription 
factors in general are low abundance proteins (there are only 5,000-10,000 Sp1 
molecules per cell i.e. 0.001% of total cell protein), purification procedures are lengthy 
and require large amounts of starting material. The one attempt made at attaining pure 
Sp1 following the fractionation method of Dynan and Tjian (1983) was unsuccessful. The 
procedure involves several chromatographic steps and the assay for Sp1 relied on its 
stimulatory activity in an in vitro transcription assay. The result was a very dilute 
product and activity was barely detectable using this system. However a technique 
introduced by Kadonaga and Tjian (1986), known as recognition site affinity 
chromatography has since made the purification of low abundance DNA binding proteins, 
like Sp1, much easier. Unfortunately time did not allow this to be pursued. Therefore all 
the experiments presented in this chapter were performed using Hela cell nuclear extracts. 
The advantage of purifying Sp1 for these experiments is that from its already defined
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properties (Kadonaga etal.,1985) e.g; molecular weight, ability to stimulate early 
transcription, etc., one can be sure that it is Sp1 that is being studied.
However, the advantage of using of using nuclear extracts rather than pure 
protein is that it mimics more closely the in vivo situation. If one considers the presence 
of a methyl cytosine binding protein (Huang et al., 1984, see section 1.4.2), Sp1 binding 
may only be blocked by the interference of another protein at its binding site and not 
merely by a CH3 group. The use of nuclear extracts containing both proteins would allow
for the effect of methylation to be observed whereas the use of pure Sp1 in these binding 
reactions would not.
5.3. Choice of Restriction Fragment for Use in Gel 
Retardation Assays
The region of approximately 350bp constituting the SV40 control region 
contains several functional elements. For example, the 72bp repeat enhancer sequence, 
the early and late transcription initiation sites, the TATA box like sequence, the origin of 
replication and the 21 bp repeat sequence. All of these features are known to interact with 
sequence specific binding proteins (Lee e ta/.,1987;Fromental etal.,1988;Yamaguchi and 
DePamphilis,1986; Reinberg et a/.,1987; Reinberg and Roeder, 1987). The enhancer 
sequence itself is known to bind several transcription factors (see chapter 1.3.2 for 
details). All of these factors will be present in a HeLa cell nuclear extract, hence to avoid 
a very complex picture in the gel retardation assays it is important to use’the smallest
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possible restriction fragment containing the 21 bp repeat region. This is evident in figure 
5.2 (b) where restriction fragments containing different amounts of the promoter region 
were compared in a gel retardation assay. The SV40 control region is deficient in 
restriction enzyme recognition sites limiting the choice of restriction fragments available. 
Figure 5.2 (b) shows that the Sph I / Nco I fragment isolated from pSVC1 (see section 4.2 
) is most suitable for analysing Sp1 binding by this method since it results in the 
formation of discrete retarded bands rather than the large multi-protein complexes 
observed for the other fragments. Hence this restriction fragment was chosen for use in 
the following gel retardation assays.
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Figure 5.2 Choice of Restriction Fragment for Use in Gel Retardation 
Assays
(a) SV40 promoter region showing Sp1 binding region and the binding sites of 
some enhancer binding proteins. The restriction fragments considered were: the Kpn I 
/Xho 1 fragment isolated from pVHC1; the Sph \/Xho i fragment and the Sph MNco I 
fragment isolated from pSVC1 (section 4.2).
(b) Comparison of these fragments in a gel retardation assay; 5ng of labelled 
DNA (section 2.2.4.3.) was incubated with 0,1,5 or 10jug of nuclear extract in conditions 
described in section 2.2.4.7. The products were analysed on a 4% polyacrylamide gel and 
(visualised I by autoradiography.
139a
K p n  I / X h o  I 
N . E x t r a c t  ( j j D  0  1 5 1 0
S p h  I / X h o  I S p h  I / N c o  I 
0  1 5 1 0  0  1 5 1 0
m m - •
140
5.4. The Effect of Increasing Protein Concentration
When nuclear extract is incubated with a DNA fragment containing the 21 bp 
repeat region three protein-DNA complexes with differing electrophoretic mobilities are 
observed. Figure 5.3 shows that the intensity of all three retarded bands increases with 
increasing protein concentration. The Sph I / Nco I fragment of pSVC1 contains only the 
21 bp repeat region and approximately 20bp of the enhancer sequence and all three 
retarded bands are sensitive to competition with GC box containing oligonucleotides (see 
section 5.5.2.), indicating that the protein(s) involved are binding to the GC box motifs.
These retarded bands could represent different numbers of Sp1 molecules 
binding to the DNA. Fried and Crothers (1981), found that when titrating the lac 
repressor in gel retardation assays, the mobility of the DNA decreased as a function of the 
number of protein molecules bound. This region of SV40 contains six potential Sp1 
binding sites each with differing affinity for the protein. Dimethyl sulphate footprinting 
and experiments involving the mutagenesis of the GC box motifs indicated the presence of 
up to 5 independently bound Sp1 molecules in this region ( I  Gidoni e ta l ., (1984])- 
However it is thought that Sp1 binds to DNA as a monomer, the molecular weight of which 
is 95-105KDa. It is unclear whether the stereochemistry of the binding reaction will 
allow 5 molecules to bind simultaneously to a region of only 70bp i.e. 7 turns of the DNA 
helix. It is more likely that under the non-denaturing conditions of the gel retardation 
assay only one Sp1 molecule will bind. Once bound the DNA may wrap round the protein 
preventing others binding. Westin et al., (1988) observed only one major retarded 
Sp1-DNA complex when using an oligonucleotide containing two strong Sp1 binding sites in 
a gel retardation assay. ( Probing the gel with anti-Sp1 antiserum would indicate which 
of the retarded bands represent Sp1 -DNA complexes).
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Alternatively these retarded bands may represent different sequence specific 
proteins binding to the same DNA. Kim et al .,(1987) identified a second transacting 
factor that interacts with the 21 bp repeat region of SV40. The late SV40 transcription 
factor (LSF) is a cellular factor that stimulates late transcription. It is known to interact 
with the 21 bp repeat region but its precise binding site has not yet been identified. When 
partially purified LSF was used in gel retardation assays, two major protein - DNA 
complexes were formed both of which migrated more rapidly than the Sp1 -DNA complex. 
When both Sp1 and LSF (distinguished by their ability to stimulate early and late 
transcription respectively) were present a pattern of retardation similar to that observed 
in figure 5.3 was observed. It is more probable then that in these experiments only the 
slowest migrating complexes are due to Sp1 -DNA interactions.
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Figure 5.3. The Effect of Increasing Protein Concentration
5ng of 32P labelled Sph \/Nco I fragment was incubated with 0, 3,6,9,12 or 15pg of 
nuclear extract in conditions described in section2.2.4.8.. Protein-DNA complexes were 
separated from free DNA on a 4% polyacrylamide gel and visualised by autoradiography 
(overnight exposure).
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5.5. Competition with Methylated and Unmethylated 
Oligonucleotides
The original strategy for studying the effect of methylation on Sp1 binding 
was to isolate a restriction fragment containing the 21 bp repeat region, methylate it using 
mouse ascites DNA methylase and study the effect on Sp1 binding.
However this approach was not feasible for two reasons: (a) DNA methylase 
does not methylate small DNA fragments with high efficiency and recovery of these small 
methylated fragments is poor, (b) Since the SV40 promoter region does not possess any 
methylation sensitive restriction enzyme sites, it is difficult to assess the extent of
methylation and the position of the methyl groups added , the only possibility being Maxam j 
and Gilbert sequencing (1980) which requires pg amounts of methylated fragment. For 
these reasons the approach was changed to using methylated oligodeoxynucleotides. 
Synthetic oligonucleotides can be produced with a 5-methylcytosine replacing a cytosine 
residue at the desired site. Hence the methyl groups added can be limited to the sites of 
interestand these DNA molecules are always 100% methylated at these sites.
Figure 5.4 shows the three oligonucleotide used. Oligonucleotide 22 contains GC 
box I and 3' flanking sequence. Oligonucleotide m22 is identical but with a 5-methyl 
cytosine residue replacing the cytosine immediately preceding the guanine in the GC box. 
Oligonucleotide m40 contains GC boxes I, II and ill all in the methylated state. The 
complementary oligonucleotides of all three were also synthesised.
GC box I was chosen because initially these oligonucleotides were used in a separate set of 
experiments (see section 6.3). These experiments involved the use of these methylated 
and unmethylated oligonucleotides as primers for complementary strand synthesis by DNA 
polymerase 1 Klenow fragment. The 3' GC box 1 flanking sequence was included to ensure
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that binding of the oligonucleotide to the template DNA was limited to GC box 1 only.
Ideally a strong Sp1 binding site such as GC box III would be used in these gel retardation 
experiments and figure 5.6. shows that oligonucleotide m40 containing GC boxes I, II and III 
has greater affinity for Sp1. ( However, in the absence of a strong binding site, Sp1 will 
bind to GC box I ).
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5.5.1. Annealing and Ligation of Oligonucleotides
Since GC boxes exist as multiple copies in SV40 and in other Sp1 sensitive 
promoters it is reasonable to assume that oligonucleotides containing more than one GC box 
would compete more efficiently for Sp1 binding than those containing only a single GC box. 
Hence, oligonucleotides were annealed, phosphorylated and ligated in conditions described 
in section 2.2.4.5. Figure 5.5.(a) shows 100% annealing of oligonucleotide 22 to its 
complementary strand. Figure 5.5(b) shows that double stranded oligonucleotides 22 and 
m22 were successfully ligated forming repeats of 1-25 units. Although, oligonucleotide 
m40 annealed to its complementary sequence, ligation was very poor. This may have been 
due to a contaminant such as phenol, inhibiting the ligation reaction. However, extraction 
with ether and reprecipitation of the oligonucleotide DNA with ethanol did not improve the 
ligation efficiency.
Figure 5.5. Annealing and Ligation of Oligonucleotides
(a) 2|ig of annealed oligonucleotide 22122s. (lane 2) were analysed on a 2% agarose gel 
with 2pg of oligonucleotide 22 and 22a (lanes 1 and 3 )
(b) 1 jug of each annealed /ligated oligonucleotide was analysed on a 2% agarose gel (lanes 
2, 4 and 6) with Hae III digested pAT153 ( Twigg and Sherratt, 1980) DNA as marker
DNA (M).
The gels were stained with ethidium bromide and the DNA visualised with U.V. irradiation.
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5.5.2.The Effect of Oligonucleotide Competition in a Gel Retardation Assay
The affinity of specifically bound protein for methylated and unmethylated GC boxes 
was compared by studying the ability of methylated and unmethylated oligonucleotides to 
compete with the labelled Sph I/ Nco I fragment from pSVC1 (see figure 5.2(a)) for 
protein binding. Annealed or ligated oligonucleotides were used in a competition gel 
retardation assay. Nuclear extract (5pg) was preincubated with of each of the 
oligonucleotides (1 OOng) at 25°C for 10 minutes. 5ng of labelled DNA fragment was 
then added and the incubation continued for a further 20 minutes before electrophoresis 
on a 4% polyacrylamide gel. The effect of methylation can be determined by comparing 
the remaining protein pool (by its ability to bind to labelled DNA fragment) after 
oligonucleotide binding.
Unfortunately competition with annealed 22mer was unsuccessful, but otherwise 
figure 5.6 (a) and (b) show that methylated and unmethylated oligonucleotides compete 
equally well for specific protein binding, indicating that cytosine methylation has no 
effect on these protein - DNA interactions. It is important to explain the origin of the 
retarded bands seen in these figures . It is clear from lane 1 that the DNA is 
heterogeneous and the slower moving band could represent some single stranded DNA 
which may have arisen as a result of excessive drying of the DNA following end labelling. 
Retardation of this material on incubation with nuclear extract probably gives rise to 
the diffuse bands as a result of nonspecific protein DNA interactions. The fact that bands 
1 and 2 are competed out with cold 22mer suggests that the protein(s) involved 
specifically bind the DNA sequence contained in these molecules. There is one proviso, 
however, since following the practice of other workers (Landolfi etal.{1986) and 
Holler etal.(1988)), the only other competitor DNA was a large excess of poly dl-dC 
which may not adopt the required conformation for optimal protein binding.
«r ik
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Figure 5.6. O ligonucleotide Competition
(a) 5ng of 32P labelled Sph \/Nco I fragment of pSVCIcwas incubated with 5pg of nuclear 
extract (with the exception of lane 1) in the presence, lanes 3-8, or absence,Iane2, of 
competing oligonucleotide in conditions described in section 2.2.4.8.. The products were 
separated on a 4% polyacrylamide gel and visualised by autoradiography.
Figure 5.6. Oligonucleotide Competition
(b) 5ng of labelled Sph \/Nco I fragment of pSVC1 was incubated with 5pg of nuclear 
extract, in the presence of 0.025,0.1,0.3,and 1 .Opg of ligated oligonucleotide 22/22a 
(lanes 3-6) or oligonucleotide m22/m22a (lanes 6-10). The products were separated on 
a 4% polyacrylamide gel and visualised by autoradiography. Lane 1 contains labelled DNA 
in identical conditions minus nuclear extract and oligonucleotides. Lane 2 contains nuclear 
extract but no competing oligonucleotides.
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5.6. The Use of labelled Oligonucleotides in a Gel 
Retardation Assay
Oligonucleotides 22a and 22b or m22a and m22b were annealed as 
described in section 2.2.4.5. and the double stranded oligonucleotides gel purified after
end labelling with [y-32P]-ATP and T4 polynucleotide kinase as described in section
2.2.4.6. Protein binding was analysed in a gel retardation assay with increasing amounts 
of nuclear extract.
Figure 5.7 shows that both unmethylated (lanes 1-5) and methylated (lanes 6-10) 
oligonucleotides bind protein with similar affinity. This suggests that cytosine 
methylation has no inhibitory effect on protein binding.
In order to determine whether the retarded bands represent the binding of sequence 
specific binding proteins to this region various types of DNA were used as competitor in 
a gel retardation assay. Figure 5.8 shows as expected the cold 22mer methylated or 
unmethylated is the most effective competitor in the reaction. p200 (described in 
section 3.4.1.) does not contain a GC box motif and, in the presence of poly dl-dC, it can 
compete for the protein only when in 50 fold excess. This shows that the retarded band 
contains a protein with a higher affinity for the SV40 promoter region than for other 
non-specific DNA. Lanes 14,15 and 16 represent the use of single stranded 22mer 
(oligo 22a, the late coding C-rich strand) at different concentrations as competitor.
This DNA is a very poor competitor indicating that the retarded material is not due to a 
single stranded DNA binding protein.
I I m  t »  v ,   P r o t e i n - D N A
c o m p l e x
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Figure 5.7. Binding of Nuclear Protein to Oligonucleotides
2ng of labelled double stranded oligonucleotide 22 or m22 were incubated with 0-20 jug 
of nuclear extract in conditions described in section 2.2.4.8. The products were 
separated on a 7% polyacrylamide gel. The gel was dried and autoradiographed (section 
2.2.1.16).
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Figure 5.8. Comparison of the Competitive Effect of Various DNAs in a Gel 
Retardation Assay
Gel retardation assays were performed using 20,000 cpm(~8ng) of end labelled 22mer, 
10pg of Hela cell nuclear extract and 1pg of poly dl-dC in conditions described in section 
2.2.4.8., in the presence or absence of competitor as indicated below. After a 30 minute 
incubation at 25°C 10pl of sample buffer containing 30% glycerol, 0.1% bromophenol 
blue in 0.5x TBE was added and the samples electrophoresed on a 7% polyacrylamide gel. 
Lane 1, no extract; lane 2, no TBE in added sample buffer; lane 3, standard assay; lane 4, 
poly dl-dC replaced by 1pg p200 with no TBE in sample buffer. Lanes 5-13 also contain 
double stranded competitor DNA as follows: lanes 5-7, p200 at 100,300 and 500ng; lanes 
8-10, oligo 22 at 25,50 and 100ng; lanes 11-13, oligo m22 at 25,50 and 100ng Lanes 
14-16, the single stranded oligo 22a (the C-rich strand of oligo22) at 25,50 and 100ng.
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There are three proteins which have been reported to bind to sequences at least 
partly contained in the 22mer: Sp1 (Dynan and Tjian, 1983), LSF(Kim etal., 1987) and 
AP1 (Mermod et at., 1988). In addition proteins such as NFI and NFlll bind to promoter 
regions of other genes and such proteins may show an intermediate affinity for the SV40 
promoter region even though there is no obvious sequence homology between their specific 
binding sequences. Oligonucleotides containing binding sites for NFI(de Vries et al.,1987) 
and NFlll (Pruijn et al.,1986)may therefore act as competitors intermediate between the 
GC box I of the 22mer and model or plasmid DNA. Furthermore an oligonucleotide 
containing GCbox III should be a better competitor than the 22mer containing GC box I.
In order to further test the binding specificity, oligonucleotides containing the 
binding sites of NFI and NFlll were used as competitors in a gel retardation assay. Figures 
5.9 (a) and (b) show that both these oligonucleotides compete with the labelled 22mers for 
protein binding. The competitive effect of these oligonucleotides was compared to that of 
the cold 22mers by excising the retarded bands from the gel and estimating the amount of 
radioactivity present by Cherenkov counting. In table 5.1. this is expressed as percentage 
competition for four separate estimations plus or minus the standard deviations. The 
results are presented graphically in figure 5.10. From these figures it appears that both 
the NFI and NFlll binding sequences compete for protein binding, although less effectively 
than the 22mer. Oligonucleotide m40 which contains GC box III, a strong Sp1 binding site 
appears to be the best competitor.
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Figure 5.9 The Competitive Effect of the NFI and NFlll Binding Sites
(a) Gel retardation assays were performed using 20,000 cpm <~8ng) of end labelled, 
double stranded o1igo22,10|jg of Hela cell nuclear extract and 1pg of poly dl-dC in 
conditions described in section 2.2.4.8. The reaction was stopped by the addition of a buffer 
containing 30% glycerol, 0.1% bromophenol blue in 0.5xTBE and electrophoresis on a 7% 
polyacrylamide gel. Lane 1 contains labelled DNA minus nuclear extract, lane 2 contains 
labelled DNA plus nuclear extract and lanes 3-17 also contain unlabelled double stranded 
competitor DNA mixed with the labelled oligo prior to addition of the extract:- lanes 
3,4,and 5 contain oligo 22 at 50,100 and 200ng respectively, lanes 6,7 and 8 contain 
oligO' n22 at 50,100 and 200ng; lanes 9,10 and 11 contain oligo m40 at 50,100 and 
200ng, Ianes12,13 and14 contain oligo NFI and lanes 15,16 and17 contain oligo NFlll also 
at 50,100 and 200ng. (Oligonucleotides NFI and NFlll were provided by Dr. R. Hay , 
University of St. Andrews)
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(b) Conditions are identical to those desribed in figure 5.9 (a) except that labelled oligo 
m22 was used in the assays. The apparently anomalous result seen in lanes 4 and 14 
was obtained when the experiment was repeated independently.
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Table 5.1 Relative Affinity of Bound Protein for Different Promoters
These figures represent the amount of retarded oligo, methylated or unmethylated, 
expressed as % of control in the absence of specific competing oligo. Standard deviations 
for 4 separate estimations are shown in parentheses.
Competing oligonucleotide
ng competitor DNA 22 m22 m40 NFI NFlll p200
10 46.7
(+/-10.6)
50 25.2 
{+1-7.0)
17.0
{+1-7.7)
15.7 
( +/-4.1)
42.7
(+/-11.2)
46
(+/-21.4)
100 20.5
(+/-6.4)
14.7
(+/-6.3)
13.0
(+/-4.5)
28.0
(+/-8.1)
41.2
(+/-17.2)
200 14.5
(+/-4.8)
8.5
(+/-1.3)
13.7 
(+/-2 .1)
16.5 
(+/-2.1)
23.0
(+/-12.1)
-70
amount(ng) required 
to give 50% 8 
competition 
(from figure 5.10)
6 3 31 40 -500
relative affinity 100
(37.5)
133
(50)
270
(100)
26
(9.7)
20
(7.5)
1.6
(0 .6)
Approximately 8ng (20,000cpm) of labelled oligonucleotide were used per assay.
Although these were qualitatively the expected results the differential binding is 
much less than expected. This could mean that under the binding conditions used Sp1 is 
less specific than in the presence of 12.5 mM MgC^ used by Kadonaga and Tjian (1986) 
for Sp1 -DNA interactions. The alternative possibility exists that the retarded band is only 
partly (or not at all) the result of Sp1 binding. If two different proteins are binding to the 
22mer one may have an affinity for any promoter region and may be competed for equally 
well by the 22mer ,NFI oligo or NFlll oligo. The other protein would be specific for the 
GCbox containing 22mer.
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It seems highly improbable that Sp1 binding is not being observed because Sp1 
retarded bands have been reported by several authors when similar GC box containing 
oligonucleotides are incubated with these Hela extracts. None of these authors however 
used promoter containing oligonucleotides in competition experiments, so these are novel 
results.
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Figure 5.10. Competition by different promoters for nuclear protein 
binding to oligo 22
Decrease in the amount of of retarded oligo22 in the presence of potential competitor
oligonucleotides (NFI •  ;NFIII A   ; 2 2 ---------- • —-------  ;
m 22-------- o  ;m 40--------- • --------- ) as shown in table 5.1.
)
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5.7. Discussion
In this chapter Sp1-containing Hela cell nuclear extracts were used to study 
the effect of methylation on protein - DNA interactions in a gel retardation assay. Although 
such extracts have been used by other workers to study Sp1-DNA interactions (Holler et 
al.,1988; Harrington et al., 1 §88)they omitted certain controls. Thus binding to the DNA 
of other "specific" or "non specific" binding proteins must be eliminated. Since specific 
and non specific are not absolute terms for DNA-protein interactions but measures of 
relative affininty of different DNAs for protein(s), varoius types of DNA ( (i) model or 
random DNA , (ii) single stranded DNA, (iii) promoter containing DNA) were used to 
distinguish them.
From figure 5.8 cold oligo 22 was a far more effective competitor thanp200 
or single stranded DNA. Both methylated and unmethylated double stranded oligo competed 
equally well indicating that cytosine methylation has no inhibitory effect on protein 
binding. Table 5.1 shows that the addition of 10ng of cold 22mer resulted in 
approximately 50% competition. Since the assay contains approximately 8ng of labelled 
22mer (estimated independently from the specific activity of the y-32P ATP used and the 
efficiency of Cherenkov counting) this implies that, cold 22mer had approximately the 
same affinity for the protein as the labelled material. However 100% competition was 
never achieved, even after the addition of 200ng of competing 22mer. The only difference 
between the labelled oligo and the competing DNA is the terminal phosphate. The 
possibility that this could in some way alter the affinity of the protein, or bind a separate 
protein was eliminated by competing with cold phosphorylated oligo. No difference in 
affinity was observed (results not shown). It is thus not known why competition by the 
22mer had reduced efficiency when in large excess .
The use of p200 as competitor DNA resulted in some affinity for the binding 
protein, even in the presence of 1jjg poly dl-dC. However, this was approximateiy
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70-100 fold weaker than that observed for the 22mer. This competing effect of p200 was 
not observed in the absence of poly dl-dC and EDTA, where the presence of 1 pg of p200 had 
no effect on complex formation, but acted to "mop up" non specific DNA binding proteins.
The presence of 12.5mM EDTA in the sample buffer eliminates some of the non specific 
binding ( compare lanes 2 and 3 , figure 5.8), presumably by those proteins requiring 
metal ions as cofactors. These results show that the proteins bind with at least 100 fold 
greater affinity for the 22mer than for the sequences contained in non promoter DNA.
When single stranded oligonucleotide 22 was used as competitor DNA, no 
competition was observed. This eliminates the possibility that the retarded material was 
due to the binding of a single strand specific DNA binding protein such as that identified by 
Gaillard et al., (1988).
However in these competition experiments double stranded oligos containing 
other promoter sites e.g. the binding site for nuclear factor I or III had an affinity for the 
protein only 2-3 fold weaker than did the 22mer. It is possible that zinc finger containing 
proteins such as Sp1 will bind to these recognition sequences in a sequence non specific 
manner and it is also possible that the conditions used for protein binding are not ideal for 
maximum specificity. This experiment should be repeated under varying conditions for 
example [Mg] and EDTA. Alternatively the retarded complex observed could represent the 
binding of two separate factors, only one of which is specific for the GC box motif. This 
could explain why less than the expected degree of specificity was obtained. The fact that 
oligo m40, containing three GC box motifs appears to be the most effective competitor 
implies that a GC box specific factor ( most likely Sp1) is involved. Sp1 is now regarded 
as a ubiquitous factor and hence is likely to be more abundant than LSF (Kim etal., 1988) 
the other factor known to bind this motif.
From the gel retardation studies presented in this chapter it appears that 
cytosine methylation has no inhibitory effect on protein binding to the SV40 promoter.
The oligonucleotides used in this study, 22 and m22 , contain GC box I. Gidoni et al.,
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(1984) have shown that GC box I is a weak Sp1 binding site compared to interaction at 
boxes III, V and VI. This weaker interaction may be more susceptible to methylation 
interference, whereas a strong Sp1 -DNA interaction may override methylation 
interference. However, this was not observed, methylation of GC box I had no inhibitory 
effect on what is interpreted to be Sp1 binding.
These findings are in accordance with those of Harrington et a /.,(1988), who 
found that both methylated and unmethylated oligonucleotides compete equally well with the 
human metallothionine HA promoter for binding to Sp1 in DNase I protection experiments.
Also, Holler et al.,(1988) using a 32bp double stranded oligonucleotide containing two 
strong Sp1 binding sites found that Sp1 bound tightly regardless of whether the central 
CpGs were methylated or not. In both these cases no attempt was made to show that Sp1 was 
the protein involved.
The effect of methylation on the binding of several transcription factors has 
been studied to date. Hoeveler and Doerfler (1987) found that a cellular factor that 
interacts upstream of the methylation sensitive Adenovirus late E2A gene binds with the 
same affinity to methylated and unmethylated promoter DNA.
In contrast, there are several examples of transacting factors that are 
sensitive to methylation. For example, Watt and Molloy (1988) in studies involving the 
Adenovirus major late promoter found that binding of the major late transcription factor 
was strongly inhibited by methylation at a CpG centrally located within the binding site. 
Whereas, methylation on only one strand caused partial inhibition of binding, the effect 
being greater when the non-coding strand was methylated. Also, Becker et a/.,(1987) 
found, using genomic sequencing, that certain CpG dinucleotides upstream of the rat 
tyrosine amino transferase gene are methylated in non-expressing cells and unmethylated 
in expressing cells. DNase I footprinting analysis revealed that in vitro methylation of 
DNA from expressing cells prevented the binding of a cellular factor to its recognition 
sequence.
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These findings suggest that DNA methylation exerts its effects by different 
mechanisms in different promoters and that not all methylation sensitive promoters 
bind methylation sensitive transcription factors. Indeed, there are at least two 
examples of transacting factors that can overcome the inhibitory effect of methylation. 
Thomson etal., (1988) have shown that a frog virus 3 induced cellular transacting 
factor allows transcription from Adenovirus promoters inactivated by methylation. 
Dobranski etal.J,1988) have shown that the inhibitory effect of methylation in the 
Adenovirus late E2A promoter can be overcome by a 289-amino acid transacting protein 
that is encoded in the E1A region of Adenovirus.
The inhibitory effect of methylation was also shown to be overcome in 
myoblast cells. Yisreali et al .,(1986), in transfection experiments found that the 
muscle specific a -  actin gene is inhibited by methylation when introduced into 
fibroblasts, but not when introduced into myoblasts. This indicates that myoblast cells 
contain the information required to recognise and activate the a -  actin gene despite the 
presence of methyl groups.
It is important to remember when drawing conclusions on the effect of 
methylation on protein-DNA interactions that the experiments discussed all involve the 
use of in vitro systems. We must consider the possibility that DNA methylation may 
affect the overall chromatin structure and hence interfere with factor binding in an 
indirect manner ( Keshet etal., (1986);Murray and Grosveld (1987)).
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Chapter 6. Alternative methods of Studying the 
Effect of Methylation on Transcription 
from the SV40 Promoter
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6.1. In  Vitro Transcription Assays
6.1.1. Introduction
The in vitro transcription assay provides a useful tool for studying the 
regulation of transcription of cloned genes. To date these assays have been used to study the 
control mechanism of a variety of genes and have been particularly useful in establishing 
the transcriptionally important motifs in promoter regions, mainly through deletion and 
mutation studies (e.g. Brady et al., 1984; Wildeman et a/.,1985). Although it is 
generally believed that an inverse relationship exists between DNA methylation and 
expression in a large number of genes, most of the evidence for this has come from DNA 
mediated gene transfer experiments (e.g. Stein et al .,1982,1983 ). There have been 
relatively few experiments involving the use of in vitro methylated genes in in vitro 
transcription assays. One such experiment was performed by Jove et al., (1984) who 
cloned long segments of poly(dC-dG) adjacent to the transcription control regions of SV40 
and Adenovirus 2. After in vitro methylation with Hha I methylase, transcription was 
assessed in a soluble in vitro system. The presence of these methyl cytosines had no affect 
on transcription. Neither did methylation at the unique Hpa II site downstream of the SV40 
late promoter. This contradicts the findings of Fradin et a l ., (1982), who found that 
methylation at this Hpa II site specifically inhibited late gene expression after 
microinjection into mouse oocytes. This may suggest that the soluble system is lacking in 
components that confer sensitivity to DNA methylation and that such components are 
distinct from those that are required for accurate transcription initiation in vitro.
Alternatively, methylation may be mediating its effect by altering chromatin formation and 
hence limiting the accessibility of target genes to the transcriptional apparatus.
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Exogenous DNA templates are packaged into chromatin in frog oocyte nuclei but not in the 
soluble in vitro system. In contrast to these findings with the SV40 promoter,
Dobranski et a l .,(1988) found that methylation of the adenovirus late E2A and major late 
promoters resulted in almost complete inhibition of transcription in an in vitro system.
These findings suggest that methylation may exert its inhibiting effect on different 
promoters in a different way. Therefore, the use of in vitro transcription assays may be 
important in discovering the mechanism by which methylation imposes its inhibitory 
effect.
6.1.2. In Vitro Transcription of pVHCI
The aim of this set of experiments was to methylate plasmid DNA in vitro using 
mouse ascites DNA methylase and study the effect this has on transcription in a soluble in 
vitro system. In chapter 4, the effect of methylation on transcription from the SV40 
promoter was studied by transfection experiments. However, transfection experiments 
require relatively large amounts of plasmid DNA (1 Ojig). Using partially purified 
mammalian methylases it is difficult to methylate such a quantity of DNA to a high degree of 
saturation. However in vitro transcription assays require only 0.1-0.5ng of template
/  <7
DNA, a quantity that can be efficiently methylated in vitro (see section 3.3).
? I
Using a cell free extract from Hela cells , prepared according to the method of 
Manley e ta l.,(1980) (see section 2.2.5.1), the plasmid pVHCI was used as a DNA template 
in a in vitro transcription assays. Transcripts were labelled by the incorporation of 
[a32P] -UTP and separated by agarose gel electrophoresis. Fig. 6.1 shows the resulting
t
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mRNA transcripts. Three separate transcripts were observed, the intensity of which 
increased with increasing template concentration. Cold RNA size markers were run 
alongside the transcripts, these were visualised by ethidium staining and U.V. irradiation.
The size of the transcripts were approximately 350, 500 and 650 nucleotides. All three 
are smaller than the expected 770 nucleotide CAT gene transcript. Unfortunately it 
appears that the same three transcripts are also produced when the promoterless p200 
construct was used template DNA. This indicates that transcription is not being initiated at 
the SV40 promoter but at some endogenous site in the pUC8 vector or within the CAT gene. 
It is obvious then, that this vector system is not suitable for this type of experiment.
Hence this line of research was discontinued.
1 66
PVHCI
Kb (ng) 100 200 300 400 500 pSVCI p200
9 .  5 ------
7 .  5 ------
Figure 6 .1. In vitro  transcription of pVHCI
pVHCI (100-500ng) lanes 1-5 was used in an in vitro transcription assay as described in 
section 2.2.5.2. In lane 6 pVHCI was replaced with pSVCI (200ng) and in lane 7, p200 
(200ng). The three major radioactive bands are present in all lanes. An incubation 
omitting the DNA produced no radioactive material on electrophoresis(results not shown).
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6.2. Cloning into M13
Another way to produce methylated plasmid for use in transcription assays, 
and a way which might circumvent the adventitious promotion observed with pVHCI is to 
use DNA cloned into M13. Since the M13 bacteriophage has the ability to produce single 
stranded DNA in addition to replicative form, it has proved to be a useful research tool in a 
wide range if areas. These include site directed mutagenesis ( Zoller and Smith, 1983) 
and DNA sequencing ( Sanger et al., 1977). Keshet et al .,(1986) found that single 
stranded recombinant M13 molecules provided a convenient way of generating 
hemimethylated DN A. Using single stranded M13 DNA as a template molecule, a short 
single stranded primer could be annealed and the complementary strand of DNA synthesised 
by the Klenow fragment of DNA polymerase I. Replacing deoxycytidinetriphosphate (dCTP) 
with deoxy- methylcytidine triphosphate (mdCTP) meant that the DNA was 
hemimethylated at every cytosine in the sequence. The unmethylated strand could then be 
methylated using mammalian methylases either in vitro or In vivo after introduction into 
tissue cultured cells (since hemimethylated DNA is the preferred substrate for these 
enzymes), and used in transcription studies.
In order to use this approach in studying the SV40 promoter, the 601 bp Kpn I /
Eco Rl fragment of pVHCI containing the SV40 enhancer and 21 bp repeat region, and the 
2107bp Kpn I / Eco Rl fragment of pVHCI containing the SV40 enhancer and promoter,
CAT gene and SV40 terminator sequence were cloned into M13 mp19. Recombinant M13 
molecules were analysed for the presence of insert by restriction digestion (results no 
shown), and by T. tracking (section 2.2.6.7.). The complementary strand of these single 
stranded recombinant molecules could then be synthesised as described above (details in
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section 2.2.6.8) in the presence or absence of mdCTP. This DNA could then be used in in 
vitro transcription and transfection studies.
It was also intended to use such constructs to study the effect of methylation
on transcription factor binding in gel retardation assays by using the approach outlined in
Fig. 6.2. The M13 sequencing primer was annealed to the template just upstream of the
| dTTP, dGTP,
insert, the second strand was synthesised as described above, in the presence o ^C T P  or 
mdCTP and [a -32P]-dATP. The SV40 promoter region was then isolated by digestion with 
the appropriate restriction enzymes and the fragments separated by polyacrylamide gel 
electrophoresis (see section 2.2.6.7.). However a major problem encountered was the 
failure of restriction enzymes to cleave DNA with a high methyl cytosine content (fig. 6.3).
The high cytosine content of the SV40 promoter meant that restriction enzymes such as Nco 
I cleaved the hemimethylated DNA with very poor efficiency, which led to very low yields of 
methylcytosine containing restriction fragment. This problem could be partially 
alleviated by 'filling in' with a 1:1 or 2:1 ratio of dCTP:mdCTP. Preliminary studies 
indicated that protein DNA interactions still occurred in the presence of 50% methyl 
cytosine.
Synthetic oligonucleotides containing 5-methylcytosine were synthesised 
for use as primers. The sequence of these oligonucleotides were complementary to GC box I „ 
, or I,II and III of the SV40 promoter. Substitution of these molecules for the universal 
primer in the above experiment produced molecules methylated at these sites only.
However, since the use of these oligonucleotides in gel retardation assays involving 
competition with the labelled Sph I/Nco I fragment of pSVCI revealed that the presence of 
5-methylcytosine had no effect on binding (presented in chapter 5), these 'fill in' 
experiments were discontinued.
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6.2.1. The Use of M13 Recombinant Molecules in Transfection Studies
Unfortunately the synthesis of sufficient double stranded DNA for transfection 
assays (1 Ojig) proved to be very difficult and this approach was abandoned and replaced by 
the synthesis of gap duplex molecules. This involves the annealing of two single stranded 
molecules: the M13 recombinant and a linearised non recombinant molecule. This 
produces a duplex molecule with a single stranded "window" at the position of the insert. 
The second strand of this region can be synthesised in the presence or absence of mdCTP. 
Alternatively, this single stranded region can be methylated using mammalian methylase 
(Adams et a / .,(1989) found that only single stranded DNA is methylated in the presence of
0.1 M NaCI.). It can then be made double stranded (using Klenow fragment), creating a 
hemimethylated region, which itself is the preferred substrate for DNA methylase. This 
gap duplex approach allows for region specific methylation of the SV40 promoter, the 
transcription initiation sites, and the CAT gene, and is important for determining which 
CpG's or CpG containing regions are required to be methylation free for efficient 
transcription to occur. These experiments are currently being continued in our 
laboratory.
t
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Figure 6.2. Use of M13 Recombinants in Gel Retardation Assays
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Figure 6.3. Isolation of Hemimethylated Restriction Fragments
Labelled restriction fragments were separated on a 8% polyacrylamide gel
(a) lane 1 Sph I / Nco I digest of DNA filled-in with dCTP
lane 2 Sph I/ Nco I digest of DNA filled-in with mdCTP
(b) lane 1 Sph I/ Nco I digest of DNA filled-in with a 1:1 ratio of dCTP:mdCTP
lane 2 Sph I/Nco I digest of DNA filled-in with dCTP
Both gels were autoradiographed with a 4 minute exposure time. In gel (a) the radioactive 
bands in lane 2 were visible after a longer exposure (several hours)
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Chapter 7. Discussion
\
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The results presented in Chapter 4 show that relatively low levels (10-25%) 
of methylation lead to inhibition of transcription from the SV40 early promoter.
Assuming an even distribution of methyl groups this level of saturation would result in 
only one to two of the ten or so CpG dinucleotides in the promoter region being methylated. 
Since there are six Sp1 binding sites in this region, each containing a CpG, on average at 
least four of these would remain unmodified. Hence it is unlikely that the inhibitory effect 
of methylation is due to inhibition of transcription factor binding to the GC boxes or indeed 
to any other site. It is more likely that it is due to methylation -induced formation of an 
altered chromatin state after the plasmid DNA has been introduced into mouse cells. This 
would suggest that the SV40 promoter is one of a group including the 7A.g|0bin (Murray 
and Grosveld) and HSV thymidine kinase (Keshet et a/.,1986 ,Ben Hatter and 
Jiricny,1988) genes, where it has been shown that the down regulatory effect of 
methylation is mediated via formation of inactive chromatin.
In order to establish which regions in the SV40 promoter containing 
construct are important for this inhibitory effect it is necessary to devise a system for 
carrying out region specific methylation . Murray and Grosveld (1987) investigated 
which of the six CpG s in the yA-giobin promoter were important for inhibition by 
methylation. Using mutation studies they found that both the three sites upstream of the 
cap site and the three sites downstream were required to be unmethylated for transcription
i.e the region between residues +92 and -210 in the promoter was required to be 
methylation free for expression of this gene by ubiquitous factors. It would be 
instructive to carry out such a study on the SV40 promoter region but since none of the 
CpGs lie in sequences methylated by prokaryotic methylases it is not possible to perform 
site directed methylation by this method. However methylation of specific regions of DNA
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can be achieved using gap duplex molecules. The preparation of these molecules is outlined 
in chapter 6 and involves cloning the SV40 promoter-CAT gene restriction fragment into 
M13 and annealing linearised vector DNA to the single stranded form of this recombinant, 
thus creating a single stranded window where the insert lies. If, in place of linearised 
vector, recombinant molecules containing inserts with specific deletions are used a range 
of molecules with different positions and lengths of single stranded window can be 
generated. The single stranded regions can then be preferentially methylated using mouse 
ascites cell DNA methylase. They could then be converted to the double stranded form 
using the Klenow fragment of DNA polymerase I, and used in transfection studies. Using 
this method one can study the importance of the CpGs in the promoter, transcription 
initiation site, CAT gene and vector sequences in conferring this transcription inhibition by 
methylation.
Consistent with the mechanism of transcription inactivation proposed above 
the results presented in chapter 5 indicate that the binding of Sp1 is unaffected by 
methylation. This has also been observed by Harrington et a/.,(1988)and Holler et 
al.,{1988). However studies on the effect of methylation on the binding of several other 
transcription factors revealed that methylation can interfere with binding. Such factors 
include the adenovirus major late transcription factor (MTLF) (Watt and Molloy,1988) 
and a cellular factor that binds upstream of the tyrosine aminotransferase gene promoter 
(Becker et al.,i9S7). Studying the effect of methylation on protein-DNA interactions in 
a range of genes may reveal a relationship between those genes that bind methylation 
sensitive factors and those that bind methylation insensitive factors. It is possible that, in 
vivo, ubiquitous factors that are involved in the transcription of many genes, such as Sp1, 
will be methylation insensitive; whereas tissue specific factors will be methylation
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sensitive, allowing only those genes with the appropriate methylation pattern to be 
transcribed.
Iguchi-Ariga and Schaffner (1989) compared the effect of methylation on two 
factors -the ubiquitous Sp1 and a factor that binds to the cAMP response element (CRE). 
This sequence motif has been identified in the 5' flanking regions of various cell-type 
specific genes, including hormone coding and viral genes. They found that this sequence 
element was methylation sensitive both "in vivo", in a transient expression assay, and in 
vitro in a cell free transcription system. Using gel retardation assays they found that the 
protein factor(s) that bind to this region were methylation sensitive. These findings 
indicate that the inhibitory effect of methylation in this cell type specific gene is not due to 
the disruption of chromatin since this effect is present in in vitro transcription assays 
which do not involve the formation of chromatin structures prior to transcription. It 
appears that, in these genes, methylation inhibits transcription by preventing the binding 
of cAMP induced transcription factor(s).
Another example of this type of inhibition is found in the adenovirus 2 late 
E2A gene promoter and major late promoter where methylation of Hpa II and Hha I sites in 
the promoters inhibited transcription in a cell free transcription system as well as in 
transfection assays. However footprinting analysis on the E2A promoter revealed that 
binding of specific factors was not inhibited by methylation. However it is conceivable 
that even though these host proteins bound to methylated DNA their activity may be altered 
in the presence of methyl groups.
In contrast Holler etai., (1988) found that methylation of a GC box 
upstream of the (3-globin gene had no effect on transcription in a cell free system. This is 
consistent with the argument that the inactivation by methylation in SV40 is due to
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altered chromatin formation as opposed to the direct inhibition of transcription factor 
binding.
One could propose, that house keeping genes are not under the control of 
methylation in vivo. Although methylation of several of these genes in vitro results in 
transcriptional inhibition, in vivo these genes would be unmethylated and constitutively 
expressed in all cells. This constitutive expression would be regulated by CpG islands 
upstream of these genes which are characteristically methylation free. It has been 
proposed that during development these sequences would be maintained in an unmethylated 
state by the binding of Sp1 (Holler et a/.,1988) which would prevent de novo methylation 
of these sites. Alternatively, since these islands can be up to 2 kilobases in size 
methylation may be discouraged by formation of an altered DNA structure induced by the 
high G+C content of the DNA or by the binding of a stage specific factor. On the other hand, 
tissue-specific expression of genes requires further fine tuning of the transcription 
control mechanisms which involve the establishment of site specific methylation patterns. 
Each methylcytosine in promoter regions may act independently by inhibiting the binding 
of sequence specific factors or a group of methylcytosines may act together to create an 
inactive stretch of chromatin.
An alternative theory is that methylation acts as a secondary mechanism of 
inactivation. It is possible that genes are initially silenced by other mechanisms which 
then recruit methylation as a back up system to ensure that the gene remains in an inactive 
state possibly by the formation regions of condensed inactive chromatin.
From the experiments discussed here it is clear that it is beneficial to study 
the effect of methylation on the activity of a promoter using more that one method. DNA 
mediated gene transfer experiments such as transfection assays and microinjection into
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cell nuclei result in the exogenous DNA being packaged into chromatin before expression. 
These systems mimic the| in vivo\system most closely and allow the effect of methylation 
on chromatin formation to be studied. Comparing these experiments with cell free in vitro 
transcription assays which do not involve the formation of chromatin prior to 
transcription can provide insight into the mechanism of methylation inactivation in a given 
gene. For example, Fradin et a l ., (1982) showed that in oocyte microinjection 
experiments, methylation of the single Hpa II site in SV40, located near the 5' region of 
the late gene specifically repressed late gene expression. However this effect was not 
observed in an in vitro transcription assay using Hela cell extracts (Jove et a/.,1984). 
Similarly, while Holler et a / .,(1988) found that in an in vitro transcription assay, 
methylation of a GC box inserted upstream of the p-globin gene had no effect on expression, 
when the same sequence was inserted upstream of the HSVf/c gene and used in Xenopus 
oocyte injection experiments, a 20 fold inhibition was observed (Ben-Hatter and 
Jiricny,1988). These results indicate that the down regulatory effect of methylation is 
brought about by a change in the chromatin assembly, rather than through a direct 
interference with the binding of transcription factors. This latter possibility has been 
studied in several systems using gel retardation or DNAase I footprinting assays on cloned 
genes. These assays provide a convenient method for analysing protein - DNA interactions 
and the possible effects of methylation. However,in these systems one is observing an all 
or nothing effect and the possibility that methylation results in a partial inhibition of 
binding cannot be accurately studied. Similarly the possibility that methylation allows 
factor binding but not activity, as proposed for the adenovirus E2a gene (Hoeveler and 
Doerfler,1987),would not be apparent from these studies.
When performing the above types of experiments to study the effect of
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methylation on transcription of a cloned gene it must be remembered that the results 
obtained in vitro may not necessarily mimic the in vivo situation. This is also true for 
the correlation of restriction enzyme-derived methylation patterns of cloned genes and 
their expression. However this problem has been largely overcome by the use of genomic 
sequencing. Using this technique all methylcytosines within a gene can be located and the 
involvement of these sites in specific factor binding can be studied using in vivo 
footprinting. These experiments should in time provide definitive evidence for the 
involvement of methylation in the transcription of eukaryotic genes and the role of 
methylation in specific and non specific protein binding.
Most of the in vitro methylation experiments performed to date have 
involved the use of bacterial methylases, such as Hpa II and Hha I methylase. Their major 
disadvantage is that their use is restricted solely to those genes which contain the 
methylase recognition sites in their 5' flanking regions. The binding sequences for several 
important transcription factors such as Sp1, CTF, AP-1 and AP-2, do not contain such 
sites. In recent years synthetic oligonucleotides containing m5C have provided a 
convenient way of studying the effect of methylation on the binding of these factors.
Ideally, all methylation sites within the control and coding regions of a gene should be 
studied in vitro, however this could prove difficult and very expensive using synthetic 
oligonucleotides and will only be achieved on the purification of sufficient quantities of a 
pure and stable mammalian DNA methyltransferase.
Although the effect of methylation on the expression of many genes has been 
studied to date, it is still not known where methylation fits into the complex multilevel 
control system of gene regulation. This understanding may be aided by further studies on 
the effect of methylation on the interaction with DNA of the large number of specific factors 
that have recently been identified as being involved in the transcription of eukaryotic 
genes.
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